daunorubicin has been researched along with Leukemia in 569 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 392 (68.89) | 18.7374 |
| 1990's | 58 (10.19) | 18.2507 |
| 2000's | 64 (11.25) | 29.6817 |
| 2010's | 45 (7.91) | 24.3611 |
| 2020's | 10 (1.76) | 2.80 |
| Authors | Studies |
|---|---|
| Fischer, AS; Kersh, AE; Rosenbach, M; Shields, BE; Torre, EA; Xu, X | 1 |
| Cabot, MC; Claxton, DF; Coalson, HS; Feith, DJ; Fisher-Wellman, KH; Fox, TE; Hagen, JT; Kao, LP; Kassai, M; Kester, M; Loughran, TP; McLaughlin, KL; Nelson, MAM; Tan, SF | 1 |
| Abodo, LO; Baas, J; Frias, C; Frias, J; Jakupec, MA; Keppler, BK; Prokop, A; Wilke, NL | 1 |
| Chen, X; Gao, XH; Hao, HL; Huang, C; Li, J; Li, JY; Li, Y; Liu, JY; Tu, CQ; Wang, DW; Wang, RC; Xiong, X; Yang, J; Yang, YB; Yuan, J; Zhang, XX; Zhang, XY; Zheng, CF; Zou, LL | 1 |
| Chen, J; Zhang, W; Zhu, Y | 1 |
| Alexander, TB; Galeotti, J; Hucks, G; Sperlazza, J | 1 |
| Fang, J; Kong, Q; Li, X; Li, Y; Liang, Q; Xie, J | 1 |
| Cerchione, C; Martinelli, G | 1 |
| Al-Aamri, HM; Bradley, C; Irving, HR; Meehan-Andrews, T | 1 |
| Liu, J; Wang, Y; Yang, L; Yao, Q; Zhang, L | 1 |
| Bai, H; Jiang, J; Qin, Y; Shao, S; Wang, C; Wang, X; Xu, X; Zhao, C; Zhou, L | 1 |
| Hu, R; Jiang, B; Liu, Z; Yang, Y; Zhu, K | 1 |
| Berkessel, A; Dragoun, M; Frias, C; Günther, T; Prokop, A | 1 |
| Benchimol, S; Kazakova, L; Ma, W; Miller, D; Pham, TD | 1 |
| Chen, Y; Gao, XF; Li, H; Mao, SJ; Wang, HJ; Wang, JW; Xiang, HL | 1 |
| Chen, BA; He, YJ; Jin, JF; Niu, YQ; Zhang, W | 1 |
| Klingebiel, T; Schrappe, M | 1 |
| Li, SZ; Liu, QG; Mi, YC; Wu, LH; Xu, N; Zhao, X | 1 |
| Chow, EK; Ho, D; Kim, H; Kim, HJ; Liu, WK; Man, HB; Robinson, E | 1 |
| Inoue, M; Kojima, T; Minami, Y; Mizutani, N; Murate, T; Naoe, T; Nishida, Y; Nozawa, Y; Ohnishi, K; Omori, Y; Suzuki, M; Takagi, A; Tamiya-Koizumi, K | 1 |
| Bai, H; Qin, Y; Wang, C; Wei, D; Xu, X; Zhou, L | 1 |
| Li, Y; Liao, A; Liu, Z; Wu, B; Xing, H; Yang, W; Yao, K; Zhang, R | 1 |
| Benabbou, N; Bordu, C; Faussat, AM; Marie, JP; Mirshahi, M; Mirshahi, P; Soria, J; Tang, R; Therwath, A | 1 |
| Gong, Y; Naren, D; Shi, F; Shi, R; Wu, J; Yang, X | 1 |
| Ma, J; Tang, W; Zhang, X; Zhang, Y | 1 |
| Bhuiyan, H; Broom, OJ; Islam, S; Lehtiö, J; Lindahl, A; Linnarsson, S; Nordström, A; Stäubert, C; Zhu, Y | 1 |
| Cai, XH; Chen, BA; Cheng, J; Dai, L; Fu, R; Gao, C; Guo, QL; Wang, F; Xia, GH; Zhang, XP; Zhu, H | 1 |
| Byrd, JC; Castro, CE; Halley, PD; Kural, C; Lucas, CR; Lucas, DM; McWilliams, EM; Patton, RA; Webber, MJ | 1 |
| Bhuiyan, H; Broom, O; Krakowsky, R; Lindahl, A; Nordström, A; Stäubert, C; Witek, B | 1 |
| Abnous, K; Danesh, NM; Emrani, AS; Hassanabad, KY; Lavaee, P; Ramezani, M; Taghdisi, SM | 1 |
| Chang, Y; Han, WL; Li, JL; Li, LF; Li, T; Qian, QJ; Ruan, GR; Wu, HP; Yao, QM; Zhou, J | 1 |
| Behan, JW; Heisterkamp, N; Ji, L; Mittelman, SD; Parmentier, JH; Sheng, X; Tucci, J | 1 |
| Bécsi, B; Erdodi, F; Gergely, P; Kiss, A; Lontay, B; Márkász, L; Oláh, E | 1 |
| Chen, B; Guo, D; Jiang, H; Li, Q; Wang, X; Wu, C | 1 |
| Jin, J; Jones, AT | 1 |
| Bayet, C; Darbour, N; Di Pietro, A; Dijoux-Franca, MG; Doreau, A; Dumontet, C; Guilet, D; Nguyen, VT; Phung, BH; Raad, I | 1 |
| Chen, BA; Chen, NN; Cheng, J; Dai, YY; Deng, XJ; Ding, JH; Gao, C; Gao, F; Shen, HL; Sun, Q; Sun, YY; Wang, J; Wang, XM; Xu, WL; Zhang, RY; Zhao, G | 1 |
| Chen, B; Guo, D; Hu, H; Li, X; Wang, X; Wu, C | 1 |
| Diao, S; Liu, H; Rao, Q; Wang, J; Wang, M; Xing, H; Zhang, X | 1 |
| Chen, BA; Chen, WJ; Cheng, J; Ding, JH; Gao, C; Gao, F; Lai, BB; Li, GH; Li, XM; Liu, LJ; Sun, XC; Wang, XM; Xu, WL | 1 |
| Chen, B; Chen, N; Chen, W; Cheng, H; Cheng, J; Ding, J; Gao, C; Gao, F; Li, G; Li, X; Liu, L; Shen, H; Shen, M; Sun, Q; Sun, X; Wang, X; Xu, W | 1 |
| Chen, B; Chen, N; Chen, W; Cheng, H; Cheng, J; Ding, J; Gao, C; Gao, F; Li, G; Li, X; Liu, L; Shen, H; Sun, Q; Sun, X; Wang, X; Wu, Y; Xu, W | 1 |
| Csík, G; Hudecz, F; Magyar, A; Miklán, Z; Orbán, E; Schlosser, G | 1 |
| Hou, KZ; Liu, YP; Qu, XJ; Teng, YE; Yang, XH; Zhang, JD; Zhang, Y | 1 |
| Chai, YH; Lü, H; Sun, YN; Xu, YJ | 1 |
| Adamson, PC | 1 |
| Akutsu, M; Furukawa, Y; Izumi, T; Kano, Y; Mano, H; Miyawaki, S; Tanaka, M; Tsunoda, S; Yazawa, Y | 1 |
| Chan, TH; Davenport, A; Dou, QP; Frezza, M; Ge, Y; Huo, C; Shen, M | 1 |
| Keating, A; Wang, XH; Williams, BA | 1 |
| Jiang, H; Li, Q; Lv, G; Selke, M; Shi, L; Wang, X; Wu, C; Zhao, J; Zhou, Y | 1 |
| Ishigatsubo, Y; Kanamoari, H; Maruta, A; Tachibana, T; Takasaki, H; Tanaka, M | 1 |
| Batey, RA; Datti, A; Fonseca, SB; Gronda, M; Hurren, R; Kelley, SO; Minden, MD; Schimmer, AD; Sharmeen, S; Skrtic, M; Sukhai, MA; Sun, H; Wang, X; Ward, R; Wood, TE; Wrana, J | 1 |
| Asano, S; Funayama, K; Murai, F; Nomura, H; Shimane, M | 1 |
| Cho, SY; Huh, J; Jun, KR; Kim, B; Kim, HR; Kim, MJ; Lee, JN; Lee, JY; Oh, SH; Park, TS; Shin, JH; Song, SA | 1 |
| Hu, M; Jiang, H; Xia, M | 1 |
| Gust, R; Henze, G; Hille, A; Jesse, P; Kitanovic, I; Lee, SY; Prokop, A; Wölfl, S | 1 |
| Bai, H; Cao, Z; Wang, C; Wei, D; Xu, R | 1 |
| Cen, JN; Dai, L; Liu, YH; Ruan, CG; Shen, WH; Wang, ZY; Zhang, W | 1 |
| Bao, W; Chen, B; Cheng, J; Ding, J; Gao, C; Gao, F; Sun, Y; Wang, J; Wang, X; Xia, G; Yin, L; Zhao, G | 1 |
| Chen, B; Jiang, H; Sun, F; Wang, H; Wang, X; Zhang, H; Zhao, J | 1 |
| Cai, X; Chen, B; Chen, J; Chen, P; Liu, R; Wang, J; Wang, X; Xia, G; Zhang, Y | 1 |
| Chen, B; Jiang, H; Wang, H; Wang, X; Zhang, H; Zhao, J | 1 |
| Gong, YP; He, GC; Lin, J | 1 |
| Belinka, BA; Gupta, A; Kachlany, SC; Le, A | 1 |
| Cai, X; Chen, B; Cheng, J; Liu, R; Wang, J; Wang, X; Xia, G | 1 |
| Bao, W; Cai, X; Chen, B; Cheng, J; Liu, R; Ren, Y; Wang, J; Wang, X; Xia, G | 1 |
| Gong, Y; Shan, Q; Yang, X; Zheng, B; Zhou, R | 1 |
| Brønstad, K; Døskeland, SO; Gausdal, G; Genieser, HG; Huseby, S; Keen, TJ; Kjærland, E; Kleppe, R; Krakstad, C; Kunick, C; Myhren, L; Schwede, F | 1 |
| Chiarella, MT; Feldman, EJ; Kolitz, JE; Lancet, JE; Liboiron, BD; Louie, AC; Mayer, LD; Swenson, CE; Trang, JM | 1 |
| Chauvier, D; Kegelaer, G; Manfait, M; Morjani, H | 1 |
| Ono, R | 1 |
| Boldt, S; Dartsch, DC; Kolch, W; Marquardt, H; Schaefer, A | 1 |
| Bezombes, C; Jaffrézou, JP; Laurent, G; Lerouge, S; Terrisse, AD | 1 |
| Bezombes, C; Demur, C; Filomenko, R; Hernandez, H; Jaffrézou, JP; Laurent, G; Maestre, N; Mas, VM; Plo, I; Quillet-Mary, A | 1 |
| Dabadghao, S; Gupta, M; Naik, S; Pandey, CM | 1 |
| Liu, Z; Xiao, J; Zou, P | 1 |
| Barge, RM; Honders, MW; Spoelder, HE; Veuger, MJ; Willemze, R | 1 |
| Abe, K; Nakajima, A; Ohyashiki, JH; Ohyashiki, K; Sashida, G; Sumi, M; Tauchi, T; Yamamoto, K | 1 |
| Garnier-Suillerot, A; Haj, HT; Kozlowski, H; Priebe, W; Salerno, M | 1 |
| Chen, FY; Han, JY; Ou-Yuang, RR; Shao, NX; Wang, T | 1 |
| DUBOST, M; GANTER, P; MARAL, R; NINET, L; PINNERT, S; PREUDHOMME, J; WERNER, GH | 2 |
| Ahmad, KA; Clement, MV; Hanif, IM; Pervaiz, S | 1 |
| Kimura, S; Kuroda, J; Maekawa, T; Nogawa, M; Ottmann, OG; Sato, K; Segawa, H; Yuasa, T | 1 |
| Ataullakhanov, FI; Garmaeva, TTs; Isaev, VG; Parovichnikova, EN; Savchenko, VG; Skorokhod, OA; Vitvitsky, VM | 1 |
| Agazzi, A; Bertolini, F; Calabrese, L; Cinieri, S; Cocquio, A; Goldhirsch, A; Laszlo, D; Martinelli, G; Pruneri, G; Rabascio, C | 1 |
| Chen, FY; Gu, CH; Han, JY; Ouyang, RR; Teng, Y; Wang, C; Zhong, H; Zhong, JH | 1 |
| Bainbridge, T; Cherrington, JM; Heinrich, MC; McGreevey, L; O'Farrell, AM; Schittenhelm, M; Town, AR; Yee, KW | 1 |
| Chen, FY; Han, JY; Ouyang, RR; Teng, Y; Wang, T; Zhong, JH | 1 |
| Cai, Y; Feng, W; Han, ZC; Liu, P; Lu, S; Peng, Z; Wang, Y; Xiao, Z | 1 |
| Chervontseva, AM; Romanov, IuA; Savchenko, VG | 1 |
| He, Y; Jiang, X; Ma, Y; Song, Z; Wang, S; Zhu, J | 1 |
| Seiter, K | 1 |
| Chen, XH; Kong, PY; Li, ZJ; Peng, XG; Teng, BX; Wang, JG; Yang, ZZ | 1 |
| Lei, HY; Xiao, XB; Zhao, XL | 1 |
| Barbier, M; Boutonnat, J; Morjani, H; Muirhead, KA; Ronot, X | 1 |
| Barbier, M; Bignon, J; Boutonnat, J; Colle, PE; Faussat, AM; Marie, JP; Ronot, X; Thierry, J; Wdzieczak-Bakala, J | 1 |
| Burnelli, R; Cesaro, S; Comis, M; d'Amore, ES; Garaventa, A; Giuliano, M; Moleti, ML; Pillon, M; Rosolen, A; Tamaro, P; Tettoni, K; Visintin, G; Zanesco, L | 1 |
| Aoun, M; Beguin, H; Georgala, A; Husson, M; Meuleman, N; Nolard, N; Vekemans, M | 1 |
| Chen, B; Dai, Y; Fu, D; Gao, F; Guan, Z; Gutmann, S; Li, J; Li, X; Lv, G; Song, M; Wang, X; Wu, C; Zhang, R | 1 |
| Barge, RM; de Vries, JF; Falkenburg, JH; Heemskerk, MH; Jedema, I; Nijmeijer, BA; van Dreunen, L; Wammes, LJ; Willemze, R | 1 |
| Gong, YP; Gu, L; Liu, T; Xi, YM | 1 |
| Chen, H; Han, W; Huang, XJ; Liu, DH; Liu, KY; Xu, LP | 1 |
| Hu, XF; Li, J; Vandervalk, S; Xing, PX; Yang, E | 1 |
| Ainoon, O; Cheong, SK; Fazlina, N; Hamidah, H; Hamidah, NH; Jamal, R; Maha, A; Zarina, AL; Zulkifli, SZ | 1 |
| Bandobashi, K; Ikezoe, T; Koeffler, HP; Komatsu, N; Kuwayama, Y; Nishioka, C; Taguchi, H; Taniguchi, A; Tasaka, T; Togitani, K; Yang, J; Yokoyama, A | 1 |
| Bruserud, Ø; Døskeland, SO; Gausdal, G; Gevaert, K; Gjertsen, BT; Hovland, R; Krakstad, C; McCormack, E; Van Damme, P; Vandekerckhove, J | 1 |
| Banno, Y; Furuhata, A; Gao, S; Ito, H; Ito, Y; Kimura, A; Kojima, T; Murakami, M; Murate, T; Nakamura, M; Nemoto, S; Nozawa, Y; Sobue, S; Suzuki, M; Takagi, A | 1 |
| Steuber, CP | 1 |
| Bloomfield, CD; Coleman, M; Gottlieb, AJ; Greenberg, MS; Peterson, BA | 1 |
| Chard, RL | 1 |
| Kawamura, S; Maekawa, I; Miyake, T; Sasaki, H | 1 |
| Gehan, EA | 1 |
| Baroni, MC; Butturini, U; Crotti, G; Delsignore, R; Mineo, F | 1 |
| Arimori, S; Nagao, T | 1 |
| de Alarcón, P; Mazur, EM; Miceli, L; South, K | 1 |
| Blume, KG; Fahey, JL; Farbstein, MJ; Findley, DO; Forman, SJ; Hecht, T; Krance, RA; Nademanee, AP; Scott, EP; Spruce, WE; Wolf, JL; Zaia, JA | 1 |
| Begg, CB; Bennett, JM; Bonner, H; Glick, JH; Kahn, SB; Mazza, JJ | 1 |
| Cassileth, PA | 1 |
| Hoagland, HC; Kiely, JM; Letendre, L | 1 |
| Wiernik, PH | 4 |
| Riggs, CE | 1 |
| Carter, SK | 1 |
| Burke, PJ; Karp, JE; Vaughan, WP | 3 |
| DeGregorio, MW; Holleran, WM; Linker, CA; Macher, BA; Wilbur, JR | 1 |
| Azarnia, N; Preisler, HD | 1 |
| Amaki, K | 1 |
| Horiuchi, A; Tsubaki, K | 1 |
| Abakumov, EM; Faĭnshteĭn, FE; Isaev, VG; Kovaleva, LG | 1 |
| Hattori, M; Hayashi, Y; Honda, T; Sampi, K | 1 |
| Lambertenghi-Deliliers, G; Maiolo, AT; Pacciarini, MA; Pogliani, E; Polli, EE | 1 |
| Gustavsson, A; Mitelman, F; Olofsson, T; Olsson, I | 1 |
| Carde, P; Chahine, G; Hayat, M; Hurteloup, P; Kamioner, D; Parmentier, C; Pico, JO; Schlumberger, M | 1 |
| Brincker, H; Drivsholm, A; Ellegaard, J; Freund, L; Jensen, KB; Jensen, MK; Nissen, NI; Pedersen-Bjergaard, J | 1 |
| Goldberg, J; Theodorakis, ME | 1 |
| Hiyoshi, Y; Kato, H; Ota, M; Suzuki, K; Tanaka, T; Yoshioka, F | 1 |
| Hulhoven, R | 1 |
| Moriyama, Y; Sanada, M | 1 |
| Ceranić, LJ; Cvetković, P; Jovanović, I; Simeunović, S | 1 |
| Saito, Y; Uzuka, Y | 1 |
| Begg, CB; Bennett, JM; Bozdech, M; Cassileth, PA; Glick, JH; Kahn, SB; Weiler, C | 1 |
| Cuttner, J; Dimitriu-Bona, A; Najfeld, V; Seremetis, S; Winchester, RA | 1 |
| Horiuchi, A; Kawagoe, H; Kitani, T; Masaoka, T; Shibata, H; Shinohara, Y; Taniguchi, N; Tsubaki, K; Tsubakio, T; Yonezawa, T | 1 |
| Herzig, RH; Lass, JH; Lazarus, HM; Reed, MD | 1 |
| Bishop, JF; Mathews, JD; Paton, CM; Whiteside, MG | 1 |
| Jehn, U; Wilmanns, W | 1 |
| Bloomfield, CD; Peterson, BA | 3 |
| Jouanne, M; Maral, RJ | 1 |
| Marinello, MJ; Pothier, L; Preisler, HD; Reese, PA | 1 |
| Mantel, N | 1 |
| Braine, HG; Markman, M; Vaughan, WP | 1 |
| Aoyagi, A; Fujiwara, M; Fuse, I; Hanano, M; Hattori, A; Hirosawa, H; Kashimura, M; Kishi, K; Koike, T; Koyama, S; Miura, R; Moriyama, Y; Nagayama, R; Ohnishi, M; Sakai, C; Sanada, M; Shibata, A; Shinada, S; Takahashi, M; Takai, K; Urushiyama, M | 1 |
| Bhaduri, S; Heimpel, H; Hoelzer, D; Krieger, D; Kubanek, B; Kurrle, E; Vanek, E | 1 |
| Loth, H; Seeber, S | 1 |
| Fülle, HH; Koeppen, KM; Rühl, H; Schwerdtfeger, R | 1 |
| Benjamin, RS | 2 |
| Bloomfield, CD; Kennedy, BJ; Peterson, BA; Theologides, A | 1 |
| Blum, RH; Muggia, FM; Wernz, JC | 1 |
| Boiron, M; Gisselbrecht, C; Jacquillat, C; Marty, M; Weil, M | 1 |
| Beswick, W; Chesterman, CN; Firkin, FC; Garson, OM; Januszewicz, E; Keating, MJ; Penington, DG | 1 |
| Carrera, CJ; DeGregorio, MW; Klock, JC; Wilbur, JR | 1 |
| Hamami, T; Haruyama, H; Ijichi, H; Isemura, T; Katsume, H; Nakagawa, M; Nakanishi, S; Nisio, A; Shimazaki, C | 1 |
| Adachi, T; Endo, Y; Fujimoto, S; Hara, M; Kimura, I; Kitajima, K; Kohi, F; Lai, M; Oda, Y; Ohmoto, E; Sanada, H; Takahashi, I; Takaoka, K; Tokioka, M; Uchida, K; Watanabe, S; Yorimitsu, S | 1 |
| Dabich, L | 1 |
| Myers, CE; Ozols, RF; Young, RC | 1 |
| Cheever, MA; Farewell, VT; Fefer, A; Glucksberg, H; Sale, GE; Thomas, ED | 1 |
| Björkholm, M; Christenson, I; Engstedt, L; Gahrton, G; Hast, R; Holm, G; Killander, A; Lantz, B; Lockner, D; Lönnqvist, B; Mellstedt, H; Oberg, G; Palmblad, J; Paul, C; Peterson, C; Simonsson, B; Stalfelt, AM; Udén, AM; Wadman, B | 1 |
| Shibata, A; Takahashi, M | 1 |
| Bono, VH; Weiss, RB | 1 |
| Layard, M; Von Hoff, DD | 1 |
| Andreeff, M; Büchner, T; Clarkson, BD; Hiddemann, W; Melamed, MR | 1 |
| Amare, M; Goodwin, JW; Maloney, TR; Morrison, FS; Park, CH | 1 |
| Bodey, GP; Freireich, EJ; Gehan, EA; Keating, MJ; McCredie, KB; Smith, TL | 1 |
| Freireich, EJ; Gehan, EA; Keating, MJ; Smith, TL | 1 |
| Clarkson, BD; Gee, TS; Mertelsmann, R; Miké, V; Passe, S | 1 |
| Harvengt, C; Hulhoven, R | 1 |
| Armitage, JO; Aunan, SB; Burns, CP; Dick, FR; Slymen, DJ | 1 |
| Killmann, SA; Wantzin, GL | 1 |
| Akpofure, C; Evans, WE; Riley, CA; Sinkule, JA | 1 |
| Amare, M; Balcerzak, S; Benjamin, R; Costanzi, JJ; Hussein, K; Morrison, FS; Pendleton, OJ; Ryan, DH | 1 |
| Abe, M; Aiba, K; Chinen, T; Ezaki, K; Horikoshi, N; Ichiba, K; Inagaki, J; Inoue, K; Kobayashi, T; Kuraishi, Y; Meguro, S; Nagata, T; Ogawa, M | 1 |
| Fujiwara, M; Hirosawa, H; Kishi, K; Koyama, S; Moriyama, Y; Sakai, C; Sanada, M; Shibata, A; Takahashi, M; Takai, K; Urushiyama, M | 1 |
| Schafer, AI | 1 |
| Cassileth, PA; Kahn, SB; Silber, R; Weiler, C | 1 |
| Early, AP; Gottlieb, AJ; Lanchant, NA; Preisler, HD | 1 |
| Fontebuoni, A; Izzi, T; Lucarelli, G | 1 |
| Büchner, T; Hiddemann, W; Kamanabroo, D; Schulte, H; Urbanitz, D; van de Loo, J | 1 |
| Andersson, B; Beran, M; Ehrsson, H; Eksborg, S; Nilsson, SO | 1 |
| Sonneveld, P; van den Engh, GJ | 1 |
| Miller, DR; Mitta, SK; Steinherz, L; Tan, CT | 1 |
| Baranov, AE; Nadezhina, NM; Nesterova, VI; Petrosian, LN; Shishkova, TV | 1 |
| Maekawa, T; Omine, M; Tsuchiya, J | 1 |
| Kato, Y; Suzuki, H; Yamada, K | 1 |
| Tanaka, M; Yoshida, S | 1 |
| Fujii, S; Hiroshige, Y; Ishida, Y; Kaku, K; Matsumoto, N; Miwa, S; Nakashima, K; Shinohara, K; Yaga, K | 1 |
| Brennan, DC; Lewis, JP | 1 |
| Amare, M; Goodwin, JW; Hoogstraten, B; Newcomb, MM; Park, CH; Savin, MA | 1 |
| Ezaki, K; Kato, Y; Kawashima, K; Kobayashi, M; Kodera, Y; Minami, S; Morishima, Y; Morishita, T; Nishiwaki, H; Ogura, M; Ohara, K; Ohno, R; Suzuki, H; Takeyama, H; Tanimoto, M; Watanabe, E; Yamada, H; Yamada, K; Yamaguchi, H; Yokomaku, S; Yoshikawa, S | 1 |
| Sepaniak, MJ; Yeung, ES | 1 |
| Andersson, B; Beran, M | 1 |
| Matthews, JH; Wood, JK | 1 |
| Auclerc, G; Auclerc, MF; Bernard, J; Cueille, G; Heusse, D; Jacquillat, C; Lavelle, F; Maral, J; Maral, R; Marlard, M; Weil, M | 1 |
| Frenkel, EP; Kitchens, RL; Patrizi, VW; Strauss, JF | 1 |
| Barbui, T; Cortellazzo, S; Donati, MB; Ottolenghi, L; Piazza, E; Poggi, A | 1 |
| Andrivon, W; Callais, F; Guillosson, JJ; Monneret, C; Nafziger, J | 1 |
| Barron, JT; Ghalie, R; Kaizer, H; Kakavas, PW; Parrillo, JE | 1 |
| Lucas, C; Marchal, S; Merlin, JL; Paraire, M; Poullain, MG; Ramacci, C | 1 |
| Aul, C; Bartram, CR; Heyll, A; Hildebrandt, B; Ludwig, WD; Meckenstock, G; Runde, V; Schneider, EM; Schneider, W | 1 |
| Abdulkadyrov, KM; Bessmel'tsev, SS | 1 |
| Cairoli, R; Cantoni, S; Cipriani, D; de Cataldo, F; Muti, G; Nosari, A | 1 |
| Adjei, A; Burke, PJ; Cheng, YC; Donehower, RC; Gore, SD; Grochow, LB; Jones, RJ; Kaufmann, SH; Rowinsky, EK | 1 |
| Andreeff, M; Godfrey, L; Hegewisch-Becker, S; Maslak, P | 1 |
| Collins, PW; Jiang, XR; Macey, MG; Newland, AC | 1 |
| Benson, E; Bishop, J; Bradstock, K; Matthews, J; Page, F | 1 |
| Kliasova, GA | 1 |
| Ohno, R | 1 |
| Cenacchi, A; Fogli, M; Gamberi, B; Manfroi, S; Ottaviani, E; Tosi, P; Tura, S; Visani, G | 1 |
| Areström, I; Björkholm, M; Briese, B; Gruber, A; Peterson, C; Vitols, S | 1 |
| Fukushima, T; Nakamura, T; Uchida, M; Ueda, T | 1 |
| Chihara, K; Kitazawa, F; Nagasawa, K; Natazuka, T; Nomiyama, M; Ohnishi, N; Takara, K; Tsumura, A; Yokoyama, T | 1 |
| Elonen, E; Jokipii, A; Lautenschlager, I; Lyytikäinen, O; Ruutu, P; Tiittanen, L | 1 |
| Andrivon, W; Auclair, C; Florent, JC; Guillosson, JJ; Monneret, C; Nafziger, J; Saucier, JM | 1 |
| Grahn, MF; Jia, L; Jiang, XR; Kelsey, SM; Newland, AC | 1 |
| Broxterman, HJ; Eekman, CA; Feller, N; Lankelma, J; Löwenberg, B; Ossenkoppele, GJ; Pinedo, HM; Schoester, M; Schuurhuis, GJ; Sonneveld, P; Währer, DC | 1 |
| Nagasawa, K; Natazuka, T; Nomiyama, M; Ohnishi, N; Yokoyama, T | 1 |
| Baccarani, M; Damiani, D; Ermacora, A; Fanin, R; Grimaz, S; Lauria, F; Masolini, P; Michelutti, A; Michieli, M; Raspadori, D; Russo, D | 1 |
| Allouche, M; Dubrez, L; Eymin, B; Solary, E | 1 |
| Baguley, BC; Davey, MW; Davey, RA; Hargrave, RM; Harvie, RM; Su, GM | 1 |
| Belloc, F; Bernard, P; Besnard, S; Boisseau, MR; Dumain, P; Lacombe, F; Reiffers, J; Vial, JP | 1 |
| Brodsky, AL; Melero, MJ; Minissale, CJ; Sánchez Avalos, JC | 1 |
| Asschert, J; de Vries, E; Müller, M; van der Kolk, D; Vellenga, E | 1 |
| Forman, SJ; Margolin, KA; Wright, C | 1 |
| Barrett, DJ; Ivy, SP; Li, X; Smyth, AP; von Hofe, E | 1 |
| Efferth, T; Fabry, U; Osieka, R | 1 |
| Hortobágyi, GN | 1 |
| Brieden, T; Gieseler, F; Kunze, J; Nüssler, V; Valsamas, S | 1 |
| Garnier-Suillerot, A; Mankhetkorn, S | 1 |
| Davey, MW; Davey, RA; Grech, KV | 1 |
| Barbui, T; Bassan, R; Chiodini, B | 1 |
| De Angelis, P; den Boer, M; Lehne, G; Rugstad, HE | 1 |
| Baccarani, M; Damiani, D; Ermacora, A; Masolini, P; Michelutti, A; Michelutti, T; Michieli, M; Pea, F; Russo, D | 1 |
| Goranova, M; Goranova, V; Marinckiev, M; Sapunarova, K | 1 |
| Fumihara, T; Nagasawa, K; Ohnishi, N; Yokoyama, T | 1 |
| Mandelli, F; Montefusco, E | 1 |
| Buck, S; Ozgen, U; Ravindranath, Y; Savaşan, S | 1 |
| Jaffrézou, JP; Laurent, G | 1 |
| Bucalossi, A; Ermacora, A; Michieli, M; Pea, F; Russo, D; Visani, G | 1 |
| Bascans, E; Belaud-Rotureau, MA; Belloc, F; Braz-Pereira, E; Durrieu, F; Lacombe, F; Lavignolle, V | 1 |
| Esche, H; Opalka, B; Parssanedjad, K; Pützer, BM; Stiewe, T | 1 |
| Lange, B | 1 |
| Baccarani, M; Baraldo, M; Damiani, D; Ermacora, A; Furlanut, M; Michieli, M; Pea, F; Russo, D | 1 |
| Muggia, FM | 1 |
| Ikeno, A; Ishikawa, T; Iuchi, K; Matsuda, T; Nakamura, S; Ohtake, S; Okumura, H; Takamatsu, H; Takeshima, M; Usuda, K; Yoshida, T | 1 |
| Budman, DR; Calabro, A; Kreis, W | 1 |
| Lotfi, K; Peterson, C; Zackrisson, AL | 1 |
| Deng, CQ; Gong, YP; Jia, YQ; Liu, T; Qin, L; Yang, RY | 1 |
| Jia, L; Kelsey, SM; Liu, FT; Newland, AC | 1 |
| Balwierz, W; Kowalczyk, JR; Styczynski, J; Wysocki, M | 1 |
| Austin, CA; Errington, F; Tilby, MJ; Willmore, E | 1 |
| Hirte, WE; McSheffrey, JB; Naidoo, A | 1 |
| Comelli, A; Massimo, L | 1 |
| Anteunis, A; Audebert, AA; Debray, J; Krulik, M; Robineaux, R | 1 |
| Daniel, RW; Reese, JM; Reissing, M; Shah, KV | 1 |
| Hasegawa, Y; Masaoka, T; Shibata, H; Takubo, T; Ueda, T | 1 |
| Brucksch, KP; Schmidt, CG; Seeber, B; Seeber, S | 1 |
| Gol'dberg, LE | 1 |
| Buskard, NA; Catovsky, D; Costello, C; Galton, DA; Goldman, JM; Spiers, AS | 1 |
| Auclerc, MF; Holland, JF; Jacquillat, C; Schaison, G; Weil, M | 1 |
| Domján, O; Horváth, A; István, L; Kassai, P; Kemény, P; Koós, R; Laub, MW; Révész, T; Schuler, D; Székely, K; Velkey, L; Vincellér, M; Virág, I | 1 |
| Berry, DH; Komp, D; Pullen, J; Sutow, WW; Trueworthy, RC | 1 |
| Amadori, S; De Lipsis, E; Grignani, F; Liso, V; Mandelli, F; Martelli, M | 1 |
| Higby, DJ; Preisler, HD | 1 |
| Epstein, J; Preisler, HD; Rustum, YM | 1 |
| Brucksch, KP; Busch, H; Käding, J; Meshkov, T; Schmidt, CG; Seeber, S | 1 |
| Sokal, G; Trouet, A | 1 |
| Benjamin, RS; Keating, MJ; Legha, S; McCredie, KB; Swenerton, KD | 1 |
| Libánský, J; Lukásová, M; Sedlácková, M | 1 |
| Chiyoda, S; Kubota, K; Miura, Y; Mizoguchi, H; Muto, Y; Takaku, F | 1 |
| Gahrton, G; Granström, M; Hörnsten, P; Wahren, B | 1 |
| Falk, P; Feig, S; Gale, RP; Ho, W; Rippee, C; Sparkes, R | 1 |
| Braunsteiner, H | 1 |
| Gale, RP | 1 |
| Bodey, GP; Rodriguez, V | 1 |
| Rozencweig, M; Slavik, M; Von Hoff, DD | 1 |
| Davis, HL; Davis, TE | 1 |
| Bosly, A; Cornu, G; Ferrant, A; Hulhoven, R; Michaux, JL; Sokal, G | 1 |
| Ganapathi, R; Krishan, A | 1 |
| Fujiwara, Y; Furukawa, K; Hirota, Y; Nakaide, Y; Tanaka, M | 1 |
| Gola, A | 1 |
| Amadori, S; De Luca, AM; De Rossi, G; Deriu, L; Di Giovanni, F; Isacchi, G; Mandelli, F; Mariani, G; Monarca, B; Papa, G | 1 |
| Auclerc, G; Auclerc, MF; Bernard, J; Degos, L; Jacquillat, C; Maral, J; Schaison, G; Tobelem, G; Weil, M | 1 |
| Amadori, S; Mandelli, F; Meloni, G; Pacilli, L; Papa, G | 1 |
| Balleisen, L; Büchner, T; Delvos, U; Hiddemann, W; Kamanabroo, D; Lagrèze, EM; Meister, R; Schmitz-Huebner, U; Schulte, H; Urbanitz, D; van de Loo, J | 1 |
| Andersson, B; Andersson, I; Beran, M; Ehrsson, H; Eksborg, S | 1 |
| Andersson, B; Beran, M; Ehrsson, H; Eksborg, S | 2 |
| Gahrton, G; Lockner, D; Paul, C; Peterson, C | 1 |
| Björkholm, M; Brenning, G; Christenson, I; Engstedt, L; Franzén, S; Gahrton, G; Gullbring, B; Högman, C; Holm, G; Hörnsten, P; Jameson, S; Killander, A; Lockner, D; Lönnqvist, B; Mellstedt, H; Palmblad, J; Paul, C; Pauli, C; Peterson, C; Reizenstein, P; Simonsson, B; Simonsson-Lindemalm, C; Skårberg, KO; Udén, AM; Wadman, B | 1 |
| Faltermeier, MT; Hossfeld, DK; Schmidt, CG | 1 |
| Abe, T; Hanada, T; Miyazaki, M; Ohta, Y; Tanoue, K; Yoda, Y | 1 |
| Adolfsson, J; Lagerlöf, B; Lantz, B; Reizenstein, P | 1 |
| Fukunaga, Y; Kobayshi, M; Kohgo, T; Shimizu, H; Ueda, Y; Yamamoto, M | 1 |
| Auclerc, MF; Bernard, J; Boiron, M; Jacquillat, C; Maral, J; Schaison, G; Weil, M | 1 |
| Balcerzak, SP; Bickers, J; Bodey, GP; Coltman, CA; Costanzi, JJ; Freireich, EJ; Gehan, EA; Groppe, C; Haut, A; Hewlett, JS; McCredie, KB; Smith, TL | 1 |
| Mir, MA | 1 |
| Goto, M; Handa, M; Negishi, M; Nemato, K; Suzuki, H; Toyama, K; Udagawa, Y | 1 |
| Hartwich, G; Neidhardt, B; von Roemeling, R | 1 |
| Faltermaier, MT; Hossfeld, DK; Schmidt, CG | 1 |
| Haen, M; Maulbetsch, R; Rückle, H; Waller, HD; Wilms, K | 1 |
| Baynes, RD; Bezwoda, WR; Bothwell, TH; Derman, DP; Hougaard, M; Katz, J | 1 |
| Hutchison, DJ; Schmid, FA | 1 |
| Ellison, RR | 1 |
| Henderson, ES | 2 |
| Hennemann, HH | 1 |
| Cassileth, PA; Katz, ME | 1 |
| Gray, PJ; Phillips, DR | 1 |
| Avramović, D; Konecni, J; Kovacević, M; Ristić, M; Stefanović, S | 1 |
| Böhnel, J | 1 |
| Gross, R; Hirschmann, WD | 1 |
| George, S; Haggard, ME; Humphrey, GB; Lowman, JT; Starling, KA; Sutow, WW; Vietti, TJ | 1 |
| Donner, L; Dorazilová, V; Klener, P; Neuwirtová, R; Setková, O | 1 |
| Alekseev, NA; Vorob'ev, AS | 1 |
| Bouchard, M; Bousser, J; Diaz-Mayo, C; Facquet-Danis, J; Percie-du-Sert, M; Zittoun, R | 1 |
| Kremer, WB | 1 |
| Bleich, HL; Boro, ES | 1 |
| George, S; Komp, DM; Lyon, GM; Ragab, AH; Starling, KA; Sutow, WW | 1 |
| Burchenal, J; D'angio, G; Exelby, P; Fang, S; Lieberman, P; Murphy, ML; Wollner, N | 1 |
| Bruntsch, U; GAllmeier, WM; Osieka, R; Schmidt, CG; Seeber, S | 1 |
| Khvatova, NV; Zhukovskaia, ES | 1 |
| Bernard, J; Boiron, M; Bussel, A; Gemon-Auclerc, MF; Izrael, V; Jacquillat, C; Weil, M | 1 |
| Chervinsky, DS; Wang, JJ | 1 |
| Amaki, I; Ohshima, T | 1 |
| Liong, SK; Uzuka, Y; Yamagata, S | 1 |
| Bodey, GP; Coltman, CA; Freireich, EJ; Hewlett, JS | 1 |
| Aisner, J; Fortner, C; Lichtenfeld, JL; O'Connell, MJ; Schiffer, CA; Schimpff, SC; Wiernik, PH | 1 |
| Garwood, FA; Groth, D; Vogler, WR | 1 |
| Cardinali, G; Catalano, G | 1 |
| Ota, K | 1 |
| Imai, K; Kamiya, T; Nishiwaki, H; Ono, R; Yoshikawa, H | 1 |
| Ichimaru, M; Inoue, A; Okabe, N; Yamaguchi, H | 1 |
| Alberts, DS; Serpick, AA; Thompson, WL | 1 |
| Akatsuka, J; Nishimura, K; Ohmi, K; Shike, S; Ueda, Y | 1 |
| Landbeck, G | 2 |
| Daniel, JC; Lecerf, JM; Levy, SB; Slapak, CA | 1 |
| Eden, OB; Elton, R; Shaw, NJ | 1 |
| Chan, TK; Chiu, E; Liang, R; Todd, D | 1 |
| Grimfors, G; Järnmark, M; Lerner, R; Ljungman, P; Lönnqvist, B; Nyström-Rosander, C; Oberg, G; Palmblad, J; Samuelsson, J | 1 |
| Niho, Y | 1 |
| Hui, EK; Luo, KJ; Yung, BY | 1 |
| Ascari, E; Danova, M; Giordano, M; Invernizzi, R; Luoni, R; Rastaldi, MP; Riccardi, A; Ucci, G; Zambelli, ML | 1 |
| Kosaka, M; Miyamoto, Y; Mizuguchi, T; Tamura, K | 1 |
| Kawamura, S; Konuma, Y; Maeda, S; Sakata, Y; Shiratori, Y; Souma, N; Takami, H; Tsushima, K; Yoshida, Y | 1 |
| Baas, F; Herweijer, H; Nooter, K; Sonneveld, P | 1 |
| Hůla, J; Slechtová, J; Svojgrová, M | 1 |
| Ames, MM; Hammond, GD; Krailo, MD; Pendergrass, TW; Reid, JM | 1 |
| Büchner, T; Hagemeister, B; Hiddemann, W; Kusnierz-Glaz, C; Reiser, M; van de Loo, J | 1 |
| Ekberg, M; Larsson, R; Nygren, P; Slater, L | 1 |
| Cunningham, M | 1 |
| Lampkin, BC | 1 |
| Dahl, GV; Jackson, CW; Kalwinsky, DK; Look, AT; Mirro, J | 1 |
| Biddle, WC; Haruta, Y; Henderson, ES; Sarcione, EJ; Seon, BK | 1 |
| Hamada, H; Ishida, Y; Minato, K; Ohtsu, T; Shimoyama, M; Sugimoto, Y; Tobinai, K; Tsuruo, T | 1 |
| Arlin, ZA | 1 |
| Haanen, C; Minderman, H; Speth, PA | 1 |
| Joneckis, CC; Ordóñez, JV; Ross, DD; Thompson, BW | 1 |
| Caro, J; Erslev, AJ; Piroso, E | 1 |
| Griffiths, M | 1 |
| Mandelli, F; Petti, MC | 1 |
| Andreeff, M; Berman, E; Gabrilove, J; Gee, T; Gulati, S; Heller, G; Kempin, SJ; Kolitz, J; Raymond, V; Young, CW | 1 |
| Raymond, V; Young, CW | 1 |
| Egami, K; Itoh, K; Kobayashi, K; Matsuda, T; Nakamura, S; Nakanishi, J; Natori, H; Ohtake, S; Tanaka, K; Yoshida, T | 1 |
| Debusscher, L; Stryckmans, P; Velu, T | 1 |
| Paul, C; Sundman-Engberg, B; Tidefelt, U | 1 |
| Alpert, BS; de Graaf, SS; Dow, LW; Evans, WE; Murphy, SB; Pui, CH; Rodman, JH | 1 |
| Agostino, FC; Bernabei, PA; Bezzini, R; Leoni, F; Rossi Ferrini, P; Saccardi, R | 1 |
| Boscher, MY; David, JC; Fauchet, R; Lamballe, F; le Prise, PY; Maniey, D | 1 |
| Bennett, JM; Cassileth, PA; Harrington, DP; Hines, JD; Mazza, JJ; McGlave, P; O'Connell, MJ; Oken, MM | 1 |
| Berg, DT; Budman, DR; Cornwell, GG; Ellison, RR; Maguire, M; Mayer, RJ; Peterson, BA; Rai, KR; Schiffer, CA; Silver, RT | 1 |
| Amadori, S; Avvisati, G; Mandelli, F; Meloni, G; Petti, MC; Tafuri, A | 1 |
| Blunden, RW; Dart, GW; Ho, JQ; Horvath, N; Juttner, CA; Kimber, RJ; Roberts, MM; To, LB | 1 |
| Galli, V; Grego, V; Matteoli, S; Trappolini, M | 1 |
| Iida, H; Tsuruo, T | 1 |
| Annaloro, C; Lambertenghi-Deliliers, G; Pacciarini, MA; Pogliani, E; Polli, EE | 1 |
| Bishop, JF; Cobcroft, R; Dodds, A; Joshua, DE; Kronenberg, H; Lowenthal, RM; Manoharan, A; Whiteside, MG; Wolf, M | 1 |
| Fukutani, H; Kataoka, T; Takeyama, H; Watanabe, E; Yano, K | 1 |
| Coccia-Portugal, MA; Dreyer, R; Falkson, G; Terblanche, AP; Vorobiof, DA | 1 |
| Kimura, I; Kitani, T; Masaoka, T; Meguro, S; Nagai, K; Ogawa, M; Ohnoshi, T; Sampi, K; Wakui, A; Yamada, K | 1 |
| Haanen, C; Linssen, PC; Speth, PA; van de Loo, FA; Wessels, HM | 1 |
| Cable, HC; Duncan, R; Hume, I; Kopecek, J; Kopecková-Rejmanová, P; Lloyd, JB; Pohl, J; Strohalm, J | 1 |
| Bacha, DM; Dantis, E; Hancock, C; Luks, E; Meyers, P; Mondora, A; Steinherz, L; Steinherz, P; Tan, CT; Winick, N | 1 |
| Björkholm, M; Killander, A | 1 |
| Annaloro, C; Cortelezzi, A; Ganzina, F; Lambertenghi-Deliliers, G; Maiolo, AT; Pogliani, E; Polli, EE | 1 |
| Carella, AM; Cerri, R; Congiu, A; Damasio, E; Gaozza, E; Giordano, D; Martinengo, M; Nati, S; Risso, M; Santini, G | 1 |
| Di Pietro, N; Ganzina, F; Pacciarini, MA | 1 |
| Bancillon, A; Leverger, G; Schaison, G | 1 |
| Carey, R; Davis, RB; Dupre, E; Hoagland, HC; Kirshner, J; Kopel, S; Levy, RN; Preisler, H; Richards, F; Schulman, P | 1 |
| Carreras, E; Grañena, A; Marín, P; Rozman, C; Sierra, J | 1 |
| Greer, JP; Herzig, GP; Herzig, RH; Lazarus, HM; Phillips, GL; Ray, WA; Stein, RS; Wolff, SN | 1 |
| Dan, K; Fujioka, S; Hoshino, S; Mizoguchi, H; Nomura, T; Saito, T; Takaku, F; Tanaka, K; Toyama, K; Urabe, A | 1 |
| Davila, E; Krishan, A; Sridhar, KS; Sternheim, W; Vogel, C | 1 |
| Azarnia, N; Bolanowska, W; Gessner, T; Goldberg, J; Grunwald, H; Joyce, R; Preisler, HD; Vogler, WR | 1 |
| Findley, HW; Krischer, JP; Ragab, AH; Steuber, CP | 1 |
| Beguin, Y; Bury, J; Delbrouck, JM; Fillet, G; Robaye, G; Roelandts, I; Weber, G | 1 |
| Durie, BG; Garewal, H; Greenberg, B | 1 |
| Boezeman, JB; Haanen, C; Linssen, PC; Speth, PA; Wessels, HM | 1 |
| Joneckis, CC; Ross, DD; Schiffer, CA | 1 |
| de Pauw, BE; de Witte, TJ; Linssen, PC; Speth, PA | 1 |
| Burke, PJ; Karp, JE | 1 |
| Londer, HN; Mahmud, K; Manion, JC; Schrock, CG | 1 |
| Adelstein, DJ; Bennett, JM; Hines, JD; Keller, A; Mazza, JJ; O'Connell, MJ; Oken, MM | 1 |
| Arlin, ZA; Baratz, R; Budman, D; Daghestani, AN; Gee, TS; Kempin, SJ; Leyland-Jones, B; Mertelsmann, R; Schulman, P; Williams, L | 1 |
| Bron, D; Debusscher, L; Malarme, M; Rozencweig, M; Stryckmans, P | 1 |
| Carella, AM; Cerri, R; Congiu, A; Damasio, E; Giordano, D; Martinengo, M; Nati, S; Risso, M; Rossi, E; Santini, G | 1 |
| Dahl, GV; Hustu, HO; Murphy, SB; Pui, CH | 1 |
| Eridani, S; Pearson, TC; Singh, AK; Slater, NG | 1 |
| Hamajima, N; Kawashima, K; Nagura, E; Yamada, K | 1 |
| Carella, AM; Cerri, R; Congiu, A; Frassoni, F; Giordano, D; Marmont, A; Martinengo, M; Nati, S; Risso, M; Santini, G | 1 |
| Horiuchi, A; Kawagoe, H; Kitani, T; Masaoka, T; Nagai, K; Oguma, S; Shibata, H; Yasunaga, K; Yonezawa, T | 1 |
| Bodenstein, H; Büchner, T; Engelhardt, R; Ganser, A; Hoelzer, D; Löffler, H; Messerer, D; Rühl, H; Thiel, E; Zwingers, T | 1 |
| Asou, N; Kawano, F; Matsuoka, Y; Tajima, H; Takatsuki, K | 1 |
| Brody, JP; Krause, JR; Penchansky, L | 1 |
| Bukowski, R; Fishleder, A; Ganapathi, R; Grabowski, D; Gulick, P; Miller, R; Turinic, R; Valeunzuela, R | 1 |
| Cavalli, F; Fopp, M; Sessa, C; Tschopp, L | 1 |
| Bayle, C; Berger, R; Carde, P; Finaud, M; Hayat, M; Hurteloup, P; Morardet, N; Parmentier, C; Schlumberger, M | 1 |
| Takaku, F | 1 |
| Benger, A; Browman, G; Goldberg, J; Gottlieb, AJ; Grunwald, H; Miller, KB; Rai, K; Vogler, WR; Walker, I; Winton, E | 1 |
| Capizzi, RL; Cooper, MR; Jackson, DV; Muss, HB; Powell, BL; Richards, F; Spurr, CL; Stuart, JJ; White, DR; Zekan, PJ | 1 |
| Edelstein, M; Valeriote, F | 1 |
| Herzig, GP; Herzig, RH; Lazarus, HM; Phillips, GL; Wolff, SN | 1 |
| Ahmed, NK | 1 |
| Höcker, P | 1 |
| Elias, M; Naparstek, E; Or, R; Polliack, A; Rachmilewitz, EA; Zajicek, G | 1 |
| Boyett, JM; Falletta, J; Frankel, L; Ragab, AH | 1 |
| Kurita, S; Masaoka, T; Ogawa, N; Ota, K; Uzuka, Y; Yamada, K | 1 |
| Flexner, JM; Herzig, GP; Herzig, RH; Lazarus, HM; Marion, J; Phillips, GL; Spitzer, TR; Stein, RS; Wolff, SN | 1 |
| Bohinjec, J; Kralj, J; Zontar, D | 1 |
| Bloomfield, CD; Duane, SF; Hurd, DD; Michels, SD; Peterson, BA | 1 |
| Blume, KG; DuBois, NJ; Fahey, JL; Farbstein, MJ; Forman, SJ; Lazar, GS; Nademanee, AP; O'Donnell, MR; Snyder, DS | 1 |
| Lewis, JP; Meyers, FJ; Tanaka, L | 1 |
| Advani, SH; Ahuja, HG; Gopal, R; Kamat, DM; Nair, CN; Pai, MR; Saikia, TK | 1 |
| Beguin, Y; Bury, J; Fillet, G; Lennes, G | 1 |
| Faucon, G; Fière, D; Lakhal, M; Lang, J; Perrin-Fayolle, E; Timour Chah, Q; Trillet, V | 1 |
| Gross, R | 1 |
| Warner, TF | 1 |
| Meister, H; Trux, F | 1 |
| Beard, ME; Fairley, GH | 1 |
| Haas, H; Kurz, R | 1 |
| Abbrederis, K; Schmalzl, F | 1 |
| Atkinson, K; Clink, HM; Kay, HE; McElwain, TJ; Powles, R; Wells, DG | 1 |
| Stacher, A | 1 |
| Altman, DH; Rajurkar, MG; Raskin, MM | 1 |
| Amiel, JL; Cattan, A; Ceoara, B; Hayat, M; Mathé, G; Schlumberger, JR; Schneider, M; Schwarzenberg, L | 1 |
| Fortuna, E; Fossati-Guglielmoni, A; Massimo, L | 1 |
| Hisamatsu, T; Koeda, T | 1 |
| Amiel, JL; Cattan, A; Ceoara, B; Hayat, M; Mathe, G; Schenider, M; Schlumberger, JR; Schwarzenberg, L | 1 |
| Berry, DH | 1 |
| Masaoka, T; Yoshitake, J | 1 |
| Fortuny, IE; Hadlock, DC; McCullough, JJ; Mishler, JM; Nicora, RW | 1 |
| Cornu, G; Michaux, JL; Sokal, G; Trouet, A | 2 |
| Hoshino, A; Ogawa, M | 1 |
| Bateman, CJ; Beard, ME; Crowther, D; Malpas, JS; Whitehouse, JM | 1 |
| Götze-Bender, C; Kurme, A; Landbeck, G; Pauka, B; Winkler, K | 1 |
| Amiel, JL; Beyer, HP; de Vassal, F; Fajbisowicz, S; Hayat, M; Jasmin, C; Mathé, G; Pouillart, P; Schneider, M; Schwarzenberg, L; Weiner, R | 1 |
| Böhnel, J; Höcker, P; Stacher, A | 1 |
| Duttera, MJ; Geelhoed, GW; Graff, KS; Henderson, ES | 1 |
| Flieder, J; Gehanno, P; Lallemant, Y | 1 |
| Infelise, V; Paolino, W; Resegotti, L; Rossi, M | 1 |
| Cain, F; Havard, CW; Marcovitch, H | 1 |
| Frei, E; Goldin, A; Schabel, FM | 1 |
| Hamblin, TJ; Jones, JV | 1 |
| Burchenal, JH; Cole, MT; Dowling, MD | 1 |
| Litwin, J; Stacher, A | 1 |
| Buckley, J; Metcalf, D; Moore, MA; Spitzer, G; Williams, N | 1 |
| Gunz, FW; Levi, JA; Vincent, PC | 1 |
| Keating, MJ; Penington, DG | 1 |
| Cline, MJ; Haskell, CM | 1 |
| Burchenal, JH; Clarkson, BD; Cunningham, B; Dowling, MD; Gee, TS; Haghbin, M; Tan, CT | 1 |
| Bernard, J; Jacquillat, C; Weil, M | 1 |
| Sinkus, AG | 1 |
| Brilliant, MD | 1 |
| Faĭnshteĭn, FE | 1 |
| Alekseev, GA | 1 |
| Pruzanski, W; Saito, S | 1 |
| Bernard, J | 1 |
| Reizenstein, P | 1 |
| Heimpel, H; Olischläger, A; Queiser, U; Queisser, W | 1 |
| De Pasquale, A; Quaglino, D; Zanni, G | 1 |
| Barosi, G; Fontana, G; Rizzo, SC | 1 |
| Hirano, M; Koie, K; Morita, A; Sako, F; Uetani, T | 2 |
| Stryckmans, P | 1 |
| Hobson, RW; Kingry, RL; Muir, RW | 1 |
| Bornuz, F; Cucuianu, M; Deac, M; Macavei, I | 1 |
| Brunning, RD | 1 |
| Kötz, F; Oehme, J | 1 |
| Desbuquois, G; Julienne, O; Laine, JL; Lamagnère, JP; Laugier, J; Leroy, J | 1 |
| Hanawa, Y; Mimaya, J; Nagao, T; Toyosaka, H; Tsukimoto, I | 1 |
| Pole, JG | 1 |
| Ernst, P; Killmann, SA | 1 |
| Killmann, SA | 1 |
| Fennelly, JJ; O'Connell, L | 1 |
| Bezwoda, WR; Bothwell, TH; Gale, D; Lynch, SR; Sacks, P; Stevens, K | 1 |
| Cahalane, SF; Fennelly, JJ; Gorman, A; Keane, T; McBride, A; O'Connell, LG | 1 |
| Nakamura, T; Tatsumi, K; Wakisaka, G | 1 |
| Hartmann, JR; Shore, NA | 1 |
| Ravina, A | 1 |
| Bollag, W | 1 |
| Bernard, J; Boiron, M | 1 |
| Morrone, G | 1 |
| Henderson, ES; Serpick, AA | 1 |
| Bonfatti, A; Chériè Lignière, EL; Esposito, S; Robustelli della Cuna, G | 1 |
| Lattanzi, E; Santoro, A; Schettini, F; Violante, N | 1 |
| Bile, G; De Biasi, R | 1 |
| Bianco, G; Bravi, A; Di Paolo, N; Marcolongo, R | 1 |
| Esposito, S; Taylor, LA | 1 |
| Gerwelowa, H; Michalewska, D; Radwańska, U; Rafińska, J | 1 |
| Kötz, F; Ochme, J | 1 |
| Fernbach, DJ; Gooch, WM | 1 |
| D'Attoma, G | 1 |
| Asamer, H; Braunsteiner, H; Huber, CH; Huber, H; Michlmayr, G | 1 |
| Gerhartz, H | 1 |
| Holland, JF | 2 |
| Baudo, F; Bussi, L; Camera, G; Cipriani, D; de Cataldo, F; Pensabene, A; Tiso, R | 1 |
| Dano, K; Nissen, NI | 1 |
| Burgess, MA; de Gruchy, GC; Garson, OM | 1 |
| Cauchie, C; Kenis, Y; Maurus, R; Naets, JP; Stryckmans, P; Tagnon, PH | 1 |
| Lane, DM; Lonsdale, D; Starling, K; Vietti, TJ; Wilbur, JR | 1 |
| Fujinaga, S; Hattori, K; Kitanaka, I; Kitao, T | 1 |
| Honetz, N; Neumann, E | 1 |
| Wilmanns, W | 1 |
| Begemann, H; Gerhartz, H | 1 |
| Bernard, J; Boiron, M; Bussel, A; Dreyfus, B; Jacquillat, C; Larrieu, MJ; Loisel, JP; Rouesse, T; Weil, M | 1 |
| de Vaan, GA; Marcar, JR; Schretlen, ED | 1 |
| Meyer-Beeck, D; Oehme, J | 1 |
| Butoianu, E; Nicoară, ST; Popescu, ER | 1 |
| Massimo, L | 1 |
| Hirano, M; Miura, M; Yamada, K | 1 |
| Burchenal, JH | 1 |
| Roth, J | 1 |
| Chiarioni, T; Sasso, GF | 1 |
| Holton, CP; Lonsdale, D; Nora, AH; Thurman, WG; Vietti, TJ | 1 |
| Andino Pavlovsky, A; Bergna, L; Bustelo, FM; De Bonezana, AC; Gonzalez, N; Maro, V; Pavlovsky, S; Peñalver, JA; Rivara, A; Sackmann, F | 1 |
| Carnelli, V; Masera, G | 1 |
| Heynen, U | 1 |
42 review(s) available for daunorubicin and Leukemia
| Article | Year |
|---|---|
Toxicity of the topoisomerase II inhibitors.
Topics: Antineoplastic Agents; Cardiovascular Diseases; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Epirubicin; Etoposide; Humans; Idarubicin; Leukemia; Middle Aged; Mitoxantrone; Mucositis; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors; Vascular Diseases | 2005 |
Therapy in childhood acute nonlymphocytic leukemia (ANLL). Evolution of current concepts of chemotherapy.
Topics: Acute Disease; Adolescent; Adult; Asparaginase; Azauridine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Prednisone; Thioguanine; Thioinosine; Vincristine | 1981 |
Adult acute nonlymphocytic leukemia.
Topics: Acute Disease; Adult; Aged; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Humans; Leukemia; Meningeal Neoplasms; Methotrexate; Middle Aged; Thioguanine | 1984 |
Clinical pharmacology of daunorubicin in patients with acute leukemia.
Topics: Acute Disease; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Animals; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Kinetics; Leukemia | 1984 |
New cytotoxic drugs for breast cancer and their clinical evaluation.
Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Female; Gallium; Humans; Ifosfamide; Leukemia; Vinblastine; Vindesine; Zinostatin | 1980 |
Toxicology of daunorubicin in animals and man.
Topics: Abnormalities, Drug-Induced; Animals; Bone Marrow; Chick Embryo; Cricetinae; Daunorubicin; Dogs; Doxorubicin; Drug Evaluation; Female; Guinea Pigs; Haplorhini; Humans; Immunity; Lethal Dose 50; Leukemia; Lymphocytes; Macrophages; Male; Mice; Mutagenicity Tests; Neoplasms, Experimental; Pregnancy; Rabbits; Rats; Spleen | 1981 |
Adult acute nonlymphocytic leukemias.
Topics: Acute Disease; Aged; Anemia; Anemia, Aplastic; Anemia, Sideroblastic; Blood Transfusion; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Drug Resistance; Female; Hemorrhage; Humans; Immunotherapy; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Platelet Transfusion; Spinal Cord; Syndrome | 1980 |
The anthracycline antineoplastic drugs.
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Daunorubicin; Doxorubicin; Female; Glycosides; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Naphthacenes; Ovarian Neoplasms; Sarcoma | 1981 |
[In-vitro prediction of clinical response to chemotherapy in leukemia].
Topics: Cell Division; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Humans; In Vitro Techniques; Leukemia; Mitotic Index | 1981 |
[State of the art of chemotherapy for adult acute leukemia in Japan].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Humans; Japan; Leukemia; Mercaptopurine; Middle Aged; Multicenter Studies as Topic; Prednisolone; Remission Induction; Survival Rate | 1993 |
Anthracyclines in the treatment of cancer. An overview.
Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Heart Diseases; Humans; Leukemia; Neoplasms; Neutropenia; Stomatitis | 1997 |
[Treatment of acute and chronic leukemias].
Topics: Acute Disease; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosome Aberrations; Combined Modality Therapy; Daunorubicin; Humans; Idarubicin; Karyotyping; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Transplantation, Autologous; Transplantation, Homologous | 1999 |
[Role of lipid second messengers involved in the response of leukemic cells to anticancer drugs].
Topics: Antineoplastic Agents; Apoptosis; Cell Survival; Daunorubicin; Humans; Leukemia; Lipids; Second Messenger Systems; Tumor Cells, Cultured | 1999 |
The management of neoplastic disorders of haematopoiesis in children with Down's syndrome.
Topics: Acute Disease; Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Down Syndrome; Female; Genetic Predisposition to Disease; Humans; Infant; Infant, Newborn; Leukemia; Leukemia, Myeloid; Male; Maternal Age; Myeloproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vincristine | 2000 |
Liposomal encapsulated anthracyclines: new therapeutic horizons.
Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Liposomes; Lymphoma; Multiple Myeloma; Ovarian Neoplasms; Sarcoma, Kaposi | 2001 |
[Antibacterial and antineoplastic antibiotics].
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bacteria; Bacterial Infections; Chemical Phenomena; Chemistry; Choriocarcinoma; Daunorubicin; Erythromycin Ethylsuccinate; Female; Hodgkin Disease; Humans; Leukemia; Lincomycin; Lymphoma, Large B-Cell, Diffuse; Olivomycins; Ovarian Neoplasms; Pregnancy; Ristocetin; Streptonigrin; Uterine Neoplasms | 1977 |
[Prognostic significance of cytochemical findings in differentiated myelogenous leukaemias of adults (author's transl)].
Topics: Acid Phosphatase; Adult; Aged; Alkaline Phosphatase; Bone Marrow Cells; Cerebral Hemorrhage; Daunorubicin; Female; Gastrointestinal Hemorrhage; Glucuronidase; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukocytes; Male; Middle Aged; Monocytes; Muramidase; Naphthol AS D Esterase; Periodic Acid-Schiff Reaction; Peroxidases; Pregnancy; Prognosis; Remission, Spontaneous | 1977 |
Approaches to the treatment of acute leukemia and lymphoma in adults.
Topics: Acute Disease; Adult; Animals; BCG Vaccine; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Environment, Controlled; Humans; Immunotherapy; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Mice; Prednisone; Vincristine | 1978 |
Daunomycin: an anthracycline antibiotic effective in acute leukemia.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Daunorubicin; Drug Resistance; Humans; Kinetics; Leukemia | 1978 |
Adriamycin and other anthracycline antibiotics under study in the United States.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Doxorubicin; Drug Combinations; Hodgkin Disease; Humans; Leukemia; Neoplasm Metastasis; Neoplasms; Soft Tissue Neoplasms; United States | 1978 |
Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations.
Topics: Breast Neoplasms; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia; Lymphoma; Neoplasms; Sarcoma; Soft Tissue Neoplasms | 1979 |
Drug resistance in leukemia.
Topics: Alkylating Agents; Antimetabolites; Antineoplastic Agents; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Leukemia; Methotrexate; Prednisone; Purines; Pyrimidines; Vinblastine; Vincristine | 1975 |
Management of acute leukemia in adults.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Blood Transfusion; Cytarabine; Daunorubicin; Drug Therapy, Combination; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Middle Aged; Prognosis; Remission, Spontaneous; Thioguanine; Thrombocytopenia; Time Factors | 1975 |
[Therapy of leukemia].
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Antimetabolites, Antineoplastic; Asparaginase; Child; Chronic Disease; Cyclophosphamide; Daunorubicin; Doxorubicin; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Vincristine | 1976 |
Nonhematologic toxicities of selected chemotherapeutic agents used in the treatment of adult leukemia.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Leukemia; Mitoxantrone; Nursing Assessment | 1990 |
Cell kinetics as related to treatment of patients with acute nonlymphoid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow; Bone Marrow Cells; Cell Cycle; Child; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Flow Cytometry; Hematopoietic Stem Cells; Humans; Hydrocortisone; Leukemia; Methotrexate; Mitotic Index; Neoplastic Stem Cells; Prednisone; Prognosis; Vincristine | 1985 |
Idarubicin in acute leukemia: an effective new therapy for the future.
Topics: Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Forecasting; Humans; Idarubicin; Leukemia; Remission Induction | 1989 |
Idarubicin v daunorubicin: preclinical and clinical pharmacokinetic studies.
Topics: Animals; Cells, Cultured; Daunorubicin; Humans; Idarubicin; Leukemia; Leukemia, Experimental; Leukemia, Myeloid, Acute; Mice | 1989 |
Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Topics: Aclarubicin; Anthraquinones; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Cell Survival; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Heart; Humans; Idarubicin; Leukemia; Menogaril; Mitoxantrone; Naphthacenes; Nogalamycin; Sarcoma; Structure-Activity Relationship | 1986 |
Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies.
Topics: Administration, Oral; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Idarubicin; Infusions, Parenteral; Kinetics; Leukemia | 1986 |
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
Topics: Aging; Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Asparaginase; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; DNA; Dose-Response Relationship, Drug; Drug Resistance; Humans; Kinetics; Leukemia; Leukemia, Lymphoid; Middle Aged; Time Factors | 1985 |
Cytosine arabinoside in experimental combination therapy.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Cisplatin; Cyclophosphamide; Cytarabine; Daunorubicin; DNA; DNA Repair; Doxorubicin; Drug Interactions; Drug Resistance; Humans; Interphase; Leukemia; Mercaptopurine; Phosphorylation; Thioguanine; Thymidine; Time Factors | 1985 |
Acute leukemia in adults.
Topics: Adult; Alkaline Phosphatase; BCG Vaccine; Blood Transfusion; Bone Marrow Examination; Central Nervous System Diseases; Cytarabine; Daunorubicin; Diagnosis, Differential; Drug Combinations; Drug Therapy, Combination; Esterases; Humans; Immunotherapy; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphocyte Transfusion; Meningitis; Microscopy, Electron; Neutrophils; Staining and Labeling; Subarachnoid Hemorrhage; Thioguanine | 1974 |
Combined treatment of leukaemias and reticuloses.
Topics: Antineoplastic Agents; Asparaginase; Daunorubicin; Humans; Leucovorin; Leukemia; Lymphatic Diseases; Mercaptopurine; Methotrexate; Prednisolone; Vincristine | 1970 |
[Treatment of acute leukemias].
Topics: Acute Disease; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Child; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methods; Methotrexate; Prednisolone; Recurrence; Remission, Spontaneous; Vincristine | 1973 |
[Clinical aspects of the problem of treating leukemias].
Topics: Acute Disease; Antineoplastic Agents; Chlorambucil; Chlorine; Chronic Disease; Daunorubicin; Dimethoate; Drug Therapy, Combination; Ethylamines; Glucocorticoids; Humans; Immunoglobulins; Immunosuppression Therapy; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphocytosis; Mercaptopurine; Methotrexate; Prednisolone; Remission, Spontaneous | 1973 |
[Current aspects of the treatment of acute leukemia].
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Blood Coagulation Disorders; Cell Transformation, Neoplastic; Daunorubicin; Humans; Immunotherapy; Leukemia; Leukemia, Lymphoid; Mercaptopurine; Middle Aged; Mitosis; Prednisolone; Prednisone; Remission, Spontaneous; Vincristine | 1973 |
Present treatment of acute leukemias.
Topics: Asparaginase; Blood Transfusion; Cytarabine; Daunorubicin; Humans; Immunotherapy; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocytes; Meninges; Mercaptopurine; Methotrexate; Prednisone; Remission, Spontaneous | 1973 |
[Breakthrough in hematology?].
Topics: Acute Disease; Adult; BCG Vaccine; Blood Transfusion; Daunorubicin; Drug Therapy, Combination; Humans; Immunotherapy; Leukemia; Prednisolone; Remission, Spontaneous; Vincristine | 1974 |
[Burkitt's lymphoma and acute leukemias].
Topics: Acute Disease; Animals; Asparaginase; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Fluorouracil; Humans; Leukemia; Melphalan; Mercaptopurine; Methotrexate; Mice; Oncogenic Viruses; Prednisolone; Prednisone; Vincristine | 1969 |
[Biochemistry of antileukemic drugs].
Topics: Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agents; Asparaginase; Busulfan; Chlorambucil; Cyclophosphamide; Cytarabine; Daunorubicin; Leukemia; Mannomustine; Mercaptopurine; Methotrexate; Vincristine | 1970 |
[Cytostatic chemotherapy of neoplasms in children].
Topics: Adrenal Cortex Hormones; Aminopterin; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Cytarabine; Daunorubicin; Fluorouracil; Humans; Leukemia; Lymphoma; Mercaptopurine; Methotrexate; Nitrogen Mustard Compounds; Procarbazine; Sarcoma; Vinblastine; Vincristine | 1971 |
50 trial(s) available for daunorubicin and Leukemia
| Article | Year |
|---|---|
Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Liposomes; Male; Middle Aged; Nanotechnology; Prognosis | 2012 |
Anaplastic large cell lymphoma treated with a leukemia-like therapy: report of the Italian Association of Pediatric Hematology and Oncology (AIEOP) LNH-92 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Humans; Immunohistochemistry; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Agents; Benzamides; Child; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Haplotypes; Histocompatibility; HLA Antigens; Humans; Imatinib Mesylate; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukemia; Lymphocyte Transfusion; Male; Methotrexate; Mitoxantrone; Pancytopenia; Peripheral Blood Stem Cell Transplantation; Piperazines; Pyrimidines; Recurrence; Remission Induction; Salvage Therapy; Tissue Donors; Treatment Outcome | 2007 |
Studies with anthracyclines in pediatric acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Antibiotics, Antineoplastic; Azacitidine; Child; Child, Preschool; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Naphthacenes; Random Allocation; Sex Factors | 1981 |
Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly.
Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Administration Schedule; Heart; Hemorrhage; Humans; Leukemia; Quality of Life; Random Allocation; Respiratory Distress Syndrome; Thioguanine | 1984 |
Reinduction chemotherapy for acute nonlymphocytic leukemia.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Male; Middle Aged; Retrospective Studies; Thioguanine | 1984 |
New cytotoxic drugs for breast cancer and their clinical evaluation.
Topics: Altretamine; Aminoacridines; Amsacrine; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Doxorubicin; Female; Gallium; Humans; Ifosfamide; Leukemia; Vinblastine; Vindesine; Zinostatin | 1980 |
A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia; Male; Middle Aged; Random Allocation; Thioguanine; United States | 1984 |
Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabine.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Clinical Trials as Topic; Cornea; Cytarabine; Daunorubicin; Double-Blind Method; Female; Humans; Infusions, Parenteral; Keratitis; Leukemia; Male; Middle Aged; Ophthalmic Solutions | 1982 |
Immunotherapy maintenance in acute non-lymphocytic leukaemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hydroxyurea; Immunotherapy; Leukemia; Middle Aged; Prednisolone; Prognosis; Random Allocation; Vincristine | 1982 |
Adjuvant specific immunotherapy in maintenance treatment of adult acute non-lymphocytic leukemia.
Topics: Adolescent; Adult; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Immunotherapy; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Thioguanine; Vincristine | 1981 |
Daunorubicin (Cerubidine).
Topics: Bone Marrow; Clinical Trials as Topic; Daunorubicin; Heart Diseases; Humans; Leukemia | 1980 |
High-dose combination chemotherapy for acute nonlymphoblastic leukemia in adults.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Infections; Leukemia; Middle Aged; Prednisone; Prognosis; Remission, Spontaneous; Thioguanine; Vincristine | 1981 |
Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aging; Antibiotics, Antineoplastic; Bone Marrow Diseases; Clinical Trials as Topic; Daunorubicin; DNA; DNA Adducts; Female; Heart Diseases; Humans; Immunotherapy; Leukemia; Male; Middle Aged | 1981 |
Introduction to New Drug Seminar: Daunorubicin and L-asparaginase.
Topics: Acute Disease; Adult; Asparaginase; Child; Clinical Trials as Topic; Daunorubicin; Drug Evaluation; Humans; Leukemia | 1981 |
Risk factors for development of daunorubicin cardiotoxicity.
Topics: Adolescent; Adult; Age Factors; Clinical Trials as Topic; Daunorubicin; Dose-Response Relationship, Drug; Electrocardiography; Heart Failure; Humans; Leukemia; Middle Aged; Retrospective Studies; Risk; Time Factors | 1981 |
Sequential studies of daunorubicin and adriamycin in acute nonlymphocytic leukemia.
Topics: Acute Disease; Adult; Age Factors; Antineoplastic Agents; Clinical Trials as Topic; Cytarabine; Daunorubicin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leukemia | 1981 |
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Camptothecin; Daunorubicin; Drug Administration Schedule; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Immunohistochemistry; Leukemia; Male; Middle Aged; Mouth Mucosa; Quinidine; Remission Induction; Stomatitis; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1994 |
Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group.
Topics: Acute Disease; Adolescent; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Daunorubicin; Etoposide; Follow-Up Studies; HLA-DR Antigens; Humans; Immunophenotyping; Leukemia; Middle Aged; Predictive Value of Tests; Prognosis; Survival Analysis; Time Factors | 1994 |
[Chemotherapy schedules and bacteremia in adult patients with acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Cytarabine; Daunorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia; Male; Mitoxantrone; Neutropenia; Risk Factors | 1996 |
Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocyte leukemia: a randomized collaborative study.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Meningeal Neoplasms; Methotrexate; Middle Aged; Prednisone; Remission, Spontaneous; Thioguanine; Time Factors; Vincristine | 1978 |
Clinical studies with daunorubicin-DNA and adriamycin-DNA complexes: a review.
Topics: Animals; Child; Daunorubicin; Disease Models, Animal; DNA; DNA Adducts; Doxorubicin; Drug Combinations; Humans; Leukemia; Leukemia, Lymphoid; Mice; Neoplasms; Neoplasms, Experimental; Random Allocation | 1979 |
The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Middle Aged; Prednisone; Prognosis; Remission, Spontaneous; Thioguanine | 1979 |
Interhospital differences in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Finland; Humans; Leukemia; Leukemia, Myeloid, Acute; Middle Aged; Prednisone; Prognosis; Remission, Spontaneous | 1979 |
Clinical trials with daunorubicin-DNA and adriamycin-DNA in acute lymphoblastic leukemia of childhood, acute nonlymphoblastic leukemia, and bronchogenic carcinoma.
Topics: Acute Disease; Carcinoma, Bronchogenic; Child; Clinical Trials as Topic; Daunorubicin; DNA; Doxorubicin; Humans; Leukemia; Leukemia, Lymphoid; Lung Neoplasms; Time Factors | 1979 |
[Revaluation of the two step DCMP chemotherapy for acute leukemias (author's transl)].
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Prednisolone | 1979 |
Treatment of acute nonlymphoid leukaemia with five different schedules including cytosine arabinoside and 6-thioguanine.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Thioguanine; Vincristine | 1977 |
Intensification of remission induction therapy for acute nonlymphocytic leukemia (ANLL). I. Response and toxicity in four different regimens.
Topics: Acute Disease; Age Factors; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Ifosfamide; Leukemia; Methods; Middle Aged; Thioguanine; Vincristine | 1979 |
Liquid chromatographic monitoring of daunorubicin and daunorubicinol in plasma from leukemic patients treated with daunorubicin or the daunorubicin-DNA complex.
Topics: Animals; Chromatography, Liquid; Daunorubicin; DNA; Humans; Hydroxylation; Kinetics; Leukemia; Methods | 1979 |
Treatment of acute nonlymphoblastic leukemia in adults with daunorubicin-DNA complex: a preliminary report.
Topics: Acute Disease; Daunorubicin; DNA; Evaluation Studies as Topic; Humans; Leukemia; Middle Aged; Time Factors | 1979 |
Chemotherapy of acute leukemia: a comparison of vincristine, cytarabine, and prednisone alone and in combination with cyclophosphamide or daunorubicin.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Leukemia; Male; Middle Aged; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1978 |
Progress in the treatment of adults with acute leukemia: review of regimens containing cytarabine studied by the Southwest Oncology Group.
Topics: Acute Disease; Adult; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Middle Aged; Prednisone; Vincristine | 1976 |
Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia.
Topics: Acute Disease; Aged; Antineoplastic Agents; Bone Marrow; Central Nervous System Diseases; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Guanazole; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Meninges; Middle Aged; Pyrimethamine; Remission, Spontaneous; Skin Tests; Thioguanine | 1976 |
Cell kinetics in leukemia. Correlation with clinical features and response to chemotherapy.
Topics: Bone Marrow; Bone Marrow Cells; Cytarabine; Daunorubicin; DNA, Neoplasm; Drug Therapy, Combination; Humans; Kinetics; Leucovorin; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Methotrexate; Mitotic Index; Thioguanine | 1975 |
Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy. Leukemia Group of Middle Sweden.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Ceftazidime; Cytarabine; Daunorubicin; Female; Fever; Fever of Unknown Origin; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Thioguanine | 1992 |
Plasma pharmacokinetics and cerebrospinal fluid concentrations of idarubicin and idarubicinol in pediatric leukemia patients: a Childrens Cancer Study Group report.
Topics: Adolescent; Adult; Child; Child, Preschool; Daunorubicin; Drug Evaluation; Humans; Idarubicin; Infant; Leukemia | 1990 |
Induction failures in childhood acute nonlymphocytic leukemia: etoposide/5-azacytidine for cases refractory to daunorubicin/cytarabine.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia; Male | 1986 |
Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Leukemia; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Random Allocation; Remission Induction | 1989 |
Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Remission Induction | 1989 |
Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Administration Schedule; Follow-Up Studies; Humans; Leukemia; Thioguanine | 1988 |
Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B.
Topics: Acute Disease; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Humans; Leukemia; Middle Aged; Prognosis | 1987 |
Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study.
Topics: Acute Disease; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Leukemia; Prognosis; Random Allocation; Remission Induction; Research Design; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Growth response of residual leukemia after initial drug therapy.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cytarabine; Daunorubicin; Humans; Leukemia; Middle Aged | 1986 |
Treatment of patients with acute nonlymphocytic leukemia in relapse: a Leukemia Intergroup study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Clinical Trials as Topic; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Platelet Count | 1985 |
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
Topics: Aging; Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Asparaginase; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; DNA; Dose-Response Relationship, Drug; Drug Resistance; Humans; Kinetics; Leukemia; Leukemia, Lymphoid; Middle Aged; Time Factors | 1985 |
High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.
Topics: Acute Disease; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Bone Marrow; Clinical Trials as Topic; Cytarabine; Daunorubicin; Doxorubicin; Humans; Leukemia; Naphthacenes; Time Factors | 1985 |
Rubidazone in the treatment of recurrent acute leukemia in children. A Pediatric Oncology Group Study.
Topics: Acute Disease; Adolescent; Antibiotics, Antineoplastic; Child; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Leukemia; Random Allocation | 1986 |
[Results of follow-up studies on prognosis after immunotherapy with bestatin in acute nonlymphocytic leukemia].
Topics: Aclarubicin; Acute Disease; Adjuvants, Immunologic; Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Follow-Up Studies; Humans; Leucine; Leukemia; Mercaptopurine; Middle Aged; Naphthacenes; Prednisolone; Prognosis; Random Allocation | 1986 |
Daunomycin (NSC-82151) in the treatment of metastatic neuroblastoma.
Topics: Adolescent; Anemia; Bone Marrow Diseases; Child; Child, Preschool; Clinical Trials as Topic; Daunorubicin; Female; Humans; Infant; Leukemia; Male; Neuroblastoma | 1970 |
[Toxic side effects of daunomycin in children].
Topics: Alopecia; Antibody Formation; Bone Marrow; Bone Marrow Cells; Child; Child, Preschool; Chromosome Aberrations; Daunorubicin; Drug Hypersensitivity; Heart; Humans; Immunosuppressive Agents; Inflammation; Intestinal Mucosa; Leukemia; Leukocytes; Leukopenia; Lymphocyte Activation; Mercaptopurine | 1970 |
479 other study(ies) available for daunorubicin and Leukemia
| Article | Year |
|---|---|
Angiokeratoma-like purpuric palmar nodules following chemotherapy.
Topics: Angiokeratoma; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Diagnosis, Differential; Female; Hand Dermatoses; Humans; Hydroxyurea; Leukemia; Methotrexate; Middle Aged; Purpura; Skin Neoplasms | 2021 |
Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia.
Topics: Cytarabine; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Leukemia; Mitochondria; Oxidative Phosphorylation; Sphingolipids; Vincristine | 2022 |
The gallium complex KP46 sensitizes resistant leukemia cells and overcomes Bcl-2-induced multidrug resistance in lymphoma cells via upregulation of Harakiri and downregulation of XIAP in vitro.
Topics: Apoptosis; Daunorubicin; Down-Regulation; Drug Resistance, Multiple; Gallium; Humans; Leukemia; Lymphoma; Organometallic Compounds; Up-Regulation; X-Linked Inhibitor of Apoptosis Protein | 2022 |
Topics: Apoptosis; Artesunate; Caspase 3; Caspase 9; Cell Line; Cytarabine; Daunorubicin; Humans; Leukemia; Leukemia, Myeloid, Acute; Mutation; Retrospective Studies | 2022 |
Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles.
Topics: Animals; Cell Line, Tumor; Daunorubicin; Drug Delivery Systems; Leukemia; Ligands; Luteolin; Mice; Nanoparticles; Oligonucleotides; Transferrin | 2023 |
Multiple lineage switches in KMT2A rearranged infant leukemia, responsive to combination therapy with CPX-351 and inotuzumab.
Topics: Cytarabine; Daunorubicin; Humans; Infant; Leukemia | 2023 |
SIRT6-PARP1 is involved in HMGB1 polyADP-ribosylation and acetylation and promotes chemotherapy-induced autophagy in leukemia.
Topics: Acetylation; Antibiotics, Antineoplastic; Apoptosis; Autophagy; Biomarkers, Tumor; Cell Proliferation; Daunorubicin; Gene Expression Regulation, Neoplastic; HMGB1 Protein; Humans; Leukemia; Poly (ADP-Ribose) Polymerase-1; Poly ADP Ribosylation; Sirtuins; Tumor Cells, Cultured | 2020 |
Acute leukemias in 2020: state of the art.
Topics: Acute Disease; Aminopyridines; Antineoplastic Agents; Antineoplastic Agents, Immunological; Congresses as Topic; Cytarabine; Daunorubicin; fms-Like Tyrosine Kinase 3; Gemtuzumab; Glycine; Humans; Leukemia; Pyridines; Recombinant Fusion Proteins; Staurosporine; Triazines | 2020 |
Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment.
Topics: Annexin A5; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Caspases; Cell Line, Tumor; Daunorubicin; Humans; Leukemia; Membrane Potential, Mitochondrial | 2021 |
LncRNA UCA1 elevates the resistance of human leukemia cells to daunorubicin by the PI3K/AKT pathway via sponging miR-613.
Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Cycle; Cell Movement; Cell Proliferation; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Leukemia; MicroRNAs; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; RNA, Long Noncoding; Signal Transduction; U937 Cells | 2021 |
Involvement of miR-125a in resistance to daunorubicin by inhibiting apoptosis in leukemia cell lines.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Female; G-Protein-Coupled Receptor Kinase 2; Humans; Leukemia; Male; MicroRNAs; Middle Aged; Proto-Oncogene Proteins | 2017 |
DACT1 overexpression inhibits proliferation, enhances apoptosis, and increases daunorubicin chemosensitivity in KG-1α cells.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta Catenin; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Daunorubicin; G1 Phase; Gene Expression Regulation, Leukemic; Humans; Leukemia; Nuclear Proteins; Resting Phase, Cell Cycle; Transfection; Up-Regulation; Wnt Signaling Pathway | 2017 |
Metal-free salan-type compound induces apoptosis and overcomes multidrug resistance in leukemic and lymphoma cells in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia; Lymphoma; Neoplasms; Phenylenediamines; Salicylates; Vincristine | 2018 |
Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Survival; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p27; Daunorubicin; DNA Damage; Doxorubicin; Erythropoietin; Humans; Leukemia; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53 | 2019 |
Enhancing cytotoxicity of daunorubicin on drug-resistant leukaemia cells with microparticle-mediated drug delivery system.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Daunorubicin; Drug Carriers; Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Leukemia | 2019 |
Involvement of c-Jun N-terminal kinase in reversal of multidrug resistance of human leukemia cells in hypoxia by 5-bromotetrandrine.
Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Caspase 3; Cell Hypoxia; Cell Line, Tumor; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia; Phosphorylation; RNA Interference; Signal Transduction | 2013 |
[Prof. Dr. Hansjörg Riehm, a life devoted to science].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Daunorubicin; Faculty, Medical; Germany; History, 20th Century; History, 21st Century; Humans; Leukemia; Lymphoma; Medical Oncology; Pediatrics; Prednisone; Science; Vincristine | 2013 |
[Organ toxicity and efficacy of high-dose daunorubicin-based chemotherapy in the treatment of acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Female; Humans; Leukemia; Male; Middle Aged; Retrospective Studies; Young Adult | 2013 |
Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia.
Topics: Antibiotics, Antineoplastic; Cell Survival; Daunorubicin; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; K562 Cells; Leukemia; Molecular Dynamics Simulation; Nanodiamonds; Nanomedicine; Time Factors | 2014 |
Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines.
Topics: Daunorubicin; DNA Damage; DNA End-Joining Repair; DNA Ligase ATP; DNA Ligases; DNA Repair; DNA-Activated Protein Kinase; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Immunoglobulins; K562 Cells; Leukemia; Nuclear Proteins; Phosphorylation; RNA, Messenger | 2014 |
microRNA‑125b promotes leukemia cell resistance to daunorubicin by inhibiting apoptosis.
Topics: Adolescent; Adult; Aged; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Female; G-Protein-Coupled Receptor Kinase 2; Gene Expression; Gene Expression Regulation, Leukemic; Gene Knockdown Techniques; Humans; Leukemia; Male; MicroRNAs; Middle Aged; Proto-Oncogene Proteins; Young Adult | 2014 |
Knockdown of RLIP76 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to daunorubicin in U937 leukemia cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; ATP-Binding Cassette Transporters; Cell Cycle Checkpoints; Cell Differentiation; Cell Proliferation; Daunorubicin; GTPase-Activating Proteins; Humans; Leukemia; RNA Interference; RNA, Small Interfering; U937 Cells | 2014 |
A subset of bone marrow stromal cells regulate ATP-binding cassette gene expression via insulin-like growth factor-I in a leukemia cell line.
Topics: ATP-Binding Cassette Transporters; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Insulin-Like Growth Factor I; Leukemia; Mesenchymal Stem Cells; Podophyllotoxin; Receptor, IGF Type 1; Receptors, Somatomedin | 2014 |
The antileukemia roles of PP242 alone or in combination with daunorubicin in acute leukemia.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Synergism; Eukaryotic Initiation Factor-4E; Humans; Indoles; Leukemia; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Mantle-Cell; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Myeloid Cell Leukemia Sequence 1 Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Purines; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
[Therapeutic study of leukemia by pegylated liposomal daunorubicin].
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Daunorubicin; Leukemia; Mice | 2014 |
Rewired metabolism in drug-resistant leukemia cells: a metabolic switch hallmarked by reduced dependence on exogenous glutamine.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Acetyl-CoA C-Acyltransferase; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbon-Carbon Double Bond Isomerases; Cell Line, Tumor; Cyclosporins; Daunorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enoyl-CoA Hydratase; Fatty Acids; Glutamine; Glycolysis; Humans; Leukemia; Metabolome; Oxidation-Reduction; Pantothenic Acid; Perhexiline; Racemases and Epimerases; RNA, Messenger; Transcriptome | 2015 |
[Effects of Garcinia Acid Combined with Daunorubicin on Expression of Pregnane X Receptor in Leukemia Cell Line K562/A02].
Topics: Citrates; Daunorubicin; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells; Leukemia; Pregnane X Receptor; Real-Time Polymerase Chain Reaction; Receptors, Steroid; Xanthones | 2015 |
Daunorubicin-Loaded DNA Origami Nanostructures Circumvent Drug-Resistance Mechanisms in a Leukemia Model.
Topics: Animals; Daunorubicin; DNA Adducts; Doxorubicin; Drug Delivery Systems; Drug Resistance, Neoplasm; Endocytosis; HL-60 Cells; Horses; Humans; Intercalating Agents; Leukemia; Lysosomes; Models, Biological; Nanostructures; Nucleic Acid Conformation | 2016 |
Increased lanosterol turnover: a metabolic burden for daunorubicin-resistant leukemia cells.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Chromatography, Liquid; Daunorubicin; Drug Resistance, Neoplasm; Humans; Lanosterol; Leukemia; Mass Spectrometry; Polymerase Chain Reaction | 2016 |
Double targeting, controlled release and reversible delivery of daunorubicin to cancer cells by polyvalent aptamers-modified gold nanoparticles.
Topics: Antineoplastic Agents; Aptamers, Nucleotide; Cell Line, Tumor; Cell Survival; Daunorubicin; Drug Carriers; Gold; Humans; Hydrogen-Ion Concentration; Leukemia; Metal Nanoparticles; Oligonucleotides, Antisense | 2016 |
Synergistic antitumor activity of triple-regulated oncolytic adenovirus with VSTM1 and daunorubicin in leukemic cells.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Combined Modality Therapy; Daunorubicin; Female; Genetic Therapy; Genetic Vectors; Humans; Leukemia; Mice; Mice, Inbred BALB C; Mice, Nude; Oncolytic Virotherapy; Oncolytic Viruses; Receptors, Immunologic | 2016 |
Adipocytes cause leukemia cell resistance to daunorubicin via oxidative stress response.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Antibiotics, Antineoplastic; Antioxidants; Cell Death; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Profiling; Glutathione; Humans; Leukemia; Mice; Oxidative Stress; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species | 2016 |
Myosin phosphatase interacts with and dephosphorylates the retinoblastoma protein in THP-1 leukemic cells: its inhibition is involved in the attenuation of daunorubicin-induced cell death by calyculin-A.
Topics: Caspase 3; Cell Death; Cell Line; Cell Survival; Daunorubicin; Humans; Immunoprecipitation; Leukemia; Marine Toxins; Myosin-Light-Chain Phosphatase; Oxazoles; Phosphorylation; Protein Binding; Protein Phosphatase 1; Protein Processing, Post-Translational; Protein Subunits; Protein Transport; Retinoblastoma Protein; Subcellular Fractions; Surface Plasmon Resonance | 2008 |
Synergistic cytotoxic effect of different sized ZnO nanoparticles and daunorubicin against leukemia cancer cells under UV irradiation.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Daunorubicin; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Resistance, Neoplasm; Drug Synergism; Humans; K562 Cells; Leukemia; Metal Nanoparticles; Microscopy, Fluorescence; Photosensitizing Agents; Ultraviolet Rays; Zinc Oxide | 2008 |
The pH sensitive probe 5-(and-6)-carboxyl seminaphthorhodafluor is a substrate for the multidrug resistance-related protein MRP1.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzopyrans; Cytosol; Daunorubicin; Doxorubicin; Fluorescent Dyes; HL-60 Cells; Humans; Hydrogen-Ion Concentration; K562 Cells; Leukemia; Leukotriene Antagonists; Multidrug Resistance-Associated Proteins; Naphthols; Propionates; Quinolines; Rhodamines | 2009 |
Selective modulation of P-glycoprotein activity by steroidal saponines from Paris polyphylla.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cyclosporine; Daunorubicin; Diosgenin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ecdysteroids; Ecdysterone; Humans; Immunosuppressive Agents; K562 Cells; Leukemia; Magnoliopsida; Membrane Transport Modulators; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Plant Extracts; Rhizome; Saponins; Spirostans; Steroids | 2009 |
Synergistic effect of the combination of nanoparticulate Fe3O4 and Au with daunomycin on K562/A02 cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Drug Synergism; Ferric Compounds; Gold; Humans; K562 Cells; Leukemia; Nanoparticles | 2008 |
Study on the enhanced cellular uptake effect of daunorubicin on leukemia cells mediated via functionalized nickel nanoparticles.
Topics: Antineoplastic Agents; Biocompatible Materials; Cell Line, Tumor; Daunorubicin; Electrochemistry; Humans; K562 Cells; Leukemia; Metal Nanoparticles; Microscopy, Atomic Force; Microscopy, Fluorescence; Nanotechnology; Nickel; Permeability; Tetrazolium Salts; Thiazoles | 2009 |
siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53.
Topics: Antineoplastic Agents; Apoptosis; Base Sequence; Cell Division; Cell Line, Tumor; Daunorubicin; DNA Primers; Down-Regulation; Etoposide; Humans; Intracellular Signaling Peptides and Proteins; Leukemia; Repressor Proteins; RNA, Messenger; RNA, Small Interfering; Tumor Suppressor Protein p53 | 2009 |
Daunorubicin-loaded magnetic nanoparticles of Fe(3)O(4) greatly enhance the responses of multidrug-resistant K562 leukemic cells in a nude mouse xenograft model to chemotherapy.
Topics: Animals; Daunorubicin; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; K562 Cells; Leukemia; Magnetics; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Treatment Outcome; Xenograft Model Antitumor Assays | 2009 |
Magnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Benzylisoquinolines; Daunorubicin; Drug Carriers; Ferric Compounds; Humans; K562 Cells; Leukemia; Nanoparticles | 2009 |
Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Benzylisoquinolines; Daunorubicin; Drug Carriers; Drug Resistance, Multiple; Ferric Compounds; Humans; K562 Cells; Leukemia; Mice; Mice, Nude; Nanoparticles; Treatment Outcome | 2009 |
New daunomycin-oligoarginine conjugates: synthesis, characterization, and effect on human leukemia and human hepatoma cells.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Daunorubicin; Drug Screening Assays, Antitumor; Hep G2 Cells; HL-60 Cells; Humans; Leukemia; Peptides | 2009 |
Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromones; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; K562 Cells; Leukemia; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Stomach Neoplasms; Vincristine | 2009 |
[Relationship between pharmacokinetics and efficacy and toxicity of daunorubicin in children with acute leukemia].
Topics: Antibiotics, Antineoplastic; Child; Child, Preschool; Chromatography, High Pressure Liquid; Daunorubicin; Drug Monitoring; Female; Humans; Infant; Leukemia; Male | 2009 |
It's not easy being small.
Topics: Antineoplastic Agents; Child; Daunorubicin; Dose-Response Relationship, Drug; Humans; Infant; Leukemia; Medical Oncology; Pediatrics | 2010 |
The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro.
Topics: Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Gemtuzumab; HL-60 Cells; Humans; Idarubicin; Immunotoxins; Leukemia; Mercaptopurine; Methotrexate; Mitoxantrone; Sialic Acid Binding Ig-like Lectin 3; U937 Cells; Vincristine | 2009 |
Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cytarabine; Daunorubicin; Fusion Proteins, bcr-abl; Humans; Leukemia; Molecular Structure; Pentacyclic Triterpenes; Plant Extracts; Prodrugs; Triterpenes | 2010 |
Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays.
Topics: ADP-ribosyl Cyclase 1; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cell Culture Techniques; Cell Line, Tumor; Cell Separation; Chromium Isotopes; Cytarabine; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Daunorubicin; Flow Cytometry; Humans; Killer Cells, Natural; Leukemia; Neoplastic Stem Cells; Sensitivity and Specificity; Tumor Stem Cell Assay | 2010 |
Imaging and inhibition of multi-drug resistance in cancer cells via specific association with negatively charged CdTe quantum dots.
Topics: Antibiotics, Antineoplastic; Cadmium Compounds; Cell Line, Tumor; Cell Survival; Daunorubicin; Drug Resistance, Neoplasm; Humans; Leukemia; Quantum Dots; Tellurium | 2010 |
[Successful selection of chemotherapy based on cell surface antigens in a patient with mixed phenotype acute leukemia].
Topics: Acute Disease; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Leukemia; Male; Middle Aged; Prednisolone; Treatment Outcome; Vincristine | 2010 |
The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells.
Topics: Animals; Antineoplastic Agents; Antiparasitic Agents; Calcium; Cell Death; Cell Line, Tumor; Cell Membrane; Cell Size; Cell Survival; Chlorides; Cytarabine; Daunorubicin; Drug Synergism; Gene Expression Regulation, Leukemic; Humans; Ivermectin; Leukemia; Mice; Mice, SCID; Reactive Oxygen Species; Tumor Cells, Cultured | 2010 |
Adhesion-induced drug resistance in leukemia stem cells.
Topics: Antineoplastic Agents; Bone Marrow Cells; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Coculture Techniques; Cyclin-Dependent Kinase Inhibitor Proteins; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Leukemia; Lysosomes; Neoplastic Stem Cells; Osmolar Concentration; Proto-Oncogene Proteins c-bcl-2; Stem Cell Niche; Stromal Cells; Up-Regulation; Vacuolar Proton-Translocating ATPases | 2010 |
Acute myeloid leukemia associated with t(10;17)(p13-15;q12-21) and phagocytic activity by leukemic blasts: a clinical study and review of the literature.
Topics: Adolescent; Adult; Antigens, CD; Antimetabolites, Antineoplastic; Blast Crisis; Child; Chromosome Mapping; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Magnetic Resonance Imaging; Male; Middle Aged; Peroxidase; Phagocytes; Translocation, Genetic | 2010 |
[NT-pro-BNP in the evaluation of daunorubicin-indued cardiotoxicity in acute childhood leukemia].
Topics: Anthracyclines; Cardiotoxicity; Daunorubicin; Humans; Idarubicin; Leukemia | 2010 |
[Fe(III)(salophene)Cl], a potent iron salophene complex overcomes multiple drug resistance in lymphoma and leukemia cells.
Topics: Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ferric Compounds; Humans; Leukemia; Lymphoma; Membrane Potential, Mitochondrial; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Salicylates; Vincristine | 2011 |
Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line.
Topics: Antineoplastic Agents; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Humans; K562 Cells; Leukemia; MicroRNAs; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase | 2011 |
[Influence of arsenic trioxide and daunorubicin on the expression of annexin II and fibrinolytic activity in NB4 cells].
Topics: Annexin A2; Apoptosis; Daunorubicin; HL-60 Cells; Humans; Leukemia | 2010 |
Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; Cell Line, Tumor; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Flow Cytometry; Humans; K562 Cells; Leukemia; Morpholines | 2011 |
Rapid diagnosis of multidrug resistance in cancer by electrochemical sensor based on carbon nanotubes-drug supramolecular nanocomposites.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Electrochemical Techniques; Humans; K562 Cells; Leukemia; Nanocomposites; Nanotubes, Carbon | 2011 |
Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles.
Topics: Apoptosis; Daunorubicin; Delayed-Action Preparations; Humans; Inhibitory Concentration 50; K562 Cells; Leukemia; Magnetite Nanoparticles; Microscopy, Electron, Transmission; Nanomedicine; Oleic Acid; Particle Size; Poloxamer | 2011 |
Ultrasound mediated drug-loaded nanoparticles crossing cell membranes as a new strategy to reverse cancer multidrug resistance.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Membrane; Daunorubicin; Diffusion; Electroporation; Humans; Leukemia; Nanocapsules; Sonication; Treatment Outcome | 2011 |
[Effect of daunorubicin and rapamycin combination on the proliferation of acute leukemia cells].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Daunorubicin; Female; Humans; Leukemia; Male; Middle Aged; Sirolimus; Young Adult | 2011 |
In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells.
Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Busulfan; Cell Line, Tumor; Daunorubicin; Drug Interactions; Drug Synergism; Etoposide; Exotoxins; Flow Cytometry; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia; Leukocytes; Lymphocyte Function-Associated Antigen-1; Membrane Potential, Mitochondrial; Mitoxantrone; Piperazines; Pyrimidines; Tumor Cells, Cultured | 2011 |
Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
Topics: Analysis of Variance; Apoptosis; Benzylisoquinolines; Daunorubicin; Delayed-Action Preparations; Drug Delivery Systems; Electrophoresis, Agar Gel; Flow Cytometry; Humans; K562 Cells; Leukemia; Magnetite Nanoparticles; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
Topics: Analysis of Variance; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Daunorubicin; Dose-Response Relationship, Drug; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells; Leukemia; Magnetite Nanoparticles; Microscopy, Fluorescence | 2011 |
Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; G2 Phase Cell Cycle Checkpoints; Humans; K562 Cells; Leukemia; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyrazines | 2012 |
Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription.
Topics: Activating Transcription Factor 2; Animals; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Benzoquinones; Cell Line, Tumor; Cyclic AMP; Cyclic AMP Response Element Modulator; Cyclic AMP-Dependent Protein Kinase Type I; Cyclic AMP-Dependent Protein Kinase Type II; Cyclin-Dependent Kinases; Daunorubicin; Drug Synergism; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Lactams, Macrocyclic; Leukemia; Membrane Proteins; Proto-Oncogene Proteins; Rats; RNA Interference; Transcription, Genetic | 2011 |
Reversal of multidrug resistance-associated protein-mediated daunorubicin resistance by camptothecin.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cell Line; Cell Nucleus; Chemokines, CC; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Microscopy, Confocal; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2002 |
[Progress in the field of hematology in the last 100 years: Medical history of acute leukemia].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; History, 20th Century; Humans; Japan; Leukemia; Mercaptopurine; Prednisolone; Vincristine | 2002 |
Comparison of anthracycline-induced death of human leukemia cells: programmed cell death versus necrosis.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Caspases; Cell Death; Cell Membrane; Daunorubicin; DNA Fragmentation; Doxorubicin; Enzyme Activation; HL-60 Cells; Humans; Jurkat Cells; Leukemia; Models, Biological; Necrosis; Phosphatidylserines; Proteins | 2002 |
Daunorubicin- and Ara-C-induced interphasic apoptosis of human type II leukemia cells is caspase-8-independent.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Carrier Proteins; Caspase 8; Caspase 9; Caspases; Ceramides; Cytarabine; Daunorubicin; DNA Damage; Fas-Associated Death Domain Protein; Humans; Interphase; Jurkat Cells; Leukemia; Mutation; Time Factors; Tumor Cells, Cultured | 2002 |
Protein kinase Czeta mediated Raf-1/extracellular-regulated kinase activation by daunorubicin.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetylcysteine; Androstadienes; Antibiotics, Antineoplastic; Antioxidants; Bridged-Ring Compounds; Cell Death; Daunorubicin; Diglycerides; Enzyme Activation; Flavonoids; Humans; Leukemia; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Norbornanes; Phosphatidylcholines; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-raf; Reactive Oxygen Species; Thiocarbamates; Thiones; Transfection; Tumor Cells, Cultured; Wortmannin | 2003 |
Drug sensitivity assay for leukaemic cells by flow cytometry.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Hormonal; Daunorubicin; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Leukemia; Prednisolone; Tumor Cells, Cultured | 2002 |
The effect of the Fas/FasL pathway during chemotherapeutic drug-induced apoptosis of leukaemeic cells.
Topics: Apoptosis; Cytarabine; Daunorubicin; Fas Ligand Protein; fas Receptor; HL-60 Cells; Humans; K562 Cells; Leukemia; Membrane Glycoproteins; U937 Cells | 2001 |
Inactivation of deoxycytidine kinase and overexpression of P-glycoprotein in AraC and daunorubicin double resistant leukemic cell lines.
Topics: 2-Chloroadenosine; Alternative Splicing; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azacitidine; Biological Transport; Buthionine Sulfoximine; Calcium Channel Blockers; Cytarabine; Daunorubicin; Decitabine; Deoxyadenosines; Deoxycytidine Kinase; DNA Mutational Analysis; DNA, Neoplasm; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glutathione; Humans; Idarubicin; Leukemia; Methotrexate; Neoplasm Proteins; Rats; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Verapamil | 2003 |
Telomerase inhibition enhances apoptosis in human acute leukemia cells: possibility of antitelomerase therapy.
Topics: Acute Disease; Animals; Apoptosis; Daunorubicin; DNA-Binding Proteins; Drug Synergism; Genes, Dominant; Genetic Therapy; Humans; Leukemia; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; Telomerase; Telomere; Transfection; Tumor Cells, Cultured | 2003 |
New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA.
Topics: Antibiotics, Antineoplastic; Cell Nucleus; Circular Dichroism; Daunorubicin; DNA; Intercalating Agents; Leukemia; Tumor Cells, Cultured | 2003 |
[Study of CYP3A5 in drug resistance mechanisms in acute leukemia].
Topics: Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Daunorubicin; Drug Resistance, Neoplasm; Humans; Leukemia; RNA, Messenger; Tumor Cells, Cultured | 2003 |
[A NEW ANTIBIOTIC WITH CYTOSTATIC PROPERTIES: RUBIDOMYCIN].
Topics: Adenocarcinoma; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Benzopyrenes; Carcinoma, Ehrlich Tumor; Daunorubicin; Leukemia; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Neoplasms; Research; Sarcoma 180; Sarcoma, Experimental; Streptomyces; Toxicology | 1963 |
RUBIDOMYCIN: A NEW ANTIBIOTIC WITH CYTOSTATIC PROPERTIES.
Topics: Animals; Anti-Bacterial Agents; Carcinoma, Ehrlich Tumor; Daunorubicin; Leukemia; Leukemia, Experimental; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Neoplasms; Neoplasms, Experimental; Pathology; Research; Sarcoma 180; Sarcoma, Experimental; Toxicology | 1964 |
Resveratrol inhibits drug-induced apoptosis in human leukemia cells by creating an intracellular milieu nonpermissive for death execution.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Daunorubicin; HL-60 Cells; Humans; Hydrogen Peroxide; Leukemia; Mitochondria; NADPH Oxidases; Oxidation-Reduction; Resveratrol; Stilbenes; Superoxides; Vincristine | 2004 |
Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines.
Topics: Antineoplastic Agents; Benzamides; Cell Death; Cell Division; Cell Line, Tumor; Cytarabine; Daunorubicin; Diphosphonates; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Hydroxyurea; Imatinib Mesylate; Imidazoles; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Piperazines; Pyrimidines; Vincristine; Zoledronic Acid | 2004 |
Pharmacokinetics of erythrocyte-bound daunorubicin in patients with acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Antibiotics, Antineoplastic; Daunorubicin; Erythrocyte Deformability; Erythrocytes; Female; Humans; Leukemia; Male; Middle Aged | 2004 |
Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Case Management; Cytarabine; Daunorubicin; Etoposide; Female; Hemoglobins; Hemorrhage; Humans; Jehovah's Witnesses; Leukemia; Male; Middle Aged; Multiple Organ Failure; Patient Acceptance of Health Care; Refusal to Treat; Remission Induction; Tretinoin; Vincristine | 2004 |
[Effect of ATRA and DNR on the expression and secretion of VEGF in leukemic cells].
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Leukemia; Tretinoin; Vascular Endothelial Growth Factors | 2004 |
Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells.
Topics: Antineoplastic Agents; Cell Division; Cell Line; Cell Line, Tumor; Cytarabine; Daunorubicin; Drug Synergism; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Leukemia; Pyrroles; Sunitinib; Zinc Fingers | 2004 |
[The relationship between cytochrome P450, subfamily IIIA, polypeptide 5 gene and drug resistance in leukemia cell lines].
Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression; HL-60 Cells; Humans; Jurkat Cells; K562 Cells; Leukemia; RNA, Messenger; Transcription, Genetic; U937 Cells | 2004 |
Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blotting, Western; Daunorubicin; DNA Primers; Flow Cytometry; Humans; K562 Cells; Leukemia; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering | 2004 |
[Damage of vascular endothelium in the treatment of acute leukemia: in vitro study].
Topics: Acute Disease; Antineoplastic Agents; Cell Survival; Cells, Cultured; Culture Media; Cytarabine; Daunorubicin; Endothelial Cells; Endothelium, Vascular; Flow Cytometry; Humans; Immunohistochemistry; Leukemia; Models, Biological; Time Factors; Umbilical Veins | 2004 |
[Biological characteristics of residual leukemic cells and their drug-resistant regrowth].
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Leukemia; Male; Mice; Neoplasm, Residual | 1997 |
[Leukemic bone marrow stromal cells in vitro protect leukemic cell line Jurkat cells from daunorubicin-induced apoptosis].
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Apoptosis; Bone Marrow Cells; Child; Child, Preschool; Coculture Techniques; Daunorubicin; Female; Humans; Interphase; Jurkat Cells; Leukemia; Male; Middle Aged; Stromal Cells | 2005 |
[Inhibitory effect of daunorubicin enhanced by PDTC on drug-resistant leukemic cells in vitro].
Topics: Antineoplastic Agents; Bone Marrow Cells; Cell Proliferation; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia; Leukocytes, Mononuclear; Proline; Thiocarbamates; Tumor Cells, Cultured | 2005 |
Optimization of PKH67 labeling conditions for proliferation monitoring in daunorubicin-treated leukemic cells.
Topics: Analysis of Variance; Antibiotics, Antineoplastic; Cell Nucleus; Cell Proliferation; Cell Survival; Daunorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescence; Fluorescent Dyes; Humans; K562 Cells; Leukemia; Microscopy, Confocal; Organic Chemicals; Spectrometry, Fluorescence; Vincristine | 2005 |
Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide--AcSDKP.
Topics: Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bromodeoxyuridine; Cell Proliferation; Cytarabine; Daunorubicin; DNA; Etoposide; Flow Cytometry; Fluorescent Dyes; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydrocarbons, Chlorinated; Leukemia; Leukemia, Myeloid, Acute; Microscopy, Fluorescence; Oligopeptides; Organic Chemicals; Radiation-Protective Agents | 2005 |
Zygomycosis in the immunocompromised patient: a case report.
Topics: Absidia; Acute Disease; Aerosols; Amphotericin B; Amsacrine; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Daunorubicin; Debridement; Drug Resistance, Fungal; Drug Resistance, Neoplasm; Etoposide; Fluconazole; Humans; Immunocompromised Host; Leukemia; Liposomes; Middle Aged; Mucormycosis; Sinusitis; Tomography, X-Ray Computed | 2006 |
The application of Fe3O4 nanoparticles in cancer research: a new strategy to inhibit drug resistance.
Topics: Antibiotics, Antineoplastic; Coated Materials, Biocompatible; Daunorubicin; Drug Delivery Systems; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ferric Compounds; Humans; K562 Cells; Leukemia; Magnetics; Nanoparticles; Quaternary Ammonium Compounds | 2007 |
Involvement of caspase-8 in chemotherapy-induced apoptosis of patient derived leukemia cell lines independent of the death receptor pathway and downstream from mitochondria.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Caspase 8; Caspase 9; Cell Line, Tumor; Daunorubicin; Enzyme Activation; Humans; Leukemia; Mitochondria; Receptors, Death Domain | 2007 |
[Study on RNA interference reversing the multidrug resistance of leukemia cell].
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Cell Line, Tumor; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Leukemia; Molecular Sequence Data; RNA Interference; RNA, Messenger; Transfection | 2007 |
Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-Associated Death Protein; bcl-X Protein; Caspase 9; Cell Growth Processes; Cell Line, Tumor; Cytarabine; Daunorubicin; Drug Synergism; Enzyme Activation; Epirubicin; Female; Humans; Intercellular Signaling Peptides and Proteins; Leukemia; MAP Kinase Kinase 4; Mice; Mice, SCID; Mitogen-Activated Protein Kinases; Oncogene Protein v-akt; Proto-Oncogene Proteins c-bcl-2 | 2007 |
Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Survival; Child; Child, Preschool; Coloring Agents; Cytarabine; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Infant; Inhibitory Concentration 50; Leukemia; Leukemia, Myeloid; Male; Methylphenazonium Methosulfate; Middle Aged; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Staining and Labeling; Tetrazolium Salts; Thiazoles; Treatment Outcome; Tumor Cells, Cultured | 2007 |
AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Aurora Kinase A; Aurora Kinase B; Aurora Kinases; Case-Control Studies; Cell Cycle; Cell Proliferation; Colony-Forming Units Assay; Daunorubicin; Drug Synergism; Drug Therapy, Combination; Drug Tolerance; Enzyme Inhibitors; Female; Flow Cytometry; Humans; Immunoblotting; Leukemia; Mice; Mice, Inbred BALB C; Organophosphates; Protein Serine-Threonine Kinases; Quinazolines; Thymidine; Transplantation, Heterologous; Tubulin Modulators; Vincristine | 2007 |
Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death.
Topics: Amino Acid Sequence; Animals; Anthracyclines; Antibiotics, Antineoplastic; Cell Death; Cycloheximide; Daunorubicin; Down-Regulation; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Leukemia; Mice; Mice, SCID; Molecular Sequence Data; Neoplasm Proteins; Neoplasm Transplantation; Peptides; Phenotype; Phosphorylation; Protein Biosynthesis; Rats; Survival Analysis | 2008 |
Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells.
Topics: Antibiotics, Antineoplastic; Biomarkers; Cell Line, Tumor; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Leukemia; Lysophospholipids; Phosphotransferases (Alcohol Group Acceptor); Sphingosine | 2008 |
5-azactidine and zorubicin for patients with previously treated acute nonlymphocytic leukemia: a Cancer and Leukemia Group B pilot study.
Topics: Acute Disease; Adult; Aged; Azacitidine; Bone Marrow; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kidney; Leukemia; Liver; Male; Middle Aged; Pilot Projects | 1982 |
[Comparative evaluation of combined chemotherapeutic regimens in acute non-lymphocytic leukemia].
Topics: Aclarubicin; Acute Disease; Adult; Age Factors; Ancitabine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Mercaptopurine; Middle Aged; Naphthacenes; Prednisolone | 1983 |
Design of controlled clinical trials: use of historical controls.
Topics: Acute Disease; Adolescent; Adult; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Glioma; Humans; Leukemia; Male; Plicamycin; Random Allocation; Uracil; Vincristine | 1982 |
[Lung survival or healing? Description of a case of acute non-lymphoblastic leukosis].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Follow-Up Studies; Humans; Leukemia; Male; Methotrexate; Thioguanine | 1984 |
Prognostic factors in adult patients with acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Chromosome Aberrations; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Prednisolone; Prognosis; Vincristine; Zinostatin | 1983 |
Human serum megakaryocyte colony-stimulating activity increases in response to intensive cytotoxic chemotherapy.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cells, Cultured; Colony-Stimulating Factors; Cytarabine; Daunorubicin; Humans; Leukemia; Megakaryocytes; Platelet Count; Thioguanine | 1984 |
Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemia.
Topics: Bone Marrow; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Leukemia; Patient Isolation; Whole-Body Irradiation | 1983 |
Selected studies of daunorubicin in adult acute nonlymphocytic leukemia.
Topics: Acute Disease; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Daunorubicin; Humans; Leukemia | 1984 |
Probable cures of adult acute leukemia using short term intensive investigational chemotherapy.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Leukemia; Vincristine | 1984 |
Two-cycle timed-sequential chemotherapy for adult acute nonlymphocytic leukemia.
Topics: Acute Disease; Adult; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leukemia; Recurrence | 1984 |
Kinetics and sensitivity of daunorubicin in patients with acute leukemia.
Topics: Adolescent; Adult; Aged; Biological Transport; Cells, Cultured; Daunorubicin; DNA Replication; DNA, Neoplasm; Female; Humans; Leukemia; Male; Middle Aged | 1984 |
Assessment of the drug sensitivity of acute nonlymphocytic leukaemia using the in vitro clonogenic assay.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Survival; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Doxorubicin; Humans; Leukemia; Thioguanine; Tumor Stem Cell Assay | 1984 |
[Treatment of acute leukemia].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Deoxycytidine Monophosphate; Humans; Leukemia; Mercaptopurine; Prednisolone | 1984 |
Proliferation kinetics and prediction of chemotherapeutic effect in adult acute leukemia according to the FAB classification.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cell Division; Cytarabine; Daunorubicin; Female; Humans; Kinetics; Leukemia; Male; Mercaptopurine; Middle Aged; Neoplastic Stem Cells; Prednisolone; Prognosis | 1984 |
[Results of polychemotherapy in adult patients with acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Evaluation; Humans; Leukemia; Mercaptopurine; Middle Aged; Prednisolone | 1984 |
[Prediction of resistance to remission induction in acute leukemia in adult].
Topics: Aclarubicin; Adult; Antineoplastic Agents; Bone Marrow Examination; Daunorubicin; Drug Resistance; Drug Therapy, Combination; Humans; Leukemia; Naphthacenes; Retrospective Studies | 1983 |
Therapeutic activity of 4-demethoxydauno-rubicin (idarubicin) in adult acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukemia; Male; Middle Aged; Time Factors | 1983 |
The relationship between growth in agar, karyotype and prognosis in acute leukaemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cells, Cultured; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Karyotyping; Leukemia; Leukemia, Lymphoid; Male; Middle Aged; Neoplastic Stem Cells; Prednisolone; Prednisone; Prognosis; Thioguanine; Vincristine | 1984 |
Phase I trial of Idarubicin (4-demethoxydaunorubicin) in adult acute leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Idarubicin; Leukemia; Leukopenia; Male; Middle Aged | 1984 |
Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
Topics: Aclarubicin; Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Cytarabine; Daunorubicin; Drug Evaluation; Heart; Humans; Leukemia; Leukopenia; Middle Aged; Naphthacenes; Prospective Studies; Thrombocytopenia | 1984 |
A rapid in vitro drug-sensitivity assay in acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Cells, Cultured; Cytarabine; Daunorubicin; Drug Evaluation, Preclinical; Female; Hematopoietic Stem Cells; Humans; Leukemia; Male; Middle Aged; Sulfates; Sulfur Radioisotopes | 1983 |
[Effects of adriamycin and daunomycin on cardiac functions].
Topics: Acute Disease; Child; Child, Preschool; Daunorubicin; Doxorubicin; Female; Heart; Hemodynamics; Humans; Leukemia; Lymphoma; Male | 1983 |
[Experimental and clinical pharmacology of daunorubicin].
Topics: Animals; Chromatography, High Pressure Liquid; Daunorubicin; Humans; Infusions, Parenteral; Injections, Intravenous; Leukemia; Rabbits; Tissue Distribution | 1983 |
[Leukemic colony (L-CFU) formation in vitro: clinical correlations of the in vitro growth pattern of L-CFU and drug sensitivity in acute leukemia].
Topics: Acute Disease; Cell Division; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Deoxycytidine Monophosphate; Humans; Leukemia; Tumor Stem Cell Assay | 1983 |
[Cardiotoxic effect of anthracycline antibiotics].
Topics: Child; Child, Preschool; Daunorubicin; Female; Heart; Heart Failure; Humans; Leukemia | 1983 |
Colony forming ability of bone marrow cells from patients with acute leukemia.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Mercaptopurine; Middle Aged; Prednisolone; Prognosis | 1983 |
TdT-positive acute leukemia with monocytoid characteristics: clinical, cytochemical, cytogenetic, and immunologic findings.
Topics: Acute Disease; Adult; Aged; Antibodies, Monoclonal; Cell Membrane; Chromosome Aberrations; Cytarabine; Daunorubicin; DNA Nucleotidylexotransferase; DNA Nucleotidyltransferases; Female; Histocytochemistry; Humans; Leukemia; Male; Middle Aged; Monocytes; Neoplastic Stem Cells; Phenotype; Prednisone; Vincristine | 1984 |
[Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents].
Topics: Adolescent; Adult; Aged; Alopecia; Anorexia; Coenzymes; Daunorubicin; Diarrhea; Doxorubicin; Drug Therapy, Combination; Electrocardiography; Female; Fever; Heart Rate; Humans; Leukemia; Male; Middle Aged; Nausea; Stomatitis; Ubiquinone | 1984 |
[Acute adult leukemia. Therapeutic options including supportive measures].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Asparaginase; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Humans; Leukemia; Methotrexate; Remission, Spontaneous; Vincristine | 1980 |
Long-term disease-free survival in acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Long-Term Care; Male; Middle Aged; Prednisone; Recurrence; Thioguanine | 1981 |
Adverse effects of aneuploidy on the outcome of remission induction therapy for acute nonlymphocytic leukaemia: analysis of types of treatment failure.
Topics: Acute Disease; Aneuploidy; Bone Marrow; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Karyotyping; Leukemia; Male; Metaphase; Middle Aged; Prognosis | 1983 |
Responder versus nonresponder comparisons: daunorubicin plus prednisone in treatment of acute nonlymphocytic leukemia.
Topics: Acute Disease; Daunorubicin; Follow-Up Studies; Humans; Leukemia; Prednisone | 1983 |
Posttransfusion hepatitis in acute nonlymphocytic leukemia: lack of a beneficial influence.
Topics: Acute Disease; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis; Humans; Leukemia; Male; Prognosis; Transfusion Reaction | 1983 |
[Therapeutic results of DCMP therapy (2M-80) in acute non-lymphocytic leukemia--the relationship between the residual leukemic cells and duration of remission].
Topics: Acute Disease; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leukemia; Mercaptopurine; Middle Aged; Prednisolone | 1982 |
A potent new weapon against leukemia.
Topics: Daunorubicin; Humans; Leukemia | 1980 |
The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia.
Topics: Acute Disease; Adult; Cytarabine; Daunorubicin; Decontamination; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Patient Isolation; Retrospective Studies | 1980 |
Re-induction of complete remissions in adults with acute non-lymphocytic leukemia.
Topics: Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Thioguanine | 1981 |
Individual nuclear uptake patterns for adriamycin and daunomycin in human leukemia and lymphoma cells.
Topics: Cell Nucleus; Daunorubicin; Doxorubicin; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma | 1981 |
Chemotherapy of leukemia in mice, rats, and humans relating time of humoral stimulation, tumor growth, and clinical response.
Topics: Animals; Cell Division; Cytarabine; Daunorubicin; DNA, Neoplasm; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia L1210; Leukemia, Experimental; Leukemia, Myeloid, Acute; Mice; Rats | 1981 |
Clinical pharmacology of daunorubicin.
Topics: Antibiotics, Antineoplastic; Daunorubicin; DNA; Humans; Kinetics; Leukemia; Naphthacenes; Oxidation-Reduction; Tissue Distribution | 1981 |
Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Daunorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Male; Middle Aged; Prednisone; Time Factors | 1981 |
Future clinical investigations with anthracycline antibiotics in relation to daunorubicin.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Carubicin; Child; Daunorubicin; Doxorubicin; Drug Evaluation; Humans; Leukemia; Naphthacenes; Structure-Activity Relationship | 1981 |
Anthracyclines in the treatment of acute nonlymphocytic leukemias.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Bone Marrow; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Heart Diseases; Humans; Leukemia; Middle Aged; Naphthacenes | 1981 |
Retrospective analysis of 158 cases of adult acute leukaemia: factors influencing prognosis and treatment response.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Karyotyping; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Middle Aged; Prednisolone; Prognosis; Regression Analysis; Retrospective Studies; Thioguanine; Vincristine | 1982 |
Uptake and metabolism of daunorubicin by human leukemia cells.
Topics: Acute Disease; Animals; Biotransformation; Cell Line; Chromatography, High Pressure Liquid; Daunorubicin; Humans; Leukemia; Leukemia, Experimental; Leukemia, Myeloid, Acute; Time Factors | 1982 |
[Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
Topics: Aclarubicin; Acute Disease; Adult; Antibiotics, Antineoplastic; Daunorubicin; Electrocardiography; Female; Heart; Humans; Leukemia; Male; Naphthacenes; Systole | 1982 |
[Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
Topics: Aclarubicin; Adult; Aged; Antibiotics, Antineoplastic; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Middle Aged; Naphthacenes; Random Allocation | 1982 |
Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute leukemia.
Topics: Acute Disease; Bone Marrow; Cell Count; Cytarabine; Daunorubicin; Humans; Leukemia; Thioguanine; Thymidine | 1982 |
Chemotherapy sensitivity assessment of leukemic colony-forming cells with in vitro simultaneous exposure to multiple drugs: clinical correlations in acute nonlymphocytic leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clone Cells; Cytarabine; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Prednisone; Vincristine | 1982 |
A prognostic factor analysis for use in development of predictive models for response in adult acute leukemia.
Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Bone Marrow; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Male; Middle Aged; Prednisone; Prognosis; Vincristine | 1982 |
Prediction of remission in adult acute leukemia: development and testing of predictive models.
Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Cytarabine; Daunorubicin; Doxorubicin; Humans; Leukemia; Middle Aged; Models, Biological; Prednisone; Prognosis; Regression Analysis; Vincristine | 1982 |
Acute nonlymphoblastic leukemia: prognostic factors in adults with long-term follow-up.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Vaccines; Carmustine; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxyurea; Leukemia; Male; Methotrexate; Middle Aged; Platelet Count; Prognosis; Pseudomonas; Statistics as Topic; Thioguanine; Vincristine | 1982 |
Daunorubicin-DNA complex in acute nonlymphoblastic leukemia.
Topics: Acute Disease; Animals; Daunorubicin; DNA; DNA Adducts; Humans; Kinetics; Leukemia; Rabbits | 1982 |
Results of aggressive chemotherapy for acute nonlymphoblastic leukemia in adults.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Cytarabine; Daunorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Leukemia; Male; Middle Aged; Prednisone; Thioguanine; Time Factors; Vincristine | 1982 |
The kinetics of leukemic blast cells in man and the cytokinetic effect of cytostatic agents in vivo.
Topics: Blood Cells; Cell Cycle; Cytarabine; Daunorubicin; Humans; Kinetics; Leukemia; Methotrexate; Mitotic Index; Neoplastic Cells, Circulating; Prednisone; Vincristine | 1982 |
Quantitation of daunorubicin and its metabolites by high-performance liquid chromatography with electrochemical detection.
Topics: Chromatography, High Pressure Liquid; Daunorubicin; Electrochemistry; Humans; Leukemia; Spectrometry, Fluorescence; Time Factors | 1982 |
Rubidazone in combination with Ara-C, vincristine and prednisone (ROAP) in the treatment of adult acute leukemia. A Southwest Oncology Group Study.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Bone Marrow; Cytarabine; Daunorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Prednisone; United States; Vincristine | 1982 |
[DCTP (I) combination chemotherapy of adult acute non-lymphocytic leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Prednisolone; Thioguanine | 1982 |
[An in vitro chemotherapy sensitivity test on leukemic colony-forming cells (L-CFU) and its clinical evaluation].
Topics: Acute Disease; Antineoplastic Agents; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Drug Evaluation, Preclinical; Drug Resistance; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Leukemia | 1982 |
Teratogenic effects of antileukemic chemotherapy.
Topics: Abnormalities, Drug-Induced; Adult; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant, Newborn; Leukemia; Male; Pregnancy; Pregnancy Complications; Thioguanine; Thumb; Toes | 1981 |
Induction therapy and intensive consolidation with daunorubicin, cytosine arabinoside, and 6-thioguanine in adult acute nonlymphoblastic leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Thioguanine | 1981 |
Treatment of refractory adult acute lymphocytic leukaemia and acute undifferentiated leukaemia with an anthracycline antibiotic and cytosine arabinoside.
Topics: Adolescent; Adult; Aged; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Male; Middle Aged; Prednisone; Vincristine | 1981 |
Growth and differentiation patterns of human acute non lymphoid leukemia in diffusion chambers before and after treatment.
Topics: Acute Disease; Adolescent; Adult; Aged; Animals; Cell Differentiation; Cells, Cultured; Child; Culture Techniques; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Male; Methylprednisolone; Mice; Middle Aged; Thioguanine | 1981 |
Intensified remission induction therapy for acute nonlymphocytic leukemia (ANLL). Treatment report on 60 patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Cytarabine; Daunorubicin; Humans; Leukemia; Middle Aged; Thioguanine; Thrombocytopenia | 1981 |
Pharmacokinetics of daunorubicin after administration as free drug or as DNA complex in leukemic patients.
Topics: Daunorubicin; DNA; DNA Adducts; Drug Combinations; Humans; Kinetics; Leukemia; Models, Biological; Time Factors | 1981 |
Differences in uptake of adriamycin and daunomycin by normal BM cells and acute leukemia cell determined by flow cytometry.
Topics: Acute Disease; Animals; Bone Marrow; Bone Marrow Cells; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Fluorometry; Hematopoietic Stem Cells; Humans; Leukemia; Lymphocytes; Rats | 1981 |
Phase I trial of rubidazone (NSC 164011) in children with cancer.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Daunorubicin; Drug Evaluation; Female; Humans; Infant; Leukemia; Leukocyte Count; Lymphoma; Male; Neuroblastoma; Platelet Count; Remission, Spontaneous; Soft Tissue Neoplasms | 1981 |
[Use of patient isolation, nonabsorbable antibiotics and intravenous administration of gentamycin for prevention of infectious complications in hemoblastoses during cytostatic therapy].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Daunorubicin; Female; Gentamicins; Humans; Injections, Intravenous; Leukemia; Male; Neutropenia; Patient Isolation | 1981 |
Clinical implications of cytokinetic and biochemical features of acute leukemia cells.
Topics: Acute Disease; Cell Transformation, Neoplastic; Cytarabine; Daunorubicin; Humans; Leukemia; Prednisolone; Thioinosine | 1980 |
Phase III study of N4-behenoyl-l-beta-D-arabinofuranosylcytosine in adult acute leukemia-BH-AC-DMP therapy.
Topics: Acute Disease; Adolescent; Adult; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Male; Middle Aged; Prednisolone; Thioinosine | 1980 |
Mechanism of action of antileukemic agents: inhibition of DNA polymerases.
Topics: Animals; Cattle; Cytarabine; Daunorubicin; DNA Polymerase I; DNA Polymerase II; Doxorubicin; Guanosine; Leukemia; Nucleic Acid Synthesis Inhibitors; Thionucleosides | 1980 |
Combination chemotherapy with daunorubicin, cytosine arabinoside and prednisolone (DAP) in acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Child; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Prednisolone | 1981 |
Eighth new drug seminar on l-asparaginase and daunorubicin. Division of Cancer Treatment. National Cancer Institute. December 17, 1979 Bethesda, Maryland.
Topics: Animals; Asparaginase; Daunorubicin; Humans; Leukemia | 1981 |
Remission-induction regimens in acute nonlymphocytic leukemia.
Topics: Aged; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Leukemia; Middle Aged; Thioguanine | 1980 |
Prediction of chemotherapy response in human leukemia using an in vitro chemotherapy sensitivity test on the leukemic colony-forming cells.
Topics: Adult; Aged; Antineoplastic Agents; Cell Survival; Cells, Cultured; Cytarabine; Daunorubicin; Doxorubicin; Female; Hematopoietic Stem Cells; Humans; Leukemia; Male; Middle Aged; Prednisone; Vincristine | 1980 |
[DCTP and DCMP two step therapy in acute non-lymphocytic leukemia (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Middle Aged; Prednisolone; Thioguanine; Thioinosine | 1980 |
Determination of adriamycin and daunorubicin in urine by high-performance liquid chromatography with laser fluorometric detection.
Topics: Chromatography, High Pressure Liquid; Daunorubicin; Doxorubicin; Humans; Leukemia; Spectrometry, Fluorescence | 1980 |
Leukemic cell versus plasma levels of daunorubicin and daunorubicinol after infusion of daunorubicin as free drug or the DNA complex.
Topics: Adult; Biotransformation; Blood Cell Count; Daunorubicin; DNA; Female; Humans; Hydroxylation; Kinetics; Leukemia; Male; Middle Aged; Muramidase | 1980 |
Male fertility during chemotherapy for acute leukemia.
Topics: Acute Disease; Adult; Cytarabine; Daunorubicin; Female; Fertility; Humans; Leukemia; Male; Pregnancy; Thioguanine | 1980 |
Experimental and clinical activity of a new anthracycline derivative: detorubicin (14-diethoxyacetoxydaunorubicin).
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Daunorubicin; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Mice; Mutagens; Neoplasms; Neoplasms, Experimental | 1980 |
Extraction and quantification of daunomycin and doxorubicin in tissues.
Topics: Cell Line; Chromatography, High Pressure Liquid; Daunorubicin; Doxorubicin; Humans; Leukemia; Lymphocytes; Monocytes | 1980 |
Heparin does not modify plasma daunomycin disappearance in acute leukaemia patients.
Topics: Acute Disease; Adult; Aged; Daunorubicin; Drug Combinations; Drug Interactions; Female; Heparin; Humans; Leukemia; Male; Metabolic Clearance Rate; Middle Aged | 1980 |
A new anthracycline with potent antileukemic activity exhibits reduced mutagenicity.
Topics: Antibiotics, Antineoplastic; Biotransformation; Daunorubicin; Doxorubicin; Leukemia; Mutagenicity Tests; Mutagens; Salmonella typhimurium | 1995 |
Angiotensin converting enzyme inhibitors in bone marrow transplant recipients with depressed left ventricular function.
Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic; Antineoplastic Agents; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Doxorubicin; Echocardiography, Doppler, Color; Enalapril; Female; Gated Blood-Pool Imaging; Heart Failure; Humans; Idarubicin; Leukemia; Male; Middle Aged; Radiation Injuries; Radiotherapy; Ventricular Dysfunction, Left; Ventricular Function, Left | 1995 |
[Effect of the modality of exposure on the action of S9788 on the modulation of multidrug resistance of human tumor cell lines].
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Humans; Leukemia; Piperidines; Triazines; Tumor Cells, Cultured; Verapamil | 1994 |
Acute leukemia coexpressing myeloid, B- and T-lineage associated markers: multiparameter analysis of criteria defining lineage commitment and maturational stage in a case of undifferentiated leukemia.
Topics: Acute Disease; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Cytarabine; Daunorubicin; Fatal Outcome; Female; Hematopoietic Cell Growth Factors; Humans; Immunophenotyping; Leukemia; Middle Aged; Mitoxantrone; Neoplastic Stem Cells; Remission Induction; Thioguanine; Tumor Stem Cell Assay | 1995 |
[Changes in myocardial function in patients with acute leukemias under the influence of rubomycin].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Female; Heart; Hemodynamics; Humans; Leukemia; Male; Recurrence | 1994 |
Itraconazole in leukemic patients with invasive aspergillosis (IA): impact on intensive chemotherapy completion.
Topics: Adult; Aspergillosis; Cytarabine; Daunorubicin; Humans; Itraconazole; Leukemia; Male; Middle Aged | 1994 |
Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blast Crisis; Child; Child, Preschool; Daunorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Treatment Failure; Tumor Cells, Cultured; Verapamil; Vinblastine; Vincristine | 1994 |
Characterization and modulation of drug transport kinetics in K562 c1.6 daunorubicin-resistant cell line.
Topics: Antineoplastic Agents; Azides; Cell Survival; Cyclosporine; Daunorubicin; Drug Interactions; Drug Resistance; Glucose; Humans; Leukemia; Sodium Azide; Tumor Cells, Cultured | 1994 |
[The use of diflucan in myelotoxic agranulocytosis].
Topics: Acute Disease; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Candidiasis; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Evaluation; Female; Fluconazole; Humans; Leukemia; Prednisolone; Vincristine | 1993 |
Comparative effects of racemic verapamil vs R-verapamil on normal and leukemic progenitors.
Topics: Bone Marrow Cells; Colony-Forming Units Assay; Daunorubicin; Drug Therapy, Combination; Erythroid Precursor Cells; Humans; Leukemia; Leukemia, Myeloid, Acute; Stem Cells; Stereoisomerism; Tumor Stem Cell Assay; Verapamil | 1993 |
Effect of verapamil on daunorubicin accumulation in human leukemic cells with different levels of MDR1 gene expression.
Topics: Adult; Aged; Aged, 80 and over; Daunorubicin; Drug Resistance; Female; Flow Cytometry; Gene Expression; Humans; Leukemia; Male; Middle Aged; Phenotype; RNA, Neoplasm; Transcription, Genetic; Tumor Cells, Cultured; Verapamil | 1993 |
Action mechanism of idarubicin (4-demethoxydaunorubicin) as compared with daunorubicin in leukemic cells.
Topics: Daunorubicin; Humans; Idarubicin; Leukemia; Tumor Cells, Cultured | 1993 |
Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
Topics: Analysis of Variance; Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Transport, Active; Blotting, Northern; Cyclosporine; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Genistein; HL-60 Cells; Humans; Isoflavones; Leukemia; RNA, Messenger; RNA, Neoplasm; Temperature; Time Factors; Tumor Cells, Cultured; Verapamil | 1996 |
Pneumocystis carinii pneumonia in adults with acute leukaemia: is there a need for primary chemoprophylaxis?
Topics: Aclarubicin; Acute Disease; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Finland; Humans; Immunocompromised Host; Incidence; Leukemia; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Pneumonia, Pneumocystis; Prednisone; Premedication; Retrospective Studies; Thioguanine; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 1996 |
Enhanced topoisomerase II-induced DNA breaks and free radical production by a new anthracycline with potent antileukemic activity.
Topics: Antibiotics, Antineoplastic; Daunorubicin; DNA; DNA Damage; Electron Spin Resonance Spectroscopy; Enzyme Inhibitors; Free Radicals; Humans; Leukemia; Reactive Oxygen Species; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1996 |
Increased activity and sensitivity of mitochondrial respiratory enzymes to tumor necrosis factor alpha-mediated inhibition is associated with increased cytotoxicity in drug-resistant leukemic cell lines.
Topics: Adenosine Diphosphate; Cell Death; Cells, Cultured; Daunorubicin; Depression, Chemical; Drug Resistance, Neoplasm; Electron Transport; Electron Transport Complex II; Electron Transport Complex IV; Enzyme Inhibitors; Free Radicals; Glycolysis; Humans; Leukemia; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mitochondria; Multienzyme Complexes; NAD(P)H Dehydrogenase (Quinone); Neoplasm Proteins; Oxidoreductases; Paraquat; Succinate Dehydrogenase; Superoxides; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vinblastine | 1996 |
Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.
Topics: Acute Disease; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cryopreservation; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Feasibility Studies; Fluorescent Dyes; Humans; Leukemia; Leukemia, Myeloid; Neoplasm Proteins; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reproducibility of Results; Rhodamine 123; Rhodamines; Sensitivity and Specificity; Verapamil; Vincristine | 1996 |
Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of daunorubicin and doxorubicin in HL60 and its resistant cells and comparison with those of pirarubicin.
Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Energy Metabolism; HL-60 Cells; Humans; Kinetics; Leukemia; Temperature | 1996 |
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Leukemia; Lymphocytes; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Rhodamine 123; Rhodamines; Vault Ribonucleoprotein Particles | 1997 |
Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; CCAAT-Enhancer-Binding Proteins; Daunorubicin; DNA Fragmentation; DNA-Binding Proteins; Etoposide; HL-60 Cells; Humans; Leukemia; Nuclear Proteins; RNA, Messenger; Serine Proteinase Inhibitors; Transcription Factor CHOP; Transcription Factors; Tumor Cells, Cultured | 1997 |
The potential of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide to circumvent three multidrug-resistance phenotypes in vitro.
Topics: Acridines; Amsacrine; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Buthionine Sulfoximine; Cell Line; Cell Survival; Daunorubicin; Drug Resistance, Multiple; HL-60 Cells; Humans; Idarubicin; Leukemia; Paclitaxel; Phenotype; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Verapamil | 1997 |
Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells.
Topics: Acute Disease; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Cell Cycle; Cytarabine; Daunorubicin; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Idarubicin; Kinetics; Leukemia; Mitoxantrone | 1997 |
The combined effects of IL-3 and PSC 833 on daunorubicin- and mitoxantrone cytotoxicity in two growth factor-dependent leukemic cell lines.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Cyclosporins; Daunorubicin; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Drug Synergism; Humans; Interleukin-3; Kinetics; Leukemia; Mitoxantrone; Tumor Cells, Cultured | 1997 |
Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells.
Topics: Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Colony-Forming Units Assay; Cytarabine; Cytotoxicity, Immunologic; Daunorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cells; HL-60 Cells; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia; Lung Neoplasms; Lymphocyte Activation; Tissue Donors; Transplantation, Autologous; Transplantation, Homologous; Tumor Cells, Cultured | 1997 |
Sensitization of multidrug-resistant human leukemia cells with MDR1-targeted antisense and inhibition of drug-mediated MDR1 induction.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Drug Resistance, Multiple; Humans; Leukemia; Oligonucleotides, Antisense; Phenotype; Tumor Cells, Cultured | 1997 |
Apoptosis and resistance to daunorubicin in human leukemic cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Daunorubicin; Drug Resistance; Humans; Leukemia; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1997 |
Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Cell Nucleus; Daunorubicin; DNA Damage; DNA, Neoplasm; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Idarubicin; Leukemia | 1998 |
The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Daunorubicin; Doxorubicin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Idarubicin; Leukemia; Tumor Cells, Cultured; Verapamil | 1998 |
The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells.
Topics: Antineoplastic Agents; ATP-Binding Cassette Transporters; Buthionine Sulfoximine; Cell Division; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Genes, MDR; Glutathione; Humans; Leukemia; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured | 1998 |
Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Idarubicin; Immunosuppressive Agents; Leukemia; Tumor Cells, Cultured | 1999 |
Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Daunorubicin; Dibenzocycloheptenes; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Leukemia; Peptides, Cyclic; Phenotype; Quinolines; Tumor Cells, Cultured | 1999 |
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance.
Topics: Acute Disease; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Leukemia; Liposomes; Tumor Cells, Cultured | 1999 |
Application of low intensity laser radiation in extravasal infiltrates caused by cytostatics in children with acute leukemia.
Topics: Acute Disease; Antineoplastic Agents; Child; Child, Preschool; Daunorubicin; Granuloma; Humans; Lasers; Leukemia; Vincristine | 1999 |
Contribution of the nucleoside transport system to doxorubicin transport in HL60 cells but not in mononuclear cells.
Topics: Antibiotics, Antineoplastic; Biological Transport; Carrier Proteins; Daunorubicin; Doxorubicin; Drug Interactions; HL-60 Cells; Humans; Idarubicin; In Vitro Techniques; Leukemia; Leukocytes, Mononuclear; Membrane Proteins; Nucleoside Transport Proteins; Sodium | 1999 |
Comparison of DiOC(6)(3) uptake and annexin V labeling for quantification of apoptosis in leukemia cells and non-malignant T lymphocytes from children.
Topics: Annexin A5; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Carbocyanines; Child; Cytarabine; Daunorubicin; Flow Cytometry; Fluorescent Dyes; HL-60 Cells; Humans; Indicators and Reagents; Leukemia; Propidium; T-Lymphocytes; Tumor Cells, Cultured; U937 Cells; Vincristine | 2000 |
Liposome encapsulated daunorubicin (daunoxome) for acute leukemia.
Topics: Acute Disease; Adult; Aged; Daunorubicin; Drug Carriers; Humans; Leukemia; Liposomes; Middle Aged | 2000 |
Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells.
Topics: Adult; Annexin A5; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Apoptosis; Biomarkers; Blotting, Western; Bone Marrow Cells; Camptothecin; Caspase 3; Caspase 7; Caspases; Daunorubicin; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Idarubicin; Leukemia; Peptide Hydrolases; Protein Binding; U937 Cells | 2000 |
E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents.
Topics: Adenovirus E1A Proteins; Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Caspase 3; Caspases; CDC2 Protein Kinase; Cell Cycle; Cell Division; Daunorubicin; DNA Damage; Dose-Response Relationship, Drug; Etoposide; Flow Cytometry; Fusion Proteins, bcr-abl; Humans; K562 Cells; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Luciferases; Microscopy, Phase-Contrast; Nucleic Acid Synthesis Inhibitors; Peptides; Plasmids; Poly(ADP-ribose) Polymerases; Transfection; Tumor Cells, Cultured | 2000 |
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia.
Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Calibration; Daunorubicin; Drug Carriers; Female; Humans; Kidney; Leukemia; Liposomes; Male; Middle Aged; Pilot Projects; Spectrometry, Fluorescence | 2000 |
Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity.
Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Atrial Natriuretic Factor; Biomarkers; Cardiac Output, Low; Daunorubicin; Female; Heart Diseases; Heart Failure; Heart Function Tests; Humans; Leukemia; Male; Middle Aged; Natriuretic Peptide, Brain; Statistics, Nonparametric | 2000 |
In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy: time to consider expanded clinical trials?
Topics: Acute Disease; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Humans; Inhibitory Concentration 50; Leukemia; Mitoxantrone; Razoxane; Tumor Cells, Cultured | 2001 |
Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance.
Topics: Antibiotics, Antineoplastic; Apoptosis; Cell Survival; Daunorubicin; Drug Resistance; Drug Resistance, Neoplasm; Humans; Idarubicin; Leukemia; Tumor Cells, Cultured | 2002 |
Comparison of Pgp- and MRP-mediated multidrug resistance in leukemia cell lines.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; HL-60 Cells; Humans; K562 Cells; Leukemia; Multidrug Resistance-Associated Proteins | 2002 |
Liposomal encapsulation diminishes daunorubicin-induced generation of reactive oxygen species, depletion of ATP and necrotic cell death in human leukaemic cells.
Topics: Adenosine Triphosphate; Antibiotics, Antineoplastic; Apoptosis; Caspase 3; Caspases; Cell Cycle; Daunorubicin; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Leukemia; Liposomes; Necrosis; Reactive Oxygen Species; Tumor Cells, Cultured | 2002 |
Dexrazoxane has no impact on sensitivity of childhood leukemic blasts to daunorubicin.
Topics: Adolescent; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Survival; Child; Child, Preschool; Daunorubicin; Drug Interactions; Drug Resistance, Neoplasm; Flow Cytometry; HL-60 Cells; Humans; Infant; K562 Cells; Leukemia; Razoxane; Tumor Cells, Cultured | 2002 |
Formation and longevity of idarubicin-induced DNA topoisomerase II cleavable complexes in K562 human leukaemia cells.
Topics: Antibiotics, Antineoplastic; Catalytic Domain; Daunorubicin; DNA; DNA Topoisomerases, Type II; Enzyme Inhibitors; Fluorescent Antibody Technique; Humans; Idarubicin; K562 Cells; Leukemia; Topoisomerase II Inhibitors | 2002 |
Bone marrow transplantation with intensive combination chemotherapy/radiation therapy (SCARI) in acute leukemia.
Topics: Adolescent; Adult; Bone Marrow Cells; Bone Marrow Transplantation; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Graft vs Host Reaction; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Middle Aged; Thioguanine; Time Factors; Transplantation, Homologous | 1977 |
Acute leukemia in children: experience in Saskatchewan in 1966-72.
Topics: Acute Disease; Adolescent; Antineoplastic Agents; Blood Transfusion; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Follow-Up Studies; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Palliative Care; Prednisone; Saskatchewan; Vincristine | 1975 |
[New drugs for the therapy of acute leukemia].
Topics: Acute Disease; Antineoplastic Agents; Azacitidine; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Guanazole; Humans; Leukemia; Lomustine; Peptichemio; Podophyllotoxin; Razoxane; Zinostatin | 1975 |
The therapy of acute leukemia in the adult: a progress report.
Topics: Acute Disease; Adult; Antineoplastic Agents; Azacitidine; Blood Transfusion; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Granulocytes; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Patient Isolation; Platelet Transfusion; Pneumonia; Prednisone; Pyrimethamine; Remission, Spontaneous; Thioguanine; Vincristine; Zinostatin | 1976 |
Acute eosinophilic leukemia. An ultrastructural study.
Topics: Adult; Bone Marrow; Cytarabine; Daunorubicin; Eosinophils; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Prednisone; Recurrence | 1978 |
Occurrence of BK virus and BK virus-specific antibodies in the urine of patients receiving chemotherapy for malignancy.
Topics: Adolescent; Adult; Aged; Animals; Antibodies, Viral; BK Virus; Child; Child, Preschool; Chlorocebus aethiops; Cyclophosphamide; Cytarabine; Cytopathogenic Effect, Viral; Daunorubicin; Drug Therapy, Combination; Erythrocytes; Fluorescent Antibody Technique; Hemagglutination Inhibition Tests; Humans; Immunosuppression Therapy; Kidney; Leukemia; Middle Aged; Polyomavirus; Prednisone; Simian virus 40; Urine; Vincristine; Virus Cultivation | 1975 |
On the mode of decrease of leukemic cells during treatment of acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aminobiphenyl Compounds; Antineoplastic Agents; Asparaginase; Bone Marrow; Cell Survival; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukocyte Count; Male; Mercaptopurine; Mesylates; Methotrexate; Middle Aged; Neutrophils; Prednisolone; Time Factors; Zinostatin | 1976 |
Cytostatic efficacy of DNA-complexes of adriamycin, daunomycin and actinomycin D. I. Comparative studies in Novikoff hepatoma, human mammary carcinoma cells and human leukemic leukocytes.
Topics: Acute Disease; Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Hepatocellular; Dactinomycin; Daunorubicin; DNA, Neoplasm; Doxorubicin; Female; Humans; Leukemia; Liver Neoplasms; Pinocytosis; Rats; RNA, Neoplasm | 1977 |
Multiple-drug chemotherapy for acute leukemia The TRAMPCOL regimen: results in 86 patients.
Topics: Adolescent; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Methotrexate; Prednisolone; Remission, Spontaneous; Thioguanine; Vincristine | 1977 |
[Treatment of acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Aging; Asparaginase; Child; Child, Preschool; Daunorubicin; Humans; Infant; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Methotrexate; Remission, Spontaneous; Time Factors | 1977 |
[Results and problems in the treatment of childhood leukaemia (author's transl)].
Topics: Age Factors; Child; Cytarabine; Daunorubicin; Humans; Hungary; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Prednisolone; Thioguanine; Vincristine | 1978 |
Repeated use of L-asparaginase in multi-drug therapy of childhood leukemia.
Topics: Acute Disease; Adolescent; Asparaginase; Child; Daunorubicin; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Prednisone; Vincristine | 1978 |
Therapy of acute nonlymphocytic leukemia: I. Clinical aspects.
Topics: Acute Disease; Aged; Blood Transfusion; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Male; Middle Aged; Pancytopenia | 1979 |
[Therapy of acute nonlymphocytic leukemia: 2. Biological characteristics and prediction of response].
Topics: Acute Disease; Age Factors; Cytarabine; Daunorubicin; Doxorubicin; Humans; Infections; Leukemia | 1979 |
Comparative studies on phenol-soluble nonhistone chromatin proteins in normal and leukaemic human leukocytes.
Topics: Chromatin; Daunorubicin; Doxorubicin; Electrophoresis; Granulocytes; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukocytes; Lymphocytes; Neoplasm Proteins; Phenols; Solubility | 1979 |
Clinical studies with rubidazone.
Topics: Acute Disease; Adult; Breast Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Male | 1979 |
[Occurrence of infectious complications during therapy for acute leukemia].
Topics: Antineoplastic Agents; Bacterial Infections; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Neutropenia; Prednisone; Thioguanine | 1979 |
Serial studies on in vitro colony formation in patients with acute leukemia in relation to the maintenance of remission.
Topics: Acute Disease; Adult; Child; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Prednisolone; Remission, Spontaneous | 1978 |
Prognostic value of colony-stimulating and colony-forming cells in peripheral blood in acute non-lymphoblastic leukemia.
Topics: Adult; Aged; Cell Division; Cells, Cultured; Clone Cells; Colony-Stimulating Factors; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Leukocyte Count; Leukocytes; Male; Middle Aged; Prognosis; Remission, Spontaneous | 1977 |
ABO blood group system and bone marrow transplantation.
Topics: ABO Blood-Group System; Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Cells; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Graft Rejection; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppression Therapy; Isoantibodies; Leukemia; Male; Thioguanine; Transplantation Immunology; Transplantation, Homologous | 1977 |
Approaches to leukemic relapse following bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Graft vs Host Disease; HLA Antigens; Humans; Leukemia; Middle Aged; Mycoses; Neoplasm Recurrence, Local; Thioguanine; Transplantation, Homologous | 1978 |
Laser flow cytometry and cancer chemotherapy: detection of intracellular anthracyclines by flow cytometry.
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Cell Line; Cytological Techniques; Daunorubicin; DNA; Doxorubicin; Humans; Lasers; Leukemia; Mice; Nogalamycin; Propidium; Spectrometry, Fluorescence | 1979 |
Daunorubicin reductase activity in leukemia leukocyte homogenates.
Topics: Adolescent; Adult; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Daunorubicin; Female; Humans; Leukemia; Leukocytes; Male; Middle Aged | 1979 |
Clinical activity of detorubicin: a new anthracycline derivative.
Topics: Acute Disease; Animals; Daunorubicin; Doxorubicin; Drug Evaluation; Drug Evaluation, Preclinical; Humans; Leukemia; Mice; Neoplasms; Neoplasms, Experimental | 1979 |
Daunorubicin, cytosine arabinoside and 6-thioguanine (DAT) combination chemotherapy for the treatment of acute non-lymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Thioguanine | 1979 |
Comparative studies on the in vitro killing of human normal and leukemic clonogenic cells (CFUc) by daunorubicin, daunorubicinol, and daunorubicin-DNA complex.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Cells; Cell Survival; Colony-Forming Units Assay; Daunorubicin; DNA; Female; Humans; In Vitro Techniques; Leukemia; Male; Middle Aged; Time Factors | 1979 |
Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells.
Topics: Bone Marrow Cells; Daunorubicin; DNA; Doxorubicin; Granulocytes; Humans; In Vitro Techniques; Leukemia; Leukocytes; Time Factors | 1979 |
[Results of treating acute nonlymphoblastic leukaemia in adults (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Male; Middle Aged | 1979 |
[Horizontal pigmented bandings of the nails with daunorubicin therapy (author's transl)].
Topics: Adolescent; Adult; Daunorubicin; Female; Humans; Leukemia; Male; Melanosis; Nail Diseases | 1979 |
Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity.
Topics: Adult; Aged; Cardiomyopathies; Daunorubicin; Female; Humans; Leukemia; Lipofuscin; Lymphoma; Male; Middle Aged; Pulmonary Edema | 1979 |
[Tests of cell mediated immunity during the treatment of acute leukemia in infants (author's transl)].
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cytarabine; Daunorubicin; Humans; Immune Adherence Reaction; Immunity, Cellular; Infant; Leukemia; Mercaptopurine; Prednisolone; Vincristine | 1977 |
Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients.
Topics: Chromatography, Gas; Daunorubicin; Dose-Response Relationship, Drug; Leukemia; Solvents | 1978 |
[Survey of anthracyclines derivatives in haematology (author's transl)].
Topics: Adult; Animals; Anthracenes; Antibiotics, Antineoplastic; Biotransformation; Child; Daunorubicin; Doxorubicin; Heart; Humans; Leukemia; Liver | 1978 |
Evidence for non-infiltrative cardiomyopathy in acute leukaemia and lymphoma. A clinical and echocardiographic study.
Topics: Acute Disease; Adolescent; Adult; Aged; Anemia; Cardiomyopathies; Daunorubicin; Echocardiography; Female; Heart Failure; Humans; Leukemia; Lymphoma; Male; Middle Aged | 1978 |
[A case of leukemia obtained complete remission after delivery (author's transl)].
Topics: Acute Disease; Adult; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Prednisolone; Pregnancy; Pregnancy Complications, Hematologic; Remission, Spontaneous; Vincristine | 1978 |
[Treatment results of therapy resistant acute leukemias with 7 cystostatic agents (TRAMPCO-scheme)].
Topics: Acute Disease; Adolescent; Adult; Aged; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Resistance; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Methotrexate; Middle Aged; Prednisolone; Thioguanine; Vincristine | 1978 |
[Therapeutic results in adult acute non-lymphoblastic leukemia].
Topics: Acute Disease; Adult; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Male | 1978 |
[Therapeutic results in patients with acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Blood Platelets; Blood Transfusion; Cytarabine; Daunorubicin; Humans; Leukemia; Middle Aged; Prognosis | 1978 |
Further local experience in the treatment of acute non-lymphoblastic leukaemia.
Topics: Acute Disease; Adult; Aged; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Middle Aged; Prednisone; Thioguanine; Vincristine | 1978 |
Perspectives and prospectives in the management of acute leukemia.
Topics: BCG Vaccine; Cytarabine; Daunorubicin; Humans; Immunotherapy; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Life Expectancy; Mycobacterium bovis; Nucleotides, Cyclic; Prednisone; Remission, Spontaneous; Vincristine | 1976 |
Advances in the management of acute nonlymphocytic leukemia.
Topics: Acute Disease; Anti-Bacterial Agents; Blood Transfusion; Cytarabine; Daunorubicin; Drug Therapy, Combination; Granulocytes; Hemorrhage; Humans; Immunotherapy; Infection Control; Infections; Kidney Diseases; Leukemia; Platelet Transfusion; Transplantation, Homologous | 1976 |
Treatment of acute nonlymphocytic leukemia in elderly patients: a prospective study of intensive chemotherapy.
Topics: Acute Disease; Aged; Antineoplastic Agents; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Infections; Length of Stay; Leukemia; Male; Middle Aged; Prednisone; Prospective Studies; Remission, Spontaneous; Thioguanine; Time Factors | 1977 |
Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
Topics: Acute Disease; Adolescent; Adult; Aged; Central Nervous System Diseases; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Meningeal Neoplasms; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous; Time Factors | 1977 |
The interaction of daunomycin with normal and leukaemic leukocyte DNA.
Topics: Binding Sites; Daunorubicin; DNA; DNA, Neoplasm; Humans; Leukemia; Leukocytes | 1976 |
[Electrocardiographic changes in patients with acute leukoses treated with rubidomycin or adriamycin at the Internal Clinic A].
Topics: Acute Disease; Daunorubicin; Doxorubicin; Electrocardiography; Female; Hospitals, University; Humans; Leukemia; Male; Tachycardia | 1976 |
[Cytostatic therapy in haemoblastoses].
Topics: Asparaginase; Cytarabine; Daunorubicin; Doxorubicin; Humans; Leukemia; Mercaptopurine; Methotrexate; Prednisolone; Thioguanine; Vincristine | 1976 |
[Pretherapeutic sensitivity tests of human leukemia cells against cytostatic drugs in vitro in relation to the in vivo effects].
Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Cytarabine; Daunorubicin; Humans; In Vitro Techniques; Leukemia; Thymidine | 1976 |
Evaluation of dose and schedule of L-asparaginase in multidrug therapy of childhood leukemia.
Topics: Acute Disease; Adolescent; Asparaginase; Child; Child, Preschool; Daunorubicin; Drug Evaluation; Drug Hypersensitivity; Humans; Hyperglycemia; Infant; Leukemia; Prednisone; Vincristine | 1976 |
Influence of some cytostatics on leucocyte function.
Topics: Acute Disease; Blood; Candida; Cells, Cultured; Daunorubicin; Humans; Leukemia; Leukocytes; Neutrophils; Nitroblue Tetrazolium; Phagocytosis; Vincristine | 1976 |
[Side effect of rubomycin on the myocardium during treatment of acute leukemia in children].
Topics: Acute Disease; Child; Daunorubicin; Drug Therapy, Combination; Heart; Heart Rate; Humans; Leukemia; Myocardial Contraction | 1976 |
[In vitro study of sensitivity of leukemic cells to cytotoxic drugs (anticytogram)].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents; Asparaginase; Carbon Radioisotopes; Cells, Cultured; Cyclophosphamide; Cytarabine; Daunorubicin; Depression, Chemical; Humans; In Vitro Techniques; Leukemia; Leukemia, Lymphoid; Mercaptopurine; Middle Aged; Monomethylhydrazine; Prednisolone; Remission, Spontaneous; Thymidine; Tritium; Uridine; Vincristine | 1975 |
Drugs five years later: cytarabine.
Topics: Acute Disease; Adult; Animals; Bone Marrow Diseases; Central Nervous System Diseases; Cyclophosphamide; Cytarabine; Daunorubicin; DNA, Neoplasm; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Prednisone; Remission, Spontaneous; Thioguanine; Vincristine; Virus Diseases | 1975 |
Cell kinetics and practical consequences for therapy of acute leukemia.
Topics: Adrenal Cortex Hormones; Asparaginase; Bone Marrow; Bone Marrow Cells; Cell Division; Cells, Cultured; Cytarabine; Daunorubicin; DNA; DNA, Neoplasm; Drug Therapy, Combination; Humans; Kinetics; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Methotrexate; Mitosis; Prognosis; Vincristine | 1975 |
Adriamycin in the treatment of childhood acute leukemia. A Southwest Oncology Group study.
Topics: Adolescent; Alopecia; Bone Marrow; Child; Child, Preschool; Daunorubicin; Doxorubicin; Female; Fever; Heart; Humans; Infant; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Nausea; Remission, Spontaneous; Stomatitis | 1975 |
Non-Hodgkin's lymphoma in children: results of treatment with LSA2-L2 protocol.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Lymph Nodes; Lymphoma; Male; Mediastinal Neoplasms; Methotrexate; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Skin Neoplasms; Stomach Neoplasms; Thioguanine; Vincristine | 1975 |
[Results of combined chemotherapy in treatment-resistant leukaemia of adults (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Myeloid, Acute; Methotrexate; Middle Aged; Prednisone; Remission, Spontaneous; Thioguanine; Time Factors; Vincristine | 1975 |
[Changes in the blood coagulation system in patients with acute leukemia during treatment with rubomycin].
Topics: Blood Coagulation; Blood Platelets; Daunorubicin; Female; Hemorrhage; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Middle Aged | 1975 |
Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies.
Topics: Antibiotics, Antineoplastic; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Heart; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lymphoma; Remission, Spontaneous; Rhabdomyosarcoma | 1976 |
Uptake of adriamycin and daunomycin in L1210 and human leukemia cells: a comparative study.
Topics: Animals; Daunorubicin; Doxorubicin; Humans; In Vitro Techniques; Leukemia; Leukemia L1210; Mice; Temperature; Time Factors | 1976 |
Serial quantitative observations of leukemic and normal hematopoietic cells in the bone marrow of acute leukemia under chemotherapy.
Topics: Bone Marrow; Bone Marrow Cells; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Prednisolone; Remission, Spontaneous; Vincristine | 1976 |
Treatment of adult acute non-lymphoblastic leukemia using intermittent combination chemotherapy with daunomycin, cytosine arabinoside, 6-mercaptopurine and prednisolone-DCMP two step therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Middle Aged; Prednisolone; Remission, Spontaneous | 1976 |
[Models of polychemotherapy in acute leukemias].
Topics: Acute Disease; Antineoplastic Agents; Asparaginase; Carmustine; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Mercaptopurine; Thioguanine | 1975 |
[Treatment of leukemia (author's transl)].
Topics: Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia | 1975 |
[A new quadruple combination chemotherapy (Neo-DCMP) in acute leukemia (author's transl)].
Topics: Acute Disease; Adult; Child; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Mercaptopurine; Middle Aged; Prednisolone | 1975 |
[Quadruple combination chemotherapy of acute leukemia using daunomycin, cytosine arabinoside, vincristine and prednisolone (author's transl)].
Topics: Acute Disease; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Prednisolone; Vincristine | 1975 |
Hypocalcemia complicating acute leukemia.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Daunorubicin; Female; Humans; Hypercalcemia; Hypocalcemia; Leukemia; Male; Middle Aged; Prognosis; Retrospective Studies | 1975 |
[Chemotherapy with cytosine arabinoside, daunomycin and vincristine in refractory leukemia of childhood (author's transl)].
Topics: Adolescent; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Infant; Leukemia; Male; Vincristine | 1975 |
[Letter: Daunorubicin].
Topics: Acute Disease; Age Factors; Daunorubicin; Humans; Infant; Injections, Intravenous; Jugular Veins; Leukemia | 1976 |
Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Compartmentation; Chloroquine; Daunorubicin; Deoxyglucose; Dinitrophenols; Drug Interactions; Drug Resistance; Energy Metabolism; Ethylmaleimide; Humans; Leukemia; Membrane Glycoproteins; Methylamines; Microscopy, Fluorescence; Monensin; Ouabain; Sodium Azide; Tumor Cells, Cultured; Vanadates; Verapamil | 1992 |
[Treatment of leukemia: discussion].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Granulocyte Colony-Stimulating Factor; Hematologic Tests; Humans; L-Lactate Dehydrogenase; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mercaptopurine; Prednisolone; Remission Induction | 1992 |
Pneumonia and pneumonitis in childhood malignancy.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Child; Clinical Protocols; Daunorubicin; Humans; Immunocompromised Host; Leukemia; Methotrexate; Neoplasms; Opportunistic Infections; Pneumonia; Pneumonia, Viral; Prednisolone; Prednisone; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 1992 |
Non-aggressive therapy for chronic myeloid leukaemia in blastic transformation.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Child; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Hydroxyurea; Leukemia; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Remission Induction; Thioguanine; Vincristine | 1992 |
[Clinical study of leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Humans; Leukemia; Mercaptopurine; Prednisolone | 1992 |
Interaction of antileukemia agents adriamycin and daunomycin with sphinganine on the differentiation of human leukemia cell line HL-60.
Topics: Cell Differentiation; Daunorubicin; Doxorubicin; Humans; Leukemia; Leukemia, Promyelocytic, Acute; Protein Kinase C; Sphingosine; Tumor Cells, Cultured | 1992 |
[p170 in multiple myeloma and acute leukemia].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Colonic Neoplasms; Cytarabine; Daunorubicin; Drug Resistance; Female; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Male; Melphalan; Membrane Glycoproteins; Middle Aged; Multiple Myeloma; Neoplasm Proteins; Neoplastic Stem Cells; Peptichemio; Plasma Cells; Prednisone; Remission Induction; Survival Rate; Tumor Cells, Cultured; Vincristine | 1991 |
[Kinetics of circulating hematopoietic stem cells following chemotherapy in patients with hematopoietic malignancies].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Colony-Stimulating Factors; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Vincristine | 1990 |
[Seven cases of eye involvement in adult with acute leukemia].
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Male; Middle Aged; Ophthalmoplegia; Optic Nerve Diseases; Prednisolone; Vincristine | 1991 |
Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporins; Daunorubicin; Drug Resistance; Flow Cytometry; Gene Expression; Humans; Intracellular Fluid; Leukemia; Membrane Glycoproteins; RNA, Messenger; Tumor Cells, Cultured | 1990 |
[Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
Topics: Daunorubicin; Doxorubicin; Electrocardiography; Heart; Heart Diseases; Heart Rate; Humans; Leukemia; Lymphoma | 1991 |
Magnetic resonance imaging follow-up in patients with acute leukemia during induction chemotherapy.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Daunorubicin; Humans; Leukemia; Magnetic Resonance Imaging; Middle Aged; Mitoxantrone; Remission Induction; Thioguanine | 1990 |
Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay.
Topics: Cell Count; Cell Survival; Daunorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fluoresceins; Fluorometry; Humans; Leukemia; Leukemia, Myeloid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Vincristine | 1990 |
In vitro and in vivo cytotoxic activity of anti-human leukemia monoclonal antibodies SN5c and SN6 daunorubicin conjugates.
Topics: Animals; Antibodies, Monoclonal; Antigens, Differentiation; Antigens, Neoplasm; Cell Line; Cell Survival; Daunorubicin; Drug Screening Assays, Antitumor; Female; Fibrosarcoma; Humans; Immunotoxins; Leukemia; Lymphocytes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neprilysin | 1989 |
Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16.
Topics: Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dactinomycin; Daunorubicin; Doxorubicin; Drug Resistance; Etoposide; Gene Expression; Humans; Leukemia; Lymphoma; Membrane Glycoproteins; Mitoxantrone; RNA, Messenger; Tumor Cells, Cultured; Vinblastine; Vincristine; Vindesine | 1989 |
Improvement of flow-cytometric detection of multidrug-resistant cells by cell-volume normalization of intracellular daunorubicin content.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Drug Resistance; Flow Cytometry; Humans; Leukemia; Mice; Predictive Value of Tests; Tumor Cells, Cultured | 1989 |
Inappropriate increase in erythropoietin titers during chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Erythropoietin; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 1989 |
Acute leukaemia during pregnancy.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Female; Humans; Infant, Newborn; Labor, Induced; Leukemia; Pregnancy; Pregnancy Complications, Neoplastic; Thioguanine | 1988 |
[New combination chemotherapy of adult acute nonlymphocytic leukemia].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Male; Methotrexate; Middle Aged; Prednisolone; Vincristine; Zinostatin | 1985 |
Daunorubicin in patients with relapsed and refractory acute nonlymphoblastic leukemia previously treated with anthracycline.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Male; Middle Aged; Naphthacenes; Neoplasm Recurrence, Local | 1988 |
Effects of verapamil on uptake and in vitro toxicity of anthracyclines in human leukemic blast cells.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Body Fluids; Cell Transformation, Neoplastic; Daunorubicin; Doxorubicin; Drug Resistance, Microbial; Drug Synergism; Humans; Intracellular Fluid; Leukemia; Middle Aged; Naphthacenes; Remission Induction; Verapamil | 1988 |
Phase I clinical trial of orally administered 4-demethoxydaunorubicin (idarubicin) with pharmacokinetic and in vitro drug sensitivity testing in children with refractory leukemia.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Daunorubicin; Drug Evaluation; Female; Heart; Humans; Idarubicin; Leukemia; Liver; Male; Tumor Stem Cell Assay | 1988 |
In vitro short-term sensitivity test for the prediction of response to chemotherapy in acute non-lymphocytic leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Cytarabine; Daunorubicin; Drug Screening Assays, Antitumor; Female; Humans; Leukemia; Male; Middle Aged; Time Factors; Uridine | 1988 |
Effects of clinical combinations of antileukemic drugs on DNA ligase from human thymocytes and normal, stimulated, or leukemic lymphocytes.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; DNA Ligases; Doxorubicin; Drug Screening Assays, Antitumor; Female; Humans; Kinetics; Leukemia; Lymphocytes; Male; Middle Aged; Polynucleotide Ligases; Prednisone; T-Lymphocytes; Vincristine | 1988 |
Sequential pilot studies of intensive postremission chemotherapy for acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia; Male; Middle Aged; Mitoxantrone; Pilot Projects; Thioguanine | 1987 |
Consolidation therapy without maintenance for acute non-lymphoblastic leukaemia.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Leukemia; Male; Middle Aged; Prognosis; Remission Induction; Retrospective Studies; Thioguanine; Time Factors | 1988 |
Mitoxantrone.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Daunorubicin; DNA; Drug Administration Schedule; Humans; Leukemia; Mitoxantrone | 1988 |
[Evaluation of peak filling rate for the early identification of daunorubicin cardiotoxicity].
Topics: Acute Disease; Aged; Blood Pressure; Daunorubicin; Diastole; Female; Heart Rate; Humans; Leukemia; Male; Middle Aged; Stroke Volume; Systole | 1988 |
Effects of cytochalasins and colchicine on the accumulation and retention of daunomycin and vincristine in drug resistant tumor cells.
Topics: Animals; Cell Line; Cell Survival; Colchicine; Cytochalasin B; Cytochalasin D; Cytochalasins; Daunorubicin; Drug Resistance; Humans; Leukemia; Leukemia P388; Leukemia, Myeloid, Acute; Mice; Verapamil; Vincristine | 1986 |
Oral idarubicin in adult acute leukemia: a preliminary experience.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Female; Humans; Idarubicin; Leukemia; Leukocyte Count; Male; Middle Aged | 1986 |
A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia.
Topics: Acute Disease; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Etoposide; Female; Humans; Leukemia; Male; Middle Aged; Nausea; Stomatitis; Vomiting | 1986 |
[Mucosal injury of aclacinomycin A in patients with adult acute leukemia--comparison of BH-AC. AMP therapy and BH-AC. DMP therapy].
Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Hemorrhage; Humans; Leukemia; Male; Mercaptopurine; Middle Aged; Mucous Membrane; Naphthacenes; Prednisolone; Urinary Bladder Diseases | 1986 |
Oral idarubicin in combination with cytosine-arabinoside in previously untreated patients with acute non-lymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Leukemia; Male; Middle Aged | 1986 |
[Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Aged; Blast Crisis; Child; Daunorubicin; Drug Evaluation; Drug Resistance; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Naphthacenes | 1986 |
Plasma and human leukemic cell pharmacokinetics of oral and intravenous 4-demethoxydaunomycin.
Topics: Administration, Oral; Daunorubicin; Humans; Idarubicin; Infusions, Intravenous; Kinetics; Leukemia | 1986 |
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromycin conjugates in vitro.
Topics: Acrylates; Animals; Cell Division; Cell Survival; Chemical Phenomena; Chemistry; Daunorubicin; Dose-Response Relationship, Drug; Humans; Leukemia; Leukemia L1210; Leukemia, Lymphoid; Methacrylates; Mice; Pharmaceutical Vehicles; Puromycin | 1987 |
Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancer.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Idarubicin; Infant; Leukemia; Metabolic Clearance Rate; Neoplasms | 1987 |
Daunorubicin versus aclarubicin in combination with cytarabine and thioguanine in elderly patients with acute nonlymphocytic leukemia, a preliminary report.
Topics: Aclarubicin; Acute Disease; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Male; Middle Aged; Naphthacenes; Thioguanine | 1987 |
Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Leukemia; Male; Middle Aged | 1987 |
Idarubicin in combination with etoposide and cytarabine in adult untreated acute non lymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Leukemia; Male; Middle Aged | 1987 |
[Importance of anthracyclines in infants in the treatment of acute lymphoblastic and non-lymphoblastic leukemias].
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Humans; Infant; Leukemia; Leukemia, Lymphoid; Prednisone; Risk; Vincristine | 1987 |
[Intensive polychemotherapy in the treatment of acute non-lymphoblastic leukemia: comparison of the prospective protocols DATOP/79 and DATOP/82].
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Male; Middle Aged; Prednisone; Thioguanine; Vincristine | 1987 |
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Humans; Leukemia; Middle Aged; Prognosis | 1987 |
High-dose cytosine arabinoside in the consolidation therapy of acute nonlymphocytic leukemia in remission.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Female; Humans; Leukemia; Male; Methotrexate; Methylprednisolone; Middle Aged | 1987 |
Patterns of anthracycline retention modulation in human tumor cells.
Topics: Bone Marrow; Breast Neoplasms; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Lung Neoplasms; Microscopy, Fluorescence; Neoplasms | 1987 |
Plasma levels of daunorubicin metabolites and the outcome of ANLL therapy.
Topics: Acute Disease; Biotransformation; Daunorubicin; Humans; Injections, Intravenous; Kinetics; Leukemia; Naphthacenes | 1987 |
Pediatric Oncology Group Study of in vitro clonal growth patterns of leukemic cells in childhood acute nonlymphocytic leukemia as a predictor of induction response.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Child; Clone Cells; Cytarabine; Daunorubicin; Dexamethasone; Humans; Leukemia; Prognosis; Remission Induction; Thioguanine; Tumor Stem Cell Assay; Vincristine | 1987 |
Serum zinc and copper as prognostic factors in acute nonlymphocytic leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Copper; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Male; Middle Aged; Prognosis; Remission Induction; Vincristine; Zinc | 1987 |
High-dose cytosine arabinoside, daunomycin and 6-thioguanine in relapsed or refractory acute nonlymphocytic leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Diseases; Cytarabine; Daunorubicin; Gastrointestinal Diseases; Humans; Leukemia; Recurrence; Remission Induction; Thioguanine | 1987 |
Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion.
Topics: Adolescent; Adult; Aged; Bone Marrow; Daunorubicin; Female; Flow Cytometry; Humans; Leukemia; Male; Middle Aged | 1987 |
Effects of verapamil on in vitro intracellular accumulation and retention of daunorubicin in blast cells from patients with acute nonlymphocytic leukemia.
Topics: Acute Disease; Animals; Bone Marrow; Daunorubicin; Drug Resistance; Humans; In Vitro Techniques; Kinetics; Leukemia; Leukemia P388; Mice; Stimulation, Chemical; Verapamil | 1986 |
Cellular pharmacokinetics of daunomycin administered as continuous intravenous infusion in the treatment of acute non-lymphocytic leukaemia.
Topics: Acute Disease; Daunorubicin; Humans; Kinetics; Leukemia | 1986 |
Comprehensive protective care in the management of acute leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cross Infection; Cytarabine; Daunorubicin; Humans; Leukemia; Middle Aged; Patient Care Planning; Prednisone; Thioguanine; Vincristine | 1986 |
High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology Group.
Topics: Aminoacridines; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Drug Resistance; Humans; Leukemia | 1985 |
Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Kinetics; Leukemia; Male; Middle Aged | 1985 |
Phase I-II evaluation of carminomycin in adults with acute leukemia.
Topics: Acute Disease; Adult; Aged; Carubicin; Daunorubicin; Drug Evaluation; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged | 1985 |
4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study.
Topics: Acute Disease; Adolescent; Adult; Daunorubicin; Drug Evaluation; Drug Resistance; Female; Humans; Idarubicin; Leukemia; Leukemia, Lymphoid; Male; Middle Aged; Pilot Projects | 1985 |
Epidural spinal cord compression as the initial finding in childhood acute leukemia and non-Hodgkin lymphoma.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Daunorubicin; Dexamethasone; Female; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Male; Prednisone; Spinal Cord Compression; Vincristine | 1985 |
Intravenous and oral demethoxydaunorubicin (NSC 256-439) in the treatment of acute leukemia and lymphoma: a pilot study.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Antineoplastic Agents; Daunorubicin; Female; Humans; Idarubicin; Injections, Intravenous; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Pilot Projects | 1985 |
Leukemia relapse in long-term survivors of acute leukemia.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Health Surveys; Humans; Infant; Japan; Leukemia; Leukemia, Lymphoid; Male; Mercaptopurine; Middle Aged; Nervous System Neoplasms; Prednisolone; Recurrence; Testicular Neoplasms | 1985 |
Idarubicin alone or in combination with cytarabine and etoposide (3 + 3 + 5 protocol) in acute non-lymphoblastic leukaemia.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Leukemia; Male; Middle Aged | 1985 |
A phase II study of mitoxantrone in acute leukemia.
Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Alanine Transaminase; Anthraquinones; Antineoplastic Agents; Child; Daunorubicin; Doxorubicin; Drug Evaluation; Drug Resistance; Electrocardiography; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukocyte Count; Male; Middle Aged; Mitoxantrone; Naphthacenes | 1985 |
Risk groups in a multicenter pilot study for treatment of acute lymphoblastic and acute undifferentiated leukemia in adults.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Daunorubicin; Humans; Leukemia; Leukemia, Lymphoid; Mercaptopurine; Methotrexate; Prednisone; Prognosis; Risk; Thioguanine; Vincristine | 1985 |
[Gastrointestinal symptoms of aclacinomycin A in patients with adult acute nonlymphocytic leukemia--comparison of BH-AC-DMP therapy and BH-AC-AMP therapy].
Topics: Aclarubicin; Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Digestive System; Female; Gastrointestinal Diseases; Humans; Leukemia; Male; Mercaptopurine; Naphthacenes; Prednisolone | 1985 |
Bone marrow response to chemotherapy in acute lymphocytic leukaemia and acute non-lymphocytic leukaemia.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Asparaginase; Bone Marrow; Bone Marrow Cells; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Humans; Leukemia; Leukemia, Lymphoid; Lymphocyte Depletion; Middle Aged; Plasma Cells; Prednisone; Thioguanine; Vincristine | 1985 |
Analysis of heterogeneity in daunorubicin uptake by human leukemia cells using laser flow cytometry.
Topics: Adolescent; Adult; Aged; Animals; Bone Marrow; Daunorubicin; Doxorubicin; Female; Flow Cytometry; Humans; In Vitro Techniques; Lasers; Leukemia; Leukemia P388; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mice; Middle Aged | 1985 |
Phase-I trial of 4-demethoxydaunorubicin in acute leukaemias.
Topics: Acute Disease; Adult; Antineoplastic Agents; Bone Marrow; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukemia; Male; Middle Aged | 1985 |
Preliminary results in secondary acute non-lymphocytic leukemia (ANLL) treated with Idarubicin.
Topics: Adult; Aged; Daunorubicin; Female; Humans; Idarubicin; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local | 1985 |
[High-dose treatment].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Doxorubicin; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Humans; Infusions, Parenteral; Leucovorin; Leukemia; Methotrexate; Neoplasms | 1985 |
Daunorubicin reductase activity in human normal lymphocytes, myeloblasts and leukemic cell lines.
Topics: Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Bone Marrow; Cell Line; Daunorubicin; Humans; Hydrogen-Ion Concentration; Isoelectric Focusing; Leukemia; Leukemia, Myeloid, Acute; Lymphocytes | 1985 |
[Thrombocyte replacement in hematologic diseases].
Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Blood Platelets; Blood Transfusion; Bone Marrow Transplantation; Child; Child, Preschool; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Doxorubicin; Fever; Hematologic Diseases; Hemorrhage; Histocompatibility; HLA Antigens; Humans; Leukemia; Leukemia, Myeloid, Acute; Middle Aged; Plateletpheresis | 1985 |
Results of therapy in adult acute nonlymphoblastic leukemia: experience in Jerusalem, Israel, during 1975-1982.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Israel; Leukemia; Middle Aged; Thioguanine; Time Factors | 1985 |
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot study.
Topics: Acute Disease; Adolescent; Adult; Aged; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia; Life Expectancy; Male; Middle Aged; Recurrence | 1985 |
Monitoring the remission induction therapy of acute nonlymphoblastic leukemia by bone marrow cell culture criteria.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cells, Cultured; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Humans; Leukemia; Monitoring, Physiologic; Thioguanine | 1985 |
Response of therapy-associated acute nonlymphocytic leukemia to intensive induction chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Leukemia, Radiation-Induced; Male; Middle Aged; Neoplasms; Prednisone; Prognosis; Thioguanine; Vincristine | 1985 |
High-dose cytosine arabinoside and daunomycin as primary therapy for adults with acute nonlymphoblastic leukemia: a pilot study.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Infections; Leukemia; Middle Aged | 1985 |
Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Humans; Infusions, Parenteral; Leukemia; Middle Aged; Thioguanine; Time Factors | 1985 |
Outcome of aggressive induction therapy in acute non-lymphocytic leukaemia.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Male; Mercaptopurine; Prednisolone; Vincristine | 1985 |
Treatment of acute nonlymphocytic leukemia in young and elderly patients.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Male; Middle Aged; Prognosis; Recurrence; Sex Factors; Vincristine | 1985 |
Cellular pharmacokinetics of daunorubicin: uptake by leukaemic cells in vivo and fate.
Topics: Adult; Aged; Daunorubicin; Female; Humans; Kinetics; Leukemia; Male; Middle Aged | 1985 |
[Cytostatics in hematology].
Topics: Antineoplastic Agents; Asparaginase; Cell Division; Chemistry; Culture Techniques; Cytarabine; Daunorubicin; Depression, Chemical; DNA; Drug Combinations; Drug Resistance; Germ-Free Life; Half-Life; History, 20th Century; Hodgkin Disease; Humans; Leukemia; Lymphatic Diseases; Mercaptopurine; Remission, Spontaneous; Stimulation, Chemical; Thioguanine | 1972 |
Apoptosis.
Topics: Binding Sites; Daunorubicin; DNA; Humans; Leukemia; Lymphoma | 1972 |
[Immature cell panmyelosis].
Topics: Acid Phosphatase; Adult; Antibiotics, Antineoplastic; Asparaginase; Blood Transfusion; Bone Marrow Examination; Daunorubicin; Drug Combinations; Esterases; Glucuronidase; Hematologic Diseases; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Male; Megakaryocytes; Methotrexate; Peroxidases; Prednisolone; Spleen; Staining and Labeling; Thrombocytopenia; Vincristine | 1973 |
Editorial: Adriamycin and the heart.
Topics: Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Heart; Heart Diseases; Humans; Leukemia; Myocardium | 1974 |
Value of the combined cytological and cytochemical classification in the management of acute childhood leukemia.
Topics: Bone Marrow Examination; Child; Child, Preschool; Daunorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Hematopoietic Stem Cells; Histocytochemistry; Humans; Infant; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Periodic Acid; Peroxidases; Prednisone; Prognosis; Remission, Spontaneous; Retrospective Studies; Staining and Labeling; Vincristine | 1974 |
[Acute undifferentiated leukemia--acute lymphocytic leukemia of adults. Differential diagnosis, prognosis, results of therapy].
Topics: Acute Disease; Adult; Age Factors; Aged; Aminosalicylic Acids; Asparaginase; Cytarabine; Cytodiagnosis; Cytoplasm; Daunorubicin; Diagnosis, Differential; Drug Therapy, Combination; Female; Glycogen; Histocytochemistry; Humans; Leukemia; Leukemia, Lymphoid; Male; Methotrexate; Middle Aged; Prognosis; Staining and Labeling; Vincristine | 1974 |
Adult acute leukaemia.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Cytosine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Humans; Injections, Intravenous; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Middle Aged; Prednisone; Remission, Spontaneous; Staining and Labeling; Thioguanine; Vincristine | 1974 |
[Therapy of acute leukoses].
Topics: Acute Disease; Adult; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infection Control; Leukemia; Life Expectancy; Male; Mercaptopurine; Methotrexate; Middle Aged; Patient Isolators; Prednisolone; Thioguanine; Time Factors; Vincristine | 1973 |
Daunomycin cardiac toxicity.
Topics: Cardiomegaly; Child; Child, Preschool; Daunorubicin; Drug Synergism; Heart; Heart Failure; Humans; Leukemia; Male; Radiography | 1973 |
[Trial treatment of acute leukemia and Hodgkin's disease with rubidomycin (or daunomycin) alone or in combination].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Child; Child, Preschool; Cortisone; Daunorubicin; Female; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Male; Middle Aged; Vincristine | 1967 |
Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood.
Topics: Adenocarcinoma; Age Factors; Child; Child, Preschool; Daunorubicin; Female; Hemangiosarcoma; Hodgkin Disease; Humans; Infant; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Neoplasm Recurrence, Local; Neoplasms; Neuroblastoma; Peritoneal Neoplasms; Sarcoma, Ewing; Teratoma; Testicular Neoplasms; Wilms Tumor | 1968 |
Effects of neopluramycin on ascites tumors implanted in experimental animals.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Daunorubicin; Female; Injections, Intraperitoneal; Leukemia; Liver Neoplasms; Male; Mice; Neoplasms, Experimental; Rats | 1971 |
[Attemp at treatment of acute leukemia and Hodgkin's disease by rubidomycin or daunomycin alone or combined].
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Cortisone; Daunorubicin; Drug Synergism; Female; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Middle Aged; Vincristine | 1967 |
The child with acute leukemia.
Topics: Age Factors; Asparaginase; Chickenpox; Child, Preschool; Counseling; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Daunorubicin; Drug-Related Side Effects and Adverse Reactions; Humans; Injections, Spinal; Leukemia; Mercaptopurine; Methotrexate; Patient Care Planning; Pediatrics; Physician-Patient Relations; Prednisone; Prognosis; Sex Factors; Vincristine | 1974 |
On the decrease curve of leukemic cells and the treatment of acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Asparaginase; Biphenyl Compounds; Daunorubicin; Female; Humans; Leukemia; Leukocyte Count; Male; Mercaptopurine; Mesylates; Methotrexate; Prednisolone | 1974 |
Increased efficiency of leukocyte collection by the addition of hydroxyethyl starch to the continuous flow centrifuge.
Topics: Alanine Transaminase; Alkaline Phosphatase; Bilirubin; Blood Bactericidal Activity; Blood Coagulation; Blood Coagulation Tests; Blood Donors; Blood Transfusion; Cell Separation; Daunorubicin; Ethanol; Humans; Leukemia; Leukocytes; Leukopenia; Liver Function Tests; Plasmapheresis; Starch | 1974 |
Daunorubicin-DNA: further clinical trials in acute non-lymphoblastic leukemia.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cytarabine; Daunorubicin; DNA; Drug Combinations; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Remission, Spontaneous; Vincristine | 1974 |
DCMP therapy in acute leukemia--the experimental and clinical study.
Topics: Acute Disease; Adult; Animals; Child; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Leukemia L1210; Mercaptopurine; Prednisolone; Time Factors | 1974 |
Adriamycin in the treatment of acute leukaemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Resistance; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission, Spontaneous | 1972 |
[Use of Adriamycin (NSC 123, 127, Farmitalia) in acute leukemias of childhood].
Topics: Acute Disease; Bone Marrow; Child; Daunorubicin; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Monocytic, Acute | 1972 |
[Clinical trial of chemotherapeutic combinations based on the notion of attempted cellular synchronization. Preliminary administration of an antimitotic followed by the use of cycle-dependent or phase dependent product(s)].
Topics: Amino Sugars; Anthraquinones; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Daunorubicin; DNA; Drug Combinations; Drug Tolerance; Female; Hodgkin Disease; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mitosis; Neoplasm Metastasis; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllum; Prednisone; Prognosis; Time Factors | 1972 |
[Effect of daunomycin and adriamycin in cytostatic combination therapy of acute leukoses of the adult].
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Blood Coagulation Disorders; Bone Marrow Diseases; Carbenicillin; Cytarabine; Daunorubicin; Drug Synergism; Female; Glycosides; Hair; Heart Diseases; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Prednisolone; Remission, Spontaneous; Skin Diseases; Vincristine | 1972 |
Acute leukemia presenting as a breast mass.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Biopsy, Needle; Breast Neoplasms; Child; Cytarabine; Daunorubicin; Diagnosis, Differential; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Menarche; Mercaptopurine; Methotrexate; Prednisolone; Sulfates; Vincristine | 1973 |
[Otitis and leukemia].
Topics: Adult; Antineoplastic Agents; Cytarabine; Daunorubicin; Ear Neoplasms; Gentamicins; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Otitis; Otitis Externa; Punctures | 1973 |
Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Cytarabine; Daunorubicin; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; London; Middle Aged; Prednisolone; Remission, Spontaneous; Thioguanine | 1973 |
Eosinophilic leukaemia.
Topics: Aged; Chromosome Aberrations; Daunorubicin; Diagnosis, Differential; Eosinophils; Female; Humans; Leukemia; Leukemia, Myeloid | 1973 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Daunorubicin; Disease Models, Animal; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Hodgkin Disease; Humans; Leukemia; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Mechlorethamine; Melphalan; Mice; Mice, Inbred AKR; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Remission, Spontaneous; Vinblastine; Vincristine | 1974 |
Adult acute leukaemia--a suitable case for treatment?
Topics: Acute Disease; Adult; Aged; Agranulocytosis; Anemia; Blood Platelet Disorders; Blood Transfusion; Bone Marrow Diseases; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Acute; Male; Middle Aged; Mouth Diseases; Ulcer | 1973 |
Eventual control of clinical leukemia.
Topics: Administration, Oral; Africa; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Injections, Spinal; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Methotrexate; Prednisone; United States; Vincristine | 1973 |
[Therapeutical induced cytochemical changes in acute leukemia].
Topics: Adolescent; Adult; Aminosalicylic Acids; Asparaginase; Blood Cells; Bone Marrow; Bone Marrow Cells; Daunorubicin; Diagnosis, Differential; Doxorubicin; Esterases; Histocytochemistry; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Methotrexate; Middle Aged; Peroxidases; Prednisolone; Thioguanine; Vincristine | 1974 |
Agar culture studies in 127 cases of untreated acute leukemia: the prognostic value of reclassification of leukemia according to in vitro growth characteristics.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Bone Marrow; Bone Marrow Cells; Cell Division; Cells, Cultured; Child; Clone Cells; Cytarabine; Daunorubicin; Densitometry; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Middle Aged; Prognosis; Remission, Spontaneous; Vincristine | 1974 |
Proceedings: Treatment of acute leukaemia in adults.
Topics: Acute Disease; Adult; Allopurinol; Anti-Bacterial Agents; Bacterial Infections; Child; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Metabolic Diseases; Prednisone; Remission, Spontaneous; Thioguanine; Uric Acid; Vincristine | 1974 |
Prognosis of acute leukaemia in adults.
Topics: Acute Disease; Adult; Age Factors; Antineoplastic Agents; Child; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Middle Aged; Prednisolone; Prognosis; Remission, Spontaneous; Thioguanine; Vincristine | 1974 |
The treatment of acute leukemia.
Topics: Adolescent; Adult; Antimetabolites; Antineoplastic Agents; Asparaginase; Body Weight; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Gestational Age; Humans; Infant; Infant, Newborn; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Prednisone; Pregnancy; Remission, Spontaneous; Time Factors; Vincristine | 1974 |
Comparative results obtained in the treatment of acute leukemia.
Topics: Antineoplastic Agents; Asparaginase; Carmustine; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Meningitis; Methotrexate; Prednisone; Thioguanine; Vincristine | 1973 |
Treatment of the acute leukemias.
Topics: Adjuvants, Immunologic; Asparaginase; Bacterial Vaccines; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Synergism; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Mycobacterium bovis; Prednisone; Remission, Spontaneous; Thioguanine; Vincristine | 1972 |
[Chromosomal damage in human lymphocyte cultures following treatment with rubomycin C].
Topics: Adolescent; Adult; Cells, Cultured; Chromosome Aberrations; Daunorubicin; Female; Humans; Leukemia; Lymphatic Diseases; Lymphocytes; Lymphoma, Large B-Cell, Diffuse; Male | 1972 |
Influence of chemotherapeutic agents on the antibacterial activity of normal and leukemic sera.
Topics: Antineoplastic Agents; Blood Bactericidal Activity; Carmustine; Cell Membrane; Complement System Proteins; Cyclophosphamide; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Escherichia coli; Fluorouracil; Humans; Immunoglobulins; Leukemia; Mechlorethamine; Methotrexate; Microbial Sensitivity Tests; Muramidase; Prednisone; Vincristine | 1974 |
Cell proliferation in the "preleukaemic" phase of acute leukaemia. A cytophotometric and autoradiographic study.
Topics: Acute Disease; Adolescent; Anemia, Sideroblastic; Autoradiography; Blood Transfusion; Bone Marrow; Bone Marrow Cells; Bone Marrow Examination; Cryptococcosis; Daunorubicin; DNA; Erythropoiesis; Humans; Leukemia; Male; Megakaryocytes; Photometry; Precancerous Conditions; Prednisone; Thymidine; Tritium; Vincristine | 1972 |
[The role of cytarabine in polychemotherapy of leukemia].
Topics: Asparaginase; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Synergism; Female; Humans; Leukemia; Male; Nitrosourea Compounds; Thioguanine; Vincristine | 1972 |
[Preliminary results of cytosine arabinoside therapy in various chemotherapeutic combinations in acute leukemias].
Topics: Acute Disease; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; Drug Interactions; Drug Synergism; Humans; Leukemia; Mercaptopurine; Prednisone; Thioguanine | 1972 |
[Quadruple combination chemotherapy of acute leukemia using daunomycin, cytosine arabinoside, 6-mercaptopurine riboside and prednisolone].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Cytarabine; Daunorubicin; Humans; Injections, Intravenous; Leukemia; Mercaptopurine; Middle Aged; Prednisolone | 1972 |
[Relationship between parameters of cell proliferation in acute human leukemia and the effect on those cells of antileukemic drugs in vivo].
Topics: Acute Disease; Animals; Autoradiography; Blood Transfusion, Autologous; Bone Marrow; Bone Marrow Cells; Cell Division; Cell Survival; Chickens; Daunorubicin; DNA; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia; Leukocytes; Lymphocytes; Mitosis; Neoplastic Cells, Circulating; Thymidine; Tritium; Ultraviolet Rays; Vincristine | 1972 |
Cecal necrosis and perforation with systemic chemotherapy.
Topics: Adult; Asparaginase; Breast Neoplasms; Cecal Diseases; Child; Cytarabine; Daunorubicin; Female; Fluorouracil; Humans; Intestinal Perforation; Leukemia; Male; Mercaptopurine; Methotrexate; Middle Aged; Necrosis; Prednisone; Thioguanine; Vincristine | 1973 |
Effect of L-asparaginase therapy upon some indices of protein metabolism in leukemic patients.
Topics: Acute Disease; Adult; Amino Acids; Asparaginase; Blood Proteins; Ceruloplasmin; Cholesterol; Cholinesterases; Cyclophosphamide; Daunorubicin; Enzyme Activation; Factor XIII; Female; Fibrinogen; Humans; Leukemia; Lipids; Lipoproteins; Male; Plasminogen; Vincristine | 1973 |
The effects of leukemia and lymphoma chemotherapy on hematopoietic cells.
Topics: Alkylating Agents; Antimetabolites; Antineoplastic Agents; Asparaginase; Cell Division; Daunorubicin; Glucocorticoids; Hematopoiesis; Hematopoietic Stem Cells; Humans; Hydroxyurea; Leukemia; Lymphoma; Procarbazine; Vinblastine; Vincristine | 1973 |
[Polychemotherapy of acute leukemias in children and young persons].
Topics: Acute Disease; Adolescent; Ambulatory Care; Antineoplastic Agents; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Immunotherapy; Leukemia; Mercaptopurine; Methotrexate; Prednisolone; Vincristine | 1973 |
[Cardiac toxicity of rubidomycin. Apropos of 2 cases].
Topics: Child; Daunorubicin; Electrocardiography; Female; Heart; Heart Diseases; Humans; Leukemia | 1973 |
[Combination chemotherapy with cytosine arabinoside and daunomycin in childhood acute leukemia].
Topics: Acute Disease; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Infant; Leukemia; Male | 1973 |
Letter: DNA-daunorubicin complex: preliminary trials in human leukaemia.
Topics: Adult; Aged; Child, Preschool; Daunorubicin; DNA; Drug Combinations; Female; Humans; Leukemia; Male; Middle Aged | 1973 |
Childhood leukaemia presenting in the central nervous system.
Topics: Autopsy; Brain Neoplasms; Child; Child, Preschool; Daunorubicin; Humans; Leukemia; Male; Mercaptopurine; Neoplasm Metastasis; Prednisone; Time Factors; Vincristine | 1973 |
An analysis of the relationship of leukemic cell kinetics to chemotherapy.
Topics: Bone Marrow; Bone Marrow Cells; Cytarabine; Daunorubicin; DNA; Drug Therapy, Combination; Hematopoietic Stem Cells; Humans; Kinetics; Leukemia; Methotrexate; Mitosis; Prednisone; Thymidine; Tritium; Vincristine | 1973 |
Effect of cytostatic drugs on the kinetics of leukemic blast cells in man.
Topics: Antineoplastic Agents; Asparaginase; Bone Marrow; Bone Marrow Cells; Cell Division; Cytarabine; Daunorubicin; DNA, Neoplasm; Drug Therapy, Combination; Humans; Leukemia; Methotrexate; Mitosis; Prednisone; Spectrophotometry; Thymidine; Time Factors; Vincristine | 1974 |
Proceedings: Triple chemotherapy in acute non-lymphocytic leukaemia.
Topics: Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Vincristine | 1974 |
Local experience in the treatment of acute non-lymphoblastic leukaemia.
Topics: Acute Disease; Adult; Antineoplastic Agents; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia; Mercaptopurine; Middle Aged; Prednisone; Remission, Spontaneous; Retrospective Studies; Vincristine | 1974 |
Management of acute non-lymphocytic leukaemia.
Topics: Acute Disease; Age Factors; Cytarabine; Daunorubicin; Female; Humans; Injections; Leukemia; Male; Methods; Prognosis; Remission, Spontaneous; Time Factors; Vincristine | 1974 |
Comparative effect of daunomycin and adriamycin on nucleic acid metabolism in leukemic cells in vitro.
Topics: Chromatography, Thin Layer; Daunorubicin; DNA; DNA Nucleotidyltransferases; Doxorubicin; Enzyme Activation; Humans; Leukemia; Nucleic Acids; RNA | 1974 |
Preliminary evaluation of daunomycin in children with acute leukemia.
Topics: Child; Daunorubicin; Humans; Leukemia | 1967 |
Current status: treatment of acute leukemia.
Topics: Acute Disease; Asparaginase; BCG Vaccine; Bone Marrow Transplantation; Daunorubicin; Drug Synergism; Humans; Immunity, Cellular; Immunization, Passive; Leukemia; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1970 |
Observations on toxicity and clinical trials with daunomycin.
Topics: Adult; Animals; Child; Daunorubicin; Dogs; Haplorhini; Humans; Injections, Intravenous; Leukemia; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mice; Neoplasms; Neuroblastoma | 1967 |
[Studies of leukemia therapy with daunomycin].
Topics: Daunorubicin; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid | 1967 |
[Behavior of the serum lactate dehydrogenase in leukemic children treated with daunomycin].
Topics: Child; Child, Preschool; Daunorubicin; Female; Humans; L-Lactate Dehydrogenase; Leukemia; Leukocytes; Male | 1968 |
[Daunoblastine in the treatment of leukemias and lymphoreticular neoplasms].
Topics: Daunorubicin; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Waldenstrom Macroglobulinemia | 1969 |
[Clinical usefulness of eticholanolone in the evaluation of bone marrow reserves in patients treated with myelosuppressive drugs and with radiotherapy].
Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Bone Marrow Diseases; Bone Marrow Examination; Busulfan; Chlorambucil; Cortisone; Daunorubicin; Etiocholanolone; Female; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Leukocyte Count; Male; Mercaptopurine; Radiation Effects; Vinblastine | 1969 |
[Results obtained with the clinical use of adriamycin].
Topics: Adult; Aged; Amino Sugars; Antibiotics, Antineoplastic; Daunorubicin; Female; Glycosides; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Naphthacenes; Neoplasms; Plasmacytoma; Remission, Spontaneous | 1971 |
[Conbined treatment with rubidomycin and vincristine in acute leukemia in children].
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Daunorubicin; Drug Synergism; Female; Humans; Leukemia; Male; Vincristine | 1972 |
[Polychemotherapy of acute leukemias in children and adolescents].
Topics: Acute Disease; Adolescent; Age Factors; Antineoplastic Agents; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Glucocorticoids; Humans; Leukemia; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1972 |
Immunoglobulins during the course of acute leukemia in children. Effects of various clinical factors.
Topics: Acute Disease; Adolescent; Agammaglobulinemia; Antibody Formation; Antineoplastic Agents; Blood Transfusion; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulins; Immunosuppressive Agents; Infant; Infections; Leukemia; Male; Mercaptopurine; Methotrexate; Prednisone; Serum Albumin | 1971 |
[The daunomycin-L-asparaginase conbination in the treatment of infantile acute leukemia].
Topics: Acute Disease; Asparaginase; Child, Preschool; Daunorubicin; Female; Humans; Injections, Intravenous; Leukemia | 1971 |
[In vitro proliferation of leukemic blast cells and response to daunorubidomycin-cytosine arabinoside].
Topics: Autoradiography; Bone Marrow; Bone Marrow Cells; Cell Count; Cytarabine; Daunorubicin; Humans; Leukemia; Muramidase; Thymidine; Tritium | 1971 |
[Chemotherapy of acute leukemia].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Thrombocythemia, Essential; Vincristine | 1967 |
Summary: recent advances in the treatment of acute leukemia and Burkitt's tumor.
Topics: Antineoplastic Agents; Asparaginase; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Nitroso Compounds; Prednisone; Urea; Vincristine | 1967 |
Daunomycin--preliminary results of the treatment of acute leukemias in adults.
Topics: Adolescent; Adult; Aged; Daunorubicin; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Prednisone | 1968 |
[Rubidomycin-daunomycin, a new antibiotic with antineoplastic effect].
Topics: Animals; Antibiotics, Antineoplastic; Biological Assay; Chemical Phenomena; Chemistry; Daunorubicin; DNA; Drug Synergism; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Neoplasms, Experimental; Pregnancy; Pregnancy, Animal; RNA | 1968 |
Chemotherapeutic goals in acute leukemia.
Topics: Acute Disease; Antineoplastic Agents; Daunorubicin; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Prednisone | 1969 |
Daunorubicin in the treatment of adult acute leukaemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Chromosome Aberrations; Daunorubicin; Female; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Prednisolone; Thrombocytopenia; Vincristine | 1970 |
[Treatment of acute leukemia: current perspectives and relative curability].
Topics: Acute Disease; Adolescent; Adult; Asparaginase; Child; Child, Preschool; Daunorubicin; Female; Humans; Leukemia; Leukemia, Lymphoid; Male; Patient Isolators; Prognosis | 1970 |
Vincristine, prednisone, and daunomycin in acute leukemia of childhood.
Topics: Acute Disease; Adolescent; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Child; Daunorubicin; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukocyte Count; Prednisone; Vincristine | 1971 |
[Round table conference--present status and the future of treatment of leukemia].
Topics: Acute Disease; Asparaginase; Cytarabine; Daunorubicin; Glutaminase; Humans; Leukemia; Leukemia, Myeloid; Vinblastine; Vincristine | 1971 |
[Meningeal leukemia--report of an adult case].
Topics: Betamethasone; Bone Marrow Examination; Candidiasis; Daunorubicin; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Meninges; Meningitis; Mercaptopurine; Methotrexate; Middle Aged; Remission, Spontaneous | 1971 |
[Therapy of acute leukemia. 4. Remission induction and remission maintenance therapy].
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Asparaginase; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Mercaptopurine; Methotrexate; Middle Aged; Remission, Spontaneous; Vincristine | 1971 |
[Therapeutic results with daunomycin-vincristine-prednisolone in acute leucoses].
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents; Daunorubicin; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukopenia; Male; Middle Aged; Prednisolone; Thrombocytopenia; Vincristine | 1971 |
DNA synthesis in leukemic cells under the action of cytotoxic agents in vitro and in vivo.
Topics: Adult; Aged; Antineoplastic Agents; Cells, Cultured; Cytarabine; Daunorubicin; DNA, Neoplasm; Female; Glucocorticoids; Humans; In Vitro Techniques; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocytes; Male; Methotrexate; Middle Aged; Prognosis; Thymine Nucleotides; Tritium | 1971 |
Result of a cooperative study with L-asparaginase in human leukemias. Report of the section "oncology" of the Paul-Ehrlich-Society for Chemotherapy.
Topics: Asparaginase; Blood Chemical Analysis; Blood Platelets; Blood Sedimentation; Body Weight; Central Nervous System Diseases; Daunorubicin; Erythrocyte Count; Hepatomegaly; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Nausea; Splenomegaly; Time Factors; Vincristine; Vomiting | 1970 |
Treatment of acute leukemia with L-asparaginase--preliminary results on 84 cases.
Topics: Acute Disease; Asparaginase; Asparagine; Blood Coagulation Disorders; Cells, Cultured; Central Nervous System Diseases; Chemical and Drug Induced Liver Injury; Daunorubicin; Humans; Kidney Diseases; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Liver Function Tests; Methotrexate; Prednisone; Valine; Vincristine | 1970 |
Comparison of CNS-leukaemia in children with acute leukaemia, induced either with rubidomycin or L-asparaginase.
Topics: Asparaginase; Central Nervous System Diseases; Child; Child, Preschool; Daunorubicin; Drug Therapy, Combination; Female; Humans; Infant; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Methotrexate; Neoplasm Metastasis; Prednisolone; Remission, Spontaneous; Vincristine | 1971 |
[Induction and interval treatment of leukemias in children and juveniles].
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Central Nervous System Diseases; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Injections, Intravenous; Leukemia; Male; Meninges; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1969 |
[Progress in the treatment of acute leukemias].
Topics: Antineoplastic Agents; Asparaginase; Cytarabine; Daunorubicin; Humans; Leukemia; Prednisone; Vincristine | 1969 |
[Acute leukemia].
Topics: Acute Disease; Asparaginase; Cytarabine; Daunorubicin; Humans; Leukemia | 1970 |
Combinations, schedules, and new agents for the chemotherapy of acute leukemia.
Topics: Acute Disease; Adult; Antineoplastic Agents; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Leukemia; Leukemia, Lymphoid; Mercaptopurine; Methotrexate; Nitroso Compounds; Prednisone; Urea; Vincristine | 1970 |
Chemotherapy for leukemia and lymphoma.
Topics: Antineoplastic Agents; Asparaginase; Cyclophosphamide; Daunorubicin; Humans; Leukemia; Lymphoma; Vincristine | 1970 |
[New cytostatics in the treatment of acute leukemias in childhood].
Topics: Acute Disease; Aminopterin; Antineoplastic Agents; Asparaginase; Child; Cortisone; Cyclophosphamide; Cytarabine; Daunorubicin; Evaluation Studies as Topic; Humans; Leukemia; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1970 |
[Findings on the effect of acute-toxic cytostatics].
Topics: Animals; Cardiovascular System; Cricetinae; Daunorubicin; Dogs; Electrocardiography; Hominidae; Leukemia; Mice; Nervous System; Sulfates; Vincristine | 1971 |
[Clinical evaluation of daunomycin in the therapy of leukemias. (Preliminary note)].
Topics: Adult; Aged; Daunorubicin; Humans; Leukemia; Male; Middle Aged | 1967 |
[Daunomycin and rubidomycin (new antiblastic drugs)].
Topics: Animals; Daunorubicin; Humans; Leukemia; Neoplasms | 1967 |
Clinical study of daunomycin (NSC-82151) in children with acute leukemia.
Topics: Bone Marrow; Child; Child, Preschool; Daunorubicin; Female; Humans; Infant; Injections, Intravenous; Leukemia; Male; Prednisone | 1968 |
[Clinical evaluation of daunomycin combined with vincristine and prednisone in the treatment of acute leukemias].
Topics: Acute Disease; Adult; Child; Daunorubicin; Humans; Leukemia; Prednisone; Vincristine | 1968 |
[Therapy of acute leukemia in childhood with the new association of daunomycin, vincristine and prednisone].
Topics: Child; Child, Preschool; Daunorubicin; Female; Humans; Leukemia; Male; Prednisone; Vincristine | 1969 |
[Daunoblastin--antibiotic with cytostatic effect].
Topics: Adult; Antibiotics, Antineoplastic; Child; Daunorubicin; Hodgkin Disease; Humans; Injections, Intravenous; Leukemia | 1969 |